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Abstract 
The pharmaceutical formulator has a problem of setting up many variables that influence 
conflicting dosage form properties. The formulator should aim to get towards the optimum 
properties of pharmaceuticals. One should arrive at this optimum point in a minimum 
number of experiments to save time and money. To address this problem mathematical 
optimisation techniques and expert systems have been utilised. In general, work in the area 
of mathematical optimisation techniques has focused on primarily the regression model to 
address this problem. Recent work has suggested the ANN as a better model for 
optimisation of formulation variables. The comparison between ANN and regression has 
traditionally favoured the former model (e. g. Hussain et al., 1991). This work examines the 
statistical basis of these earlier works and advances upon them. 
The use of ANN and regression to model tablet properties was examined in the first study. 
Several problems were examined. It is apparent that the use of different validation methods 
will give different results. It was not possible to reduce the number of validation 
experiments by training ANN on all the data, measuring error and deciding from that value 
the best ANN topology. This study also suggests that scaling the data is critical for effective 
learning in ANN, The same data used in the first study was used in the following one. For 
improving ANN predictive ability different training methods were used apart from simple 
backpropagation. It was shown it is worth using different training methods since the 
predictive ability improves. After this comprehensive work was done, the best ANN 
models were compared with the predictive ability of the best regression models of the first 
study. This comparison was extensive and various aspects were examined like, if ANN 
predictive ability is better than regression, is this statistically significant? Which method 
predicts better the extreme values of the responses? Is ANN predictive ability more 
susceptible to the response value than regression? Does the predictive ability of ANN 
improve if modelling each response one at a time-thus reducing ANN 
complexity-minstead of all responses simultaneously? The answers to these questions are 
complex and are addressed in the thesis. The same questions were tackled in the next study 
on limited data. As opposed to the tablet properties study, this study on capsules dealt with 
experiments that were not well designed, so the data was limited. Indeed, ANN and 
regression models succeeded in predicting only 5 out of the 9 response variables. This 
study showed that the answer to the question - is it worth modelling an ANN one response 
at a time depends on the system the ANN tries to model. In these 3 studies there was 
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different emphasis on the ANN variables manipulated. 
The following study took the raw data from the tablets study. Multiobjective optimisation 
was done after ANN was trained. The optimisation was for two conflicting responses of 
disintegration time and friability. The computer generated a solution that tried to satisfy the 
two responses. This solution was achieved using an optimisation method that incorporates 
ANN with the Goal Attainment method. This new multiobjective optimisation algorithm 
runs successfully on the computer. In order to solve tablet formulation problems an expert 
system was developed. It demonstrates how ANN/Regression models are used through the 
process of data collection and decision making in the field of tablet formulation. The expert 
system that was generated in this study, apart from modelling and optimisation tools, also 
incorporates database and heuristic rules in one application called Expha expert system. 
Do ANN predict better than regression? The answer to this depends on the aspect of 
comparison studied. It is not possible to state categorically whether ANN or regression is 
better. 
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1. Introduction 
1.1 Statement of the problem 
Formulation development is a problem that has been of concern to pharmaceutical 
researchers since the early days of pharmaceutical industry. The problem is now even more 
challenging since the regulatory authorities enforce that the pharmaceutical product 
complies with the limits of the pharmacopoeia. The pharmaceutical formulator has a 
problem of coping with the many variables that influence dosage form properties often in a 
conflicting manner. For example, a common problem is that a tablet has to disintegrate 
quickly and be fast dissolving yet must be hard enough to remain intact before ingestion. If 
the formulator considers just the hardness the compaction force is increased and the tablet 
made harder but it may not be fast dissolving. The formulator should aim to get the 
optimum properties of a pharmaceutical formulation. The formulator should arrive at this 
optimum point in a minimum number of experiments to save time and money. He/she has 
to evolve towards the tablet formulation solution with a path that maintains the knowledge 
acquired. This will prevent the situation where there is no solution on the horizon after 
conducting many experiments. This removal of uncertainty regarding experiments is critical 
when submitting a research proposal to the management. Another issue is that there is a 
loss of expertise due to formulators moving from one place to another or retirement. This 
raises the problem of how to retain pharmaceutical formulation knowledge. 
To address these problems mathematical optimisation techniques and expert systems have 
been developed. However, in pharmaceuticals the use of these techniques is relatively new 
and there are many questions that still remain to be resolved. Which of the modelling 
techniques regression or Artificial Neural Networks (ANN) should be used? How should 
one validate the model that describes the pharmaceutical problem? What criterion to 
employ in identifying the superior model? How should one decide that the chosen model is 
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adequate? Is an ANN better than regression for modelling of pharmaceutical formulation 
problems? How should one compare these two modelling techniques? What is the best 
optimisation method? Are expert systems effective or likely to be effective in 
pharmaceutical development and how do ANN and regression models relate to them? 
Some of these aspects have been discussed in previous works (all of them were addressed 
in this study). There were however important questions still to be addressed like how to 
compare ANN and regression, or how to decide whether a model has genuine predictive 
ability. In addition, this study examined critically studies related to the problems of solving 
the questions presented earlier. Ibis study proposes methodology for choosing the best 
model that describes the data. The method developed was implemented for the tablet 
formulation process in this work by developing Expha, an expert system. Another goal was 
to incorporate the two domains of pharmaceutical knowledge and data modelling into one 
coherent application. 
In this introduction the need for modelling, optimisation and expert systems will be 
discussed. Afterwards, there will be a quick review of regression and ANN methodologies. 
Ile similarities and differences between these methodologies will be examined. Then the 
development of expert systems and associated literature will be reviewed. Next, the 
applications of these techniques in pharmaceutical development will be reviewed. Then, 
issues brought about by differences between this study and others, and the contribution of 
this study will be discussed. The final part will describe the structure of the thesis. 
1.2 The need for modelling, optimisation and expert 
systems 
The pharmaceutical formulator whether aware of it or not is using three basic elements: 
Heuristic rules, a database and an optimisation based on data modelling. A typical 
formulator may use their memory to remember many excipients and their advantages and 
limitations. They may also use articles and computerised databases. The use of heuristic 
rules gathered and developed through expertise are called rules of thumb. Usually, the rules 
are remembered and the formulator is not always aware that these serve as a guide when a 
new formulation is invented. These two steps are invoked automatically by the formulator 
each time a new formulation is prepared. 'Me prepared formulation is tested and response 
variables like time to dissolve and hardness are measured. If the result does not satisfy the 
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requirements, a change in quantities of excipients or process variables with a trial and error 
approach is adopted. The formulator might also build up a model by gathering the 
information from experiments designed to help build the model. The model that is built will 
give suggestions for a better formulation. The latter part belongs to the optimisation part. 
Upon trying to simplify the problem further there are two distinct domains in the 
formulation problem. They are the pharmaceutical knowledge base of the problem that is 
the database part, e. g. interactions of the drug with certain excipients, and the heuristic 
rules. The second part is the modelling which is statistical in its nature. The problem with 
the first part is that the formulator may either not be aware of certain aspects that are 
documented in the literature, or might forget to look at the recommended concentration of 
the excipient and/or its interactions with the drug. The formulator might stick to a certain 
pattern of making the formulation without considering a new method of formulation with a 
completely different range of excipients. It is quite a common problem that people want to 
be on the safe side which not only produces inferior formulations relative to what could be 
achieved, but also presents a problem that can only be solved with considerable difficulty 
with their limited knowledge. On the statistical part of building up a model they might be 
afraid to touch the subject and prefer to avoid it. Another possibility is that they may misuse 
the statistical tool of data modelling. Even the most qualified formulator who keeps up to 
date on new materials has a problem of remembering and implementing all their knowledge 
about formulation. Remembering could mean just remembering to look in the correct book 
for the relevant information; or to remember some previously-read important information 
regarding a certain excipient that is being used in the present formulation. 
The problem is that to achieve a better formulation the formulator has to spend more time 
in investigating the formulation problem. In general, formulators lack methodologies or 
tools that will allow them to save time, or to enable them to solve formulation problems that 
they did not succeed in solving before. Saving time means not simply because with the new 
approach the new formulation is developed faster but because the better formulation that is 
generated may stay a longer time on the market until there is a need to change it to new 
requirements. A common example is disintegration of tablets. As there is a relationship 
between disintegration rate and dissolution rate, tablets were in the past optimised to 
achieve fast disintegration and so were able to achieve the desired dissolution. The tablet 
formulations optimised in this manner may be perrnissible according to a new 
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pharmacopocia without any changes in their formulation. 
1.3 Regression analysis 
ANN and regression analysis are both used in analysing results of pharmaceutical 
experimentation. The ability of ANN and regression analysis to characterise experimental 
relationships makes them useful in the process of optimisation of pharmaceutical 
formulations. Both of them are used to describe functions of the response variables. The 
response variables are often termed the dependent variables (Ys). The arguments of these 
functions are the independent variables (Xs). Reverting to the example in Section 1.1, 
disintegration time and hardness are dependent variables, whereas the amounts of 
disintegrant and lubricant are the independent variables. The researcher can control the 
independent variables and by varying them can influence the response or dependent 
variables. 
Regression will be discussed here very briefly. The reader who wants comprehensive 
foundation to this subject should consult Draper & Smith's book (Draper & Smith, 1987). 
The reader who wants more specific information to the current domain about regression 
and design of experiments could find help in Armstrong & James book (Armstrong & 
James, 1996). Regression is a statistical technique and is a process of finding a 
mathematical model (an equation) that best fits the data (Mendenhall & Sincich, 1996). The 
regression equation is fitted to the data according to the least squares method. The least 
squares line is one that satisfies the property: 
That the sum of squares error (SSE), F-(YpmdicW - Yobwmed)29 is smaller than any other line. 
In more simple terms, if one wants to draw a linear (straight) regression line manually he 
will draw a line that seems to him the closest one to the data points. The mathematical 
description of the line is the regression equation. Surprising as it may seem, beginning the 
analysis of data by drawing a line manually can prevent errors. The human eye captures the 
overall trend of the data ignoring outliers. Whereas if someone does this simple line with a 
computer, they will often get a line that does not represent the data trend, since the 
computer takes into account all data points if not programmed specifically to do otherwise. 
Regression is used in many fields. From the various fields of life sciences to areas that are 
considered less scientific like economics. In economics it may be used to predict how 
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investment in advertisement will influence sales. Sometimes this tool is used in a biased 
way and subjective conclusions are derived that can often be read in the daily newspapers. 
For example, a woman getting married when pregnant will probably suffer financial 
problems. In this case only one parameter was measured (x) whether the woman was 
pregnant when she was married and the response (y) that was measured was the woman's 
economic state after a few years. The layman may think that if his/her daughter gets 
married when she is pregnant probably she will suffer from poverty. However, he should 
not jump to the latter conclusion, since a correlation does not imply a causal relationship. 
The order of a regression model is an important issue necessary to understand which 
models were built in this study. This approach presented here to model order is quite 
common (Mendenhall & Sincich, 1996; Biles & Swain 1980; Box et al., 1978). A first 
order model is a straight line model with the following equation as an example: 
y= ao + aj*xj + a2*X2 + a3*X3. 
The three xj variables stand for the independent variables being manipulated, ao the 
equation intercept and the other ai values are the regression parameters and these four 
values calculated by the least-square method. A second order model of three independent 
variables will look like: 
222 y= ao + ai*xi + a2*X2 + a3*X3 + a4*XI*X2 + a5*xl*x3 + a6*X2*X3 + a7*XI + as*X2 + ag X3 
Notice that the interaction term x, * x2 * x-; is not included since it is considered as third 
order term. To summarise, the order of model is according to the maximum power of the 
independent variables, or the maximum number of independent variables multiplied with 
each other in the regression equation. 
Variable selection is a method of controlling the way in which variables are entered into and 
removed frorn, the regression equation. The criteria for selection of variables is the 
probability of F denoted by the letter p (F is a type of distribution). The p-value is used 
extensively in statistical tests (used frequently in this study) and is also called 'the observed 
significance level'. When a statistical test is conducted the p-value is the probability of 
observing a value of the test statistic at least as contradictory to the null hypothesis as the 
observed value of the test statistic, assuming the null hypothesis is true (Mendenhall & 
Sincich, 1996). In other words, when the p-value is 0.05 then there are about 5 chances in 
100 that we would reject the null hypothesis although it is the true hypothesis. We are about 
95% confident that we have made the right decision. In regression, the null hypothesis 
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which is tested regarding each coefficient is that its value is zero and as such is not 
contributing to the prediction of the response variable, i. e. if the p-value of regression 
coefficient is less than the confidence level decided (typical value is 0.05), then the null 
hypothesis can be rejected. 
Three different methods can be used for building the regression equation: 
1. Choose the order of the regression equation without any selection of variables. 
2. Stepwise regression: selection of variables proceeds by steps. At each step, variables 
already in the equation are evaluated according to the selection criteria for removal; also 
variables not in the equation are evaluated for entry. This process is repeated until no 
variable is eligible for entry or removal. 
3. Backward elimination: all variables that are in the equation are evaluated according to the 
selection criteria for removal. Those eligible are removed one at a time until no more are 
eligible (Norusis, 1997) 
Generally, stepwise regression is considered to be the best way of variable selection. It is 
better than backward elimination because it is possible to consider starting with a very big 
model in which the number of coefficients is bigger than the number of data points. 
Whereas in backward elimination one is limited by the fact that the number of coefficients 
in the starting model cannot exceed the number of data points. Hence, the number of 
models that the stepwise regression model checks in the variable selection procedure can be 
much higher. Nevertheless, in reality one does not know from the beginning which method 
of variable selection is appropriate. And the reason for this is the fact that the disadvantage 
of a method like stepwise regression is the big number of statistical tests that are conducted 
in each of which, it is possible that an error may be made. 
1.4 ANN 
ANN are networks of adaptable nodes which through the process of learning from task 
examples store experimental knowledge and make it available to use (Aleksander & 
Morton, 1995). 'Me knowledge is stored by the weights in the ANN and is made available 
to use by the possibility of feeding the trained ANN with certain inputs and the network 
would give appropriate outputs. 
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1.4.1 Uses of ANN 
The use of ANN is widespread today in many areas. Banks use them to identify customer's 
signatures on cheques to avoid faked signatures. The computer does this job better than 
human experts. This example demonstrates why ANN systems are often called expert 
systems - because they replace human experts. ANN are very important tools for 
classification problems. In optical character recognition (OCR) software the computer 
captures the picture and it has to classify each letter it scans to match the letter in the 
alphabet it most resembles. After the ANN classification of the letters, it can be viewed and 
edited in a word processor. The less sharp the picture given to the computer, the more the 
software becomes prone to errors such as replacing the letter o with the number 0 (zero), 
and this is more challenging to the software since the classification problem has become 
more difficult. Even the simplest OCR software upon scanning a document printed on laser 
paper rarely has errors. A related problem is the task of voice recognition. The similarity to 
the OCR problem is obvious. In both of them the computer interprets data related to our 
senses, vision for OCR and hearing for voice recognition. In a voice recognition problem by 
receiving our voice the computer turns our voice into characters with voice recognition 
software. The recognition of a human face is a classification problem of pattern recognition 
just like OCR- For solving that problem, ANN that recognises a human face was built 
(Aleksander & Bumett, 1987). The ANN was trained on different facial expressions of the 
same man and was also able to identify the man with facial expressions it was not trained 
on, e. g. recognise the man by his funny face although in the training phase he never smiled. 
Since ANN are so good in solving classification and modelling type problems, they have 
been used in many fields like engineering, science, mathematics, medicine, business and 
literature. This section will describe the uses of ANN in fields related to medicine and 
especially to pharmacy. In cancer diagnostic uses, ANN have been used to predict the 
recurrence of breast-cancer (Ravdin et al., 1992). ANN are in use for the screening of new 
drug applications (NDA) candidates for anti-cancer drugs (Weinstein et al., 1992). In 
cardiac diseases, ANN can predict the occurrence of acute myocardial infarction according 
to cardiac enzymes (Furlong et al., 1991). ANN are of use in the field of structure activity 
relationship (QSAR) (Tetko, et al., 1993) which deals with the correlation of biological 
activity to various physiochernical parameters. ANN are employed in the field of molecular 
graphics (Livingstone et al., 1991). The interpretation of analytical data could be done using 
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ANN in various analytical fields like HPLC (Metting & Coenegracht 1996) or UV (Bohm 
et al., 1992). ANN are in use for the prediction of protein structure from its amino acid 
sequence (Holley & Harplus, 1991). The uses of ANN in the fields of biopharmaceutics 
(e. g. in vitro-in vivo correlation), pharmacokinetic, pharmacodynamic and pharmaceutical 
formulation will be discussed further on in this chapter. 
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1.4.2 Inside ANN 
To give a greater understanding of how ANN function inside, an example of an ANN is 





Equation Ie RX) (1+ X) 
Calculation in "Hid 1" 0.3 * (4.8) + 0.7 * 4.6 = 1.78 f(x) = 0.86 
Calculation in "Hid2" 0.3*5.1+0.7*(-5.2)=-2.11 f(x)=O. ll 
Calculation in "Out" 0.86 * 5.9 + 0.11 * 5.2 = 5.646 f(x) = 1.00 
Figure 1.1: Inside ANN 
The ANN is fed with the inputs 0.3 and 0.7; 0.3 goes into input neuron I ("In V) and 0.7 
goes into input neuron 2 ("In2"). Hidden neuron I ("Hid V) receives its inputs from the two 
input neurons but these values are first multiplied by the 'synaptic strength' (weight) 
between each of the input neurons and hidden neuron 1. The weighted inputs are then 
summed up in the hidden neuron I (Calculation in 'Tlidl'). The result is entered into the 
activation function (Equation 1) and the output of hidden neuron I is 0.86. A similar 
calculation is carried out in hidden neuron 2 (Calculation in "Hid2"). The outputs from 
"Hid V and "Hid2" are multiplied by the corresponding weights and serves as input to the 
output neuron. The previous calculation is repeated in this neuron (Calculation in "Out") to 
yield the final output. The learning process is done by comparing the output of the ANN to 
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Inside ANN 
the desired output and adjusting the weights accordingly. This process is repeated until the 
ANN has learned. Backpropagation is commonly used to adjust the weights. The weights 
adjustments are propagated backwards from the output neurons to the input neurons. 
1.4.3 ANN in relation to brain and computers 
The advantage of ANN is that they function very well with noisy data. Although a specific 
character like the letter A looks very different from one document to another because of 
factors like quality of the document etc., ANN can succeed in classiWg the picture of the 
character to the correct letter A. This task that is done intuitively by our brain is impossible 
to program in a computer code with if then rules, because the number of possibilities that 
the letter A will look like is infinite. Expert systems are not suitable when if-then rules are 
not applicable (this point will be discussed later), hence this type of problem is addressed 
with an expert system which uses ANN technology. With ANN it is possible to get rid of 
the noise and give one output of letter A whilst being exposed to numerous distorted forms 
of this letterjust like the brain. 
The method by which the brain learns is feedback. When a child does something that is 
seen as positive he/she is given positive feedback. When something is seen as wrong he/she 
is given negative feedback. The classic example is of Pavlov who trained a dog for 
conditioning behaviour. Each time he rang a bell the dog was given food. After several 
times each time the dog heard the bell it was expecting the food as shown by the saliva 
from its mouth. So it is possible to train the brain to respond to specific stimuli in a specific 
manner. A dog can be trained to produce saliva each time it hears a bell and a child can be 
trained to behave in the desired way. In the same manner it is possible to train a computer 
that will respond in a desired manner to specific stimuli. The desired manner is the output 
and the stimuli is the input. Just like the dog and the child the computer needs training 
examples which will guide it to the correct output with a certain input. 
One can perceive ANN and database systems also as devices for storing information. ANN 
can be trained to memorise the data and every time the ANN is asked by the user by putting 
certain input to the system it will give output with error close to 0. In the same way data 
may be stored in the memory of the computer and every time pull out specific data by 
addressing the correct address in the computer memory. There are two basic differences 
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between the location of the data in ANN and in computer system. In computer memory 
there is a physical location for every item in memory, in ANN just like the brain there is no 
specific place for every memory item and the memory is dispersed. 
Karl Lashley (1950) conducted experiments to fmd out the location of memory in various 
animals, especially in rats. He trained them to find the correct path in a maze that will lead 
them to the food reward. After training about 100 rats he began removing various parts of 
the cortex (part of the brain). Without any significance to the location of the part that he 
removed, the performance of the rats did not change up to a maximum removal of 10% of 
the cortex. When he removed more than 10% their mistakes were proportional to the size 
of the part removed but not to its location. Lashley was astonished to find out that the 
memory stored in the cortex was not in a specific place but everywhere in the cortex. 
Trained workers, with parts of their brain destroyed in accidents, do not lose all brain- 
functioning capability. Documentation of people that lose part of their brain and yet did not 
stop functioning completely exists. More serious damage leads to a gradual degradation in 
the brain activity without it abruptly stopping from functioning; but the location of the 
damaged area is also an important factor of this pattern. This phenomena is similar to what 
happens in ANN as the network loses more and more neuron units (also termed 
perceptrons and abbreviated as-PE's) (Rumelhart & McClelland, 1986a). 
Rumelhart & McClelland (1986b) trained a network to output the past tense of verbs in 
English. The ANN was able not just to add the common 'ed' automatically. After the 
network was trained it was examined on verbs which it had not seen before, like 'guard' 
and 'weep' and it succeeded of determining their past tense as 'guarded' and 'wept'. The 
major problem that the two inventors were faced with, was how to develop the method of 
presenting the data to the network and in this case it was the verbs and their past tense. 
A cornmon example used in training a network is training the network to output 'on' when 
the input is 'off' and vice versa. Suppose there are 4 input units and 4 output units. The 
ANN will be trained on a number of samples and after several iterations it will know to 
output the desired value with the logical rule when the opposite value is presented. As an 
example of the lean-dng ability, after the network is trained it is given the inputs 'off, 'off, 
con', 'on' in the 4 input PE's and the 4 output PE's would give the values 'on', 'on', 'off, 
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'off' respectively. The network succeeds in learning the logic without memorisation 
because it is presented vvith a pattern not seen before and is able to output the correct 
response. 
The latter two examples demonstrate that the ANN-4ike the human brain-does not work 
like conventional computer software possessing a database of rules, rather using a dynamic 
learning process. This learning process makes us behave (output of ANN) in such ways 
that are difficult to define using logical rules. 
The ANN research at this stage has focused on the electrical aspect of the behaviour of the 
nervous system neglecting the chemical aspect. In the brain chemicals involved in the 
operation of the neurotransmitters are used with success to treat brain disorders like 
schizophrenia. One of the assumptions is that they influence the brain by changing the 
connection strengths between the neurons. In an analogy to ANN, the chemicals are 
influencing the magnitude of the weights. 
In ANN no meaning is attached to the dimensional topology in which the different PE's are 
arranged. It is meaningless to depict the ANN in two or three dimensions, it is the same 
ANN. On the contrary, in the brain the common belief is that there is an important role to 
the geometry of the neurons in the brain just as there is an importance in the position of 
lenses of an optical device, or the posifion of wheels in a clock. Neurons in the brain 
function just to either enhance or inhibit the firing of other neurons only, unlike neurons in 
ANN that enhance and inhibit simultaneously. 
1.5 Comparison between ANN and regression analysis 
ANN and regression have a number of similarities in that both are used to model 
relationships. However, they also differ in a number of ways. The two methods are 
compared below in the following areas: coefficients vs. weights, extrapolation, simplicity of 
the model, computation time, cross validation, model interpretation and optimisation 
respectively. 
The coefficients in regression are analogues to the weights in ANN. The values of the 
coefficients are determined according to the least squares method. The values of the 
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weights in ANN are determined by the training process. (If biases are in use these are also 
adjusted through the learning process of training). It is not possible to calculate the 
regression equation when the number of coefficients exceeds the number of cases. In 
contrast, it is possible to train ANN when the number of weights and biases exceeds the 
number of cases. 
It is not recommended to extrapolate beyond the values of the independent variables 
(Mendenhall & Sincich, 1996). This can lead to ridiculous results. In economics one can 
plot on the x-axis the advertisement expenditure and on the y-axis the sales. Extrapolation 
to a value of x=0 could lead to a value of sales that is negative and this is physically 
impossible. In a tablet study, first presented in Chapter 3, using the method where data is 
partitioned into a training set and a small validation data set there is less chance of 
extrapolation. In the jacknife method, as described by Mendenhall & Sincich (1996), 
extrapolation is inevitable in some of the cases that are validated. The logic is: if one does 
not map a certain area, the behaviour of the function in that area is not known. With a 
number of independent variables, multi-dimensional plots are useful to determine whether 
one is extrapolating for any given values of the idependent variables. Looking at the values 
of each one of the independent variables separately it is not possible to know whether one is 
extrapolating or not. These multi-dimensional plots are also useful to examine areas where 
interpolation might be unreliable, i. e. where there are big 'holes' in the space that the 
independent variables create. 
The model must be made as simple as possible. The model is built with as few 
coefficients/weights (and biases) as possible. In doing so the problem of overfitting is 
avoided (Masters, 1993). That means that the problem of a model learning any unimportant 
details in the data instead of learning the essential general trends is avoided. The 
disadvantage of this method is that the lower number of neurons may not be sufficient to 
characterise the data adequately. "Additional neurons increase the chance that even a local 
minimum will yield a low error. " (Demuth & Beale, 1994). With fewer neurons there is 
less freedom in the network so the error surface that the function describes is less 
complicated and there is more chance for the network to be trapped in local minima with 
high error. In regression, by definition, if the number of coefficients is equal to the number 
of cases, the value of Rý is equal to 1. In the latter case, we have a model in which 100% of 
the sample variation is explained by using x to predict y. But this model is probably bad for 
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prediction. 1"he model could be memorising the data rather than generalising because it is 
too complicated. It is possible to construct a model with fewer coefficients with a lower Rý, 
with a good chance that it predicts better. 
Coding means transforming a set of variables into a new set of variables (scaling the data). 
Coding is recommended for both methods: In regression it prevents the rounding error 
which occurs when multiplication of the matrix to calculate the coefficients takes place, and 
problems of multicolfinearity (Mendenhall & Sincich, 1996). In ANN it helps the system to 
learn (Masters, 1993). For example, in this work, upon trying to train a network without 
coding, the ANN after a few iterations stops learning (the error does not decrease). After 
coding the same ANN architecture, the ANN was able to learn the data well. 
In linear regression the same model will produce the same coefficients each time and the 
same prediction. In ANN it is possible to train the same network topology but result in a 
different prediction, because there is a random factor that may enter into the learning 
process (if the ANN is initialised with random weights) producing different weights and/or 
biases each time. With non-linear regression the situation is similar to the ANN. 
The required computation time is a lot longer in ANN than in regression. Especially in the 
jacknýife procedure, a computer goes through the jacknife procedure (see below) in 
regression in a few seconds Whilst in ANN it takes the computer comparatively much 
longer to train. 
Cross validation can be used to choose the best ANN topology/regression model. The data 
is partitioned into a training and a validation data set, the latter being used for testing the 
performance of the different topologies of networks that were trained or the different 
regression equations. The network with the smallest average percentage error is chosen as 
the best network (Murtoniemi et al., 1994a & 1994b). Murtonierni et al., used cross 
validation for building the model (choosing the topology) as well as validating the chosen 
network in the same step. Another approach is to select the best topology of ANN by 
training different topologies on the entire data set and plotting a graph of the number of 
hidden neurons on the x-axis against root mean squared error (RMS) on the y-axis. Using 
the graph one can decide on the minimum number of neurons at which the RMS begins to 
stabilise. As the number of neurons increase the RMS as well as the slope of the graph 
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decreases. At this point one can use cross validation for validation of the selected ANN. 
One validation method is the leave-one-out method, or Jacknife, as in the work of Hussain 
et al. (1994). This is a special case of cross validation - the Jacknife can be used to detect 
an influential observation. Any observation for which the difference between the observed 
and the predicted value based on the model without that observation (this difference is 
called the deleted residual) is large relative to the predicted values is said to influence the 
regression fit (Mendenhall & Sincich, 1996). Once the observation is detected one can 
decide: 
1. That there may have been a mistake in measuring that observation. This may involve 
tracking previous work. 
2. To on-ýt that observation. 
3. To change the model. 
Some of the greatest discoveries in science involved detecting observations that did not fit 
the current model, (e. g. quantum mechanics) and as a result another more appropriate 
model was established. It is especially relevant when one is interested in building the model 
notjust for prediction but also for understanding the relationship between the parameters in 
the model. This leads to the next issue of how to deal with model interpretation. 
To summarise, although terms like jacknife and leave-one-out method are used 
interchangeably in this work as well as other articles, jacknife is the name given to the 
leave-one-out method used for validation purposes and not in detecting influential 
observation(s). When the data is split into two sets, one for training and one for validation, 
(e. g. splitting the 27 data points into 22 for training and 5 for validation), this method is 
called split-sample validation (although in this thesis and in other articles this is referred to 
as cross-validation) as is the norm. 
It is much more difficult to attach any physical meaning to the weights in ANN than the 
coefficients in regression analysis. Sometimes one can derive a simple regression equation 
that enables us to understand the system under investigation. In other cases it can be that it 
is not possible to interpret either the regression equation or the weights in ANN. 
"Optimisation is the process of seeking the best solution for a system or activity. " (Biles & 
Swain, 1980). The process entails manipulation of independent variables in order to get the 
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desirable response. Optimisation of the system is much more straightforward in ANN than 
in regression because one can see the entire system as a single entity. In the tablet study 
there is a network with 3 input neurons and 8 output neurons and the weights describe the 
relationship between them. One cannot, in our case, build a single regression equation that 
describes the relafionship between the independent variables and all the response variables. 
It is possible to do network inversion in ANN: the user asks the net what properties an 
input pattern must have in order for the net to generate a specific output (Zell et al., 1994). 
The formulator in that case can ask the ANN what compaction force, lubricant level and 
disintegrant level the tablet must have in order to have appropriate dissolution rate and 
other response variables suitable for the pharmacopoeia constraints. If the researcher has an 
ANN with only one output, he/she can use the same opfimisation procedures as in 
regression analysis. For example, plotting a contour plot for each response variable, 
marking the constraints based on same criteria, projecting the plots one above the other and 
finding the region of independent variables conditions that fulfils all the constraints 
(Schwartz, 1973). 
1.6 Expert systems 
Expert systems emulate the decision-making system of a human expert. Professor Edward 
Feigenbaum, an early pioneer of expert system technology, has defined an expert system as 
44 an intelligent computer program that uses knowledge and inference procedures to solve 
problems that are difficult enough to require significant human expertise for their solution" 
(Feigenbaum, 1982). An expert is one who has expertise in a specific domain. An expert is 
one who solves problems that are unsolvable by one who has no knowledge in the expert's 
field or one who solves problems much more efficiently than another who is not an expert 
in the field. 
It is common to use the term expert system in any system that uses the technology of expert 
systems. The technology can encompass computer language, programs and hardware. The 
knowledge in an expert system can come from human resources by experts in the fields or 
from literature. 
The user of an expert system supplies input and is given advice by the system based on the 
information vvithin the expert system. The expert system is made up of two parts: a 
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knowledge base and an inference engine. In response to a user query the system supplies 
answers. 
Expert systems can also aid experts in the field by supplying solutions to difficult problems 
or reducing the time to get an answer. As these systems gather more and more information 
they improve and can give more help. With time the complete expert system evolves. 
Expert systems are suitable just for a specific domain just like any human expert who has 
expertise in a specific domain. The expert system unless programmed otherwise has no 
knowledge whatsoever on other domains. 
In which cases are expert systems useful? If conventional programming can solve the 
problem then an expert system is not the best choice (Giarratano & Riley, 1994). Expert 
systems are generally designed very different from conventional programs because the 
problems they tackle usually have no algorithmic solution (Giarratano & Riley, 1994). 
Hence, if a simple program can solve a problem there is no need in using more complicated 
technology. Expert system must have a well-bounded domain for the problem it represents 
and what its capabilities should be. Sometimes solving problems in a certain domain 
requires knowledge from other domains, e. g. solving a medical problem might require 
delving into the chemistry and biochemistry and other domains as well. It is difficult to 
restrict the number of domains involved. When the problem-solving knowledge is mainly 
heuristic and uncertain it is appropriate to use an expert system. 
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1.7 Modelling, optimisation and expert systems in 
pharmaceutical development 
The following paragraphs will explain in detail what has been done in the fields relating to 
this thesis and some notable studies have been reviewed critically. 
1.7.1 Modelling and optimisation, in previous studies 
ANN have been used in all stages of pharmaceutical formulation development from trying 
to predict granule properties (Murtoniemi et al., 1994) followed by trying to predict tablet 
properties (Turkoglu et al., 1995), to optimising tablet coating (Turkoglu & Sakr, 1992) 
and finally the prediction of pharmacokinetic profiles by dissolution parameters (Hussain, 
1997; Dowell et al., 1997 & 1999). Hussain was the first one to begin simulating 
pharmaceutical tablet properties with ANN (Hussain et al., 1991). He focused on the 
predictions of dissolution profiles of sustained release products (Hussain et al., 1991 & 
1994) and he continued with in vitro - in vivo correlation of the dissolution and 
pharmacokinefic profiles (Dowell et al., 1997). These 3 stages in-process control, namely 
granule properties, the properties of the finished tablet and its pharmacokinetic profile are 
mandatory by many health authorities. The focus on the final stage is a natural continuation 
from previous studies and is the most expensive one. If tablet properties, such as 
dissolution profile are optimised, and the pharmacokinefic profile of the tablet does not 
meet the required criteria, it means loss of money to the pharmaceutical company (circa 
$30,000 based on personal knowledge of a bioavailability study done by the company I 
work for). These experiments (called bioequivalence for generic products) are expensive 
since they involve taking blood samples from healthy volunteers under hospital supervision. 
Certain health authorities do not require proof of bioequivalence for some generic products 
like paracetamol. In the following sections the modelling and optimisation of mainly solid 
dosage forms will be discussed for each of the stages of formulation development 
mentioned above. 
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1.7.1.1 Modelling (ANN & regression) and optimisation of granule 
properties 
Both ANN and regression models have been used for the prediction of granule properties 
(Murtoniemi et al. 1994a). They used a fluidised bed granulator with a software package 
that controls the process. The independent variables that were controled were inlet air 
temperature, atomizing air pressure and binder solution amount. The measured responses 
were granule size and its friability. They performed 27 experiments in a full factorial design 
with 3 levels. A separate 5 experiments were performed to generate the validation data set. 
The models were built using the results of the 27 experiments and tested on the 5. Stepwise 
regression was used for building the regression equation. Although it is not mentioned 
which model they began this procedure with, it is suggested that they began with a second 
order equation. Average percentage error was used to evaluate the ability of the models to 
predict. Tle authors state that "the number of hidden layer neurons should be much lower 
than the number of training samples. " However, the number of neurons in the hidden 
layer(s) could be much lower than the number of training samples and yet the number of 
weights could be more than the number of training samples. The number of weights 
relative to the number of training samples is the important factor that influences the 
generalisation ability. The ANN was fully connected with one or two hidden layers. The 
number of neurons ranged from 3 to IS. Hence, the number of weights in the ANN with 15 
neurons in the hidden layer is 3x 15 x2= 90 (without taking into account biases that are a 
special class of weights) and this is obviously more than the number of data points. One 
opinion regarding this subject (Hagan et al., 1996) is that "For a network to be able to 
generalize, it should have fewer parameters than there are data points in the training set". It 
is interesting to note that the best ANN chosen for both responses had more weights than 
the number of data points, since the chosen topologies were with one hidden layer that 
consisted of II neurons for modelling granule size response, and 12 neurons for modelling 
granule friability response. The authors talk about generalisation ability and how to improve 
it when using ANN models but it is not clear how they arrived at the conclusion that the 
trained ANN had generalisation ability! The average value of granule size (of the 27 
experiments used to build the model) is 370 gm. Using this value to predict the validation 
set yields 12.41 average percentage error, which is less than the 14.71 average percentage 
error arrived at by the authors (for the best ANN model). As will be seen later sometimes 
ANN or regression can not generalise well. In the study described in Chapter 5 the 
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ANN/regression models Seneralised well for 5 of the 9 response variables. Another 
problem is that a set of 5 cases is most likely too small to determine generalisation ability 
(the probability that it can represent the full population is low). In the study of Murtoniemi 
et al. the training end point of the ANN was also varied. In a second study by Murtoniemi 
et al. (1994b) modelling of granule flow rate was included in the regression and ANN 
modelling. The ANN was modelled with just one hidden layer but with up to 25 neurons in 
the hidden layer and with more training end points. The authors also repeated the modelling 
of ANN with this method for the responses of mean granule size and granule friability with 
the aim of improving the results. 
Takayama & Nagai (1989) tried to optimise indomethacin release from granules. The 
independent variables manipulated were concentration of polyvinylpyrrolidone (PVP), 
concentration of carboxyvinyl polymer (CP) and addition rate of PVP solution to 
indomethacin suspended CP solution. The responses modelled were time to release 50% of 
indomethacin from powder, time to release 50% of indomethacin from granules, moisture 
uptake of powders, indomethacin content of powder and sample recovery. The 3 
independent variables were at 5 levels, 23 cases dedicated to full 2 level factorial and the 
rest for the other 3 levels. In the end there were 15 experiments at 5 levels. They used a 
second order polynomial with 10 parameters just like Schwartz et al. (1973). Unlike 
Schwartz et al., Takayama & Nagai (1989) selected the best factors by choosing the 
equation that gave the best coefficient of correlation. This correlation coefficient took into 
account the degrees of freedom. In total there were 511 cases (294). To summarise, this 
approach selects the best regression equation from all possible combinations using the Rý 
value and taking into account the number of coefficients (which determines the degrees of 
freedom). For example, if for 3 coefficients the value is 0.8 5 and for 6 coefficients the value 
is 0.87, the equation chosen will be the one with 3 coefficients. According to Bolton et al., 
1997, stepwise regression is considered a better method than "all possible regressions" 
approach described here. The optimisation in Takayama & Nagai, 1989, study was done 
using a Monte Carlo approach that uses random number techniques to search for the 
optimum solution. 
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1.7.1.2 The use of ANN and regression to model powder properties 
Bourquin et al., published several articles on modelling using ANN focusing on different 
responses to those discussed up till now. Bourquin et al. (1998c) tried to model an in- 
process system. As opposed to the granule modelling described earlier (Murtoniemi et al. 
1994a & 1994b) here the in-process mixture was in its powder form. The properties of the 
powder are important for the success of direct compression process. The responses 
modelled were powder flow, tap and bulk density. Also modelled were ot (alpha) and P 
(beta) parameters which relate to the following equation: 
N/ VR = cc*N +P (Yamashiro et al., 1983) 
Where N is the number of taps and VR is the volume reduction. The input variables that 
were manipulated were concentrations of silica aerogel, microcrystalline cellulose, 
magnesium stearate, low substituted sodium carboxymethy1cellulose. The network was 
trained using backpropagation with hyperbolic tangent function as the activation function in 
both layers. The data was split into 14 data points for training and 3 for validation. The 
training was stopped as soon as the MSE of the validation set began to increase. The Mean 
Square Error, MSE is equal to SSE/n (where n is the number of data points). The ANN 
was trained 10 times each time with new random weights. The network/regression model 
showing the best Rý of each response was then selected for the model comparison. The 
regression models were trained on all the data using the maximum Rý to avoid overfitting. 
The conclusions of this research were that ANN and regression gave comparable fitting 
results but regressison is superior in modelling outliers. 
Bourquin et al. (1998b) explored the influence of 6 input variables that were concentrations 
of silica aerogel, microcrystalline cellulose, magnesium stearate and 
carboxymethy1cellulose as well as compression force and dwell time, on the responses of 
normalised ejection and residual forces. One hundred and two experiments were done 
overall. They were split into 87 for training and 15 for test set. The MSE in predicting the 
test data set was monitored and the training was stopped as soon as this value no longer 
decreased but began to increase (the start of overfitting). The network was trained 10 times, 
each time using new random set of initial network's weights. The network showing the best 
fit (smallest MSE) was then selected for the model comparison. The split for the 
comparison was done differently from the selection of the best ANN: 80 samples for 
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learning and a validation data set of 22 samples randomly chosen. The models were 
developed as described above but utilising the reduced training data set (i. e. statistical 
response surface modelling with 80 samples and ANN modelling with 68 samples as 
training and 12 as test data set). Since Bourquin et al. . (1998b) had enough data they could 
split the data into training and validation set with a reasonable probability that their 
validation set of 22 samples represented the population it came from. They used a simple 
backpropagation algorithm for training but in addition to the regular connections of 
multilayer perceptron (MLP) network, there were also connections from the input layer 
directly to the output layer (they were fully connected). Bourquin et al. (1998b) termed this 
type of ANN "generalised feed forward multi-layer perceptron network" (GFF-MLP). 
They began to test the optimum topology for the number of hidden neurons beginning with 
the maximum number of hidden neurons as defmed by Kolmogorov's theorem and then 
reduced the number of hidden neurons until a generalising working ANN was obtained. 
This strategy had been suggested earlier by Maren et al. (1991). KolmogoroVs theorem 
states the minimum number of hidden neurons should be twice the number of independent 
variables plus one to compute any arbitrary continuous function (Hecht-Nielsen, 1987). 
They stated in this study that six parameters give 13 hidden neurons that are enough to 
model their specific problem according to Kolmogorov's theorem, and that the neurons 
were reduced to 12 units in order to reduce the risk of overfitting. It is the opposite of the 
approach of beginning with the minimum number of hidden neurons and adding one neuron 
each time fill generating ANN which can learn and generalise (Masters, 1993). The 
approach of Bourquin et al. is an acceptable method described in the literature (Maren et 
al., 1991). 
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1.7.1.3 Modelling (ANN & regression) and optimisation of tablet 
properties 
Bourquin et al. (1997b) modelled the influence of several variables on tablet crushing 
strength (N), percentage of drug dissolved after 15 minutes (%) and time to 50% drug 
dissolution (min). The variables were: formulation factor (the drug was granulated using 
two different formulations), 3 levels of matrix filling speed (rpm), 3 levels of 
precompression force (kN), 3 levels of compression force (W) and 3 levels of rotation 
speed (1/hr). Two different ANN types were examined, GFF-MLP and self-organising 
feature map NILP (SOFM-MLP) for modelling this data. GFF-MLP has 'short cut' 
connection between the input layer and the output layer (this type of ANN was used in the 
article described earlier). Also in the output layer of the GFF-MLP and SOFM-NILP there 
is a hyperbolic tangent activation function. These ANN were trained with backpropagation. 
The regression model chosen was a polynomial of third order including all interactions. It 
was not mentioned if other regression models were investigated or if a method of variable 
selection was employed, which is a reasonable thing to do in order to reduce this large 
equation with many parameters. The training of the models was on a reduced data set, and 
validation used all the data. This approach is unique in the literature. The approach seems 
to impose the problem that there will be better validation results for the data points that the 
models had been trained on, since the models could memorise these data points. No ANN 
or regression model was able to predict the two dissolution responses since in this author's 
opinion, some additional parameters influence these responses. 
Bourquin et al. (1998a) tried to model tablet properties of tensile strength, friability, 
disintegration time and dissolution profile (percentage of drug dissolved after 15,30,45 
and 60 minutes). The input variables that were manipulated were: percent of silica aerogel, 
microcrystalline cellulose, magnesium stearate and sodium carboxymethylcellulose. As 
well as dwell time and compression force. ANN models were compared to regression 
models. The type of ANN was GFF-NIELP with the hyperbolic tangent activation function in 
both layers and the training method was backpropagation. The ANN was chosen from ten 
ANN with different initial random weights. 28 data points out of 205 were chosen. Using 
the 28 data points the ANN was fed with 24 data points for training and 4 data points were 
left to test. When the MSE of the predictions regarding the test set started to increase the 
training was stopped. The network showing the best overall fit (le for each response) was 
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then selected for comparison of the models. The authors stated that as long as the achieved 
Rý coefficients does not surpass the value of maximum k2 there is no overfitting of the 
model. Ibis value of maximum Rý was calculated from the averaged variances of the 
repeated measurements and from the variance of the means. The use of 14% out of 205 
data points for training and the rest for validation was employed to compare between the 
ANN and regression models. Two comparison experiments were performed, in one the 
trainýg set was chosen using an organised design and in the second the training set was 
selected in a random way. This research concluded that ANN methodology is much less 
sensitive to organisational level of trial design than the response surface methodology 
(RSM) and is therefore better adapted for the data analysis of the results of historical or 
poorly organised trials. This issue of which method predicts better when the experiments 
are not from a well-organised design is addressed in the current thesis. 
Turkoglu et al. (1995) used 27 experiments in a full factorial design. Twenty-two 
experiments were used for training and five were separated from the data set for validation. 
This design of experiments and validation method was used in one of the studies in Chapter 
3 of this thesis. The input parameters used were lubricant type, compression pressure and 
mixing time. Ile 3 responses modelled were crushing strength and percent released after 
30 and 60 minutes. They compared ANN to a second order regression equation. There was 
no minimisation of these equations. Nevertheless, separate equations were built for each 
lubricant type, so although they were second order they included only 5 variable terms. The 
ANN were optimised using 'network reversal'. They state that the network reversal 
function predicts appropriate input settings needed to achieve desired output settings. There 
was no elaboration of this method. This method of optimisation is also mentioned by 
Achanta, et al. (1995) where it was stated that this is an advantage of ANN since they can 
perform 'inversion' for purposes of optimization. A method of directly optimising ANN 
(although not termed as an optimisation method) was mentioned in a review of ANN 
applications in chemistry (Sumpter et al., 1994). The goal of the method is to find ideal 
input examples to specified outputs. In this method no solution can be found but a set of 
good solutions can be found. This research uses multiobjective optimisation not directly 
from ANN but using multiobjective optimisation routine with ANN. The same concept of 
optimisation, as employed in this study, is described in a review about optimisation using 
ANN (Takayama et al., 1999). This review describes optimisation of ANN trained to 
model a transdermal therapeutic system. The aim of the latter study was that the drugs from 
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this system will penetrate efficiently into the systematic circulation to achieve sufficient 
concentration for the desired therapeutic effect. The input parameters were the amount of 
ethanol as one variable and the amount of ortho-ethy1menthol as the second one. The 
responses measured were apparent penetration rate, lag time and total irritation of the skin 
score. This article also mentioned another 2 studies that used similar optimisation 
techniques (Takahara et al., 1997a & 1997b). A completely different approach to 
optimisation is presented by Shek et al. (1980). In this method there is no training of 
ANN/regression equation prior to optimýisation but it is done dynamically. The researcher 
feeds the optimisation routine with a number, and after a calculation based on the principle 
of trying to get far as possible from the worst point one gets a suggestion from the 
computer regarding the next independent parameters one should use. The system to 
optimise was a capsule formulation problem. There were 4 independent variables: percent 
of drug substance, total capsule weight, disintegrant and lubricant levels. And 3 responses: 
rate of packing down, percent dissolution after 8 and 30 minutes. The score for each set of 
the 3 responses was done by the linear combination of the 3 weighted responses. The 
weights for the responses were given by their importance. The packing down rate was 
given weight of 50%, dissolution at 30 minutes was given importance of 40% and 
dissolution at 8 minutes was given importance of 10%. So the equation that measured the 
success of each experiment looked like: 
Rt = 0.5xR, + 0.4xR2 + 0.1 xR3 
Where Rt is the objective function and the different R, (1.3) relate to the responses discussed 
previously. This concept of giving weights in optimisation of several responses 
simultaneously is common in many multiobjective optimisation routines. The ability to give 
appropriate weights depends on the expertise in pharmaceutical formulation of the one who 
performs the optimisation. 
Bohidar et al. (1979) modelled tablet response variables using also the stepwise regression 
technique which was used by Murtoniemi et al. and also was used in this thesis. They 
examined 5 input variables to model 10 responses that are similar to the tablet study in this 
thesis. They found compression pressure and lubricant level to be the most important. TIfis 
work uses these two factors as well as the disintegrant level. Bohidar et al. used 27 tablet 
formulations. Schwartz et al. (1973) also modelled tablet properties using 5 input variables 
to model 8 responses similar to the ones measured in this thesis. Schwartz et al. did not use 
a method of variable selection but used an equation of 21 terms to model 27 experiments in 
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a second order model. Hence, allowing more chance for the regression equation to 
generalise and thus better than Hussain et al. (1991) that used 15 variables to model 
regression equation with 15 coefficients. Schwartz et al. also used numerical as well as 
graphical techniques in multiobjective optimisation. This work uses multiobjective 
optimisation but with ANN instead of regression equation and also with a more modem 
method of optimisation. Hussain and co-workers continued research on predicting the 
dissolution profile using ANN this time from a tablet matrix with leave-one-out validation 
(Hussain et al., 1994). The independent variables were molecular weight, intrinsic 
dissolution rate, pKa, salt type, drug to polymer ratio and hydration rate of the polymer. 
The responses measured were percent drug released at 1,3,6 and 12 hours. They 
optimised the number of hidden neurons but also the number of epochs. The different ANN 
were trained on the training set and the one with the minimum root mean square error was 
chosen (also with graphical method that will be explained later). The leave-one-out method 
was done on the selected ANN. Regression presents no problem in term of training time for 
the leave-one-out method but in ANN it is time-consuming. On the other hand when there 
are few data points it is the most reliable way of validating the model. Hence firiding ways 
to estimate ANN leave-one-out results are under research today (Myles et al., 1997) but 
there is as yet no method that one can confidently say predicts the results of this validation 
method. 
1.7.1.4 Modelling (ANN & regression) and optimisation of in-vitro drug 
release profile 
Another important part of process modelling and optimisation is tablet coating. Turkoglu et 
al. (1992) checked the influence of the following fluidized-bed coating parameters: polymer 
amount, coating temperature and spray nozzle pressure. The responses characterised drug 
(theophylline) release profile. The regression equation was second order model with ten 
parameters. Optimisation was done using graphical methods and with simplex algorithm. 
There was no method of variable selection and there was no validation of the model. 
Turkoglu et al. (1992) did simple maximisation of the theophylline release. The goal of 
their maximisation problem was to get more than 80% theophylline release after II hours. 
Since there are 3 regression models for the release profile after 5,8 and 11 hours, 
optimisation of these three responses simultaneously according to desired release profile 
seems to be a more appropriate approach that is in accordance with the approach to 
multiobjective optimisation in the current thesis. After optimisation, a batch with the 
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opfimýised tablet coating parameters was manufactured. The batch gave more than 91% 
theophylline release after 12 hours. This can be given as an indication that the model 
generated was adequate-since the optimisation routine done on the model gave an 
optimum result which was validated with real life experimental result. 
Hussain et al. (199 1) characterised the release exponent and the dissolution half time from 
a capsule matrix. The input parameters varied were four formulation variables: 
carboxymethyl cellulose, hydroxypropylmethyl cellulose, hydroxypropyl cellulose and 
hydroxyethyl cellulose. They trained the ANN/regression models on 15 formulations and 
used a validation set of 8 formulations. The topology of the ANN was 4 input neurons, 2 
output ones and the number of hidden neurons was varied from 4 to 14 nodes. The best 
ANN selected was the one that gave the lowest sum squared error for the training set. The 
selected ANN was with 8 hidden neurons which give 4x8x2= 64 weights and this is 
more than the number of data points. Looking at the predicted values by ANN and 
regression show that ANN predicted better all dissolution half life results and regarding the 
release exponent regression gave just two predictions that were better than the ANN 
predictions, so it is obvious ANN modelled the data better. It is a puzzling fact (as well as 
in others) that they used several ANN models but just one regression model. Furthermore, 
the regression model used had 15 coefficients (on 15 data points! ) reducing the probability 
of generalisation to the regression equation. They used a first order regression equation but 
with all interaction terms added. The high Rý values of 0.989 and 0.976 for the regression 
models for the two responses suggest there is a problem of overfitting to the training set. 
The selection by the authors of a long equation without a method of variable selection is not 
appropriate because it does not give a chance to generalise since there are too many 
variables. 
Johnson et al. (1990) researched the release of drug from a controlled release matrix. The 
independent variables were component fractions of formulation constituents and the 
responses characterised the drug release profile. The statistical design of the experiments 
was composed of 8 extreme vertices (there were 4 independendent variables). These 8 
extremes defined the geometric boundaries of a seven-sided hyperpolyhedron. Eight 
additional points were put at the centre of each of the 7 faces and one at the geometric 
centre of the mixture space, designated as the centroid point. The validation of the model 
was done by choosing 5 points randon-dy from the space within the extreme vertices. The 
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average difference between the drug release profiles predicted by the model and the 
profiles determined experimentally was 2.05%, which is well within the experimental error 
(4.5%). The regression equation was optimised by stepwise regression using SPSS. The F- 
test ratio for including a regressor into the equation was initially set at 0.01 (Fi. = 0.01) and 
the F-test ratio for deleting or excluding a regressor from the model was set at 0.005 
(F.,, ý0.005). This thesis also used SPSS software for stepwise regression and the tuning of 
the F-test ratio for including or excluding regressors will be discussed later. 
Ebube et al., 1997, tried to model hypothetically eleven controlled-release formulations. 
The input variables manipulated were fractions of two polymers and the response measured 
was percent of drug dissolved after one hour. The leave-one-out method was the validation 
method. Examination of the predicting ability using this validation method shows that the 
error is big for the slowest dissolved tablet and there is no ability to extrapolate. However, 
for the fastest dissolving tablet it was possible to extrapolate efficiently. 
1.7.1.5 Modelling with ANN and optimisation of a pharmacokinetic 
drug profile 
Finally, the last stage in formulation development is attaining the desired pharmacokinetic 
profile. Previously, prediction of dissolution profile was demonstrated, the link between this 
and the prediction of pharmacokinetic profile will now be discussed. The use of ANN for 
predicting pharmcokinetic/pharmacodynamic parameters is a well developed area (Hussain 
et al., 1992; Veng-Pedersen & Modi, 1993; Brier et al., 1995; Jogarao et al, 1995; Jogarao 
et al, 1996). There is a good introduction to this field by Erb (1995). This section will 
describe just one part of this subject that relates to pharmaceutical solid dosage forms. 
Not many studies are in this new area of in vitro-in vivo correlation using ANN (Dowell et 
al., 1997/1999; Hussain, 1997). The ones by Dowell et al. will be discussed here (the two 
articles are on the same study). This study demonstrated the issue that the same data can be 
presented in a different manner to different ANN. To obtain the dissolution profile the 
percent dissolved at 7 different time points was measured (input variables). To obtain the 
pharmacokinetic profile (response variables) the plasma concentration at 15 different time 
points was sampled. 9 subjects were sampled for their pharmacokinetic data and 6 samples 
for each point in the dissolution profile. There were 4 ways of associating the data (input- 
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output pair) and each is suited to a different ANN. Association I receives as input the 7 
dissolution points and as output IS pharmacokinetic points, these represent the dissolution 
and pharmacokinetic profiles respectively. Overall they had 6x9=54 data points for each 
formulation. In Association 2 they used ANN with topology of 8 input units and I output 
unit. The first input represented the pharmacokinetic time and the output is the 
corresponding pharmacokinefic output. The other 7 input units represent the entire 
dissolution profile. Overall they had 6x9xl5=810 data points for each formulation. 
Association 3 was represented with ANN of 2 input units and one output unit. The first 
input unit represented the dissolution time, the second one represented the corresponding 
data point in the dissolution profile. The output unit represented the corresponding 
pharmacokinetic data point suitable for that time point. Overall they had 6x9x7=378 data 
points for each formulation. Association 4 used the same topology of Association 2 of 8 
input units and one output unit. One input unit represented the pharmacokinetic time. The 
other 7 input units represented the dissolution data points till that time point, and the other 
input units got the value of zero. In this manner as the pharmacokinetic time of sampling is 
progressing there are more values in the input units that are not zero represented by real 
values from the experimental data of dissolution. The output unit is the pharmcokinetic data 
corresponding to the time of the input unit. Overall they had 6x9xl5=810 data points for 
each formulation just as in Association 2. This study concluded that ANN are capable of 
predicting pharmacokinefic profile based on dissolution profile. The next step the study 
dealt with was to run an optimisation routine to get the optimised dissolution profile that 
yields the optimum pharmacokinetic profile. For that purpose they used a technique called 
genetic algorithm, which works by evaluating the pharmacokinetic profiles according to 
many dissolution profiles and retrieving the best solution. 
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1.7.2 Expert systems in pharmaceutical product formulation 
development 
Expert systems for product formulation are in use in many fields like agrochemicals, alloys, 
printing inks, resins and varnishes, lubricating oils, vinyl blowing agents (Rowe & Upjohn, 
1993). Pharmaceutical expert systems are in use in various fields: parenteral development 
(Rowe et al. 1995), skin care products (Wood, 1991), and in the field of solid dosage form 
development that will be discussed extensively in the following sections. 
Lai et al. (1996) developed an expert system utilising more than 2000 references relating to 
problems in capsule filling and related problems in powder technology. This database is 
permanently updated. A second database provides information on excipients. The database 
contains 750 different formulations of 250 drug substances. A group of 10 experts in the 
field of capsule formulation was employed to generate many facts and rules. The 
formulations are deduced automatically. The programming language used was C. 
Rowe et al. (1997) surveyed expert system shells that can be used to develop 
pharmaceutical formulation expert systems. They mention several technologies that are 
incorporated into expert systems like ANN or genetic algorithm. ANN and genetic 
algorithm are incorporated into Cad/Chem which is a software used to build models and 
optimise formulations (Colbourn & Rowe, 1996). Ile use of the software is demonstrated 
by Kesavan & Peck (1995). Rowe & Upjohn (1993 a) used an expert system to identify and 
solve film-coating defects. They developed this with an expert system shell. 
There are several tablet formulation expert systems (Podczeck, 1992; Ramani et al., 1992; 
Rowe & Upjohn, 1993b; Stricker et al. 1991 & 1994). Rowe and Upjohn (1993b) 
described a Zeneca expert system for tablet formulation. The flow of the program will be 
described in brief. Drug properties are entered into the database. Then the user selects a 
tablet profile, accordingly the system autornaticafly selects the formulation excipients. It 
selects the excipients that are characterised by their functional category groups. The 
functional category groups in the Zeneca expert system are: filler, disintegrant, binder, 
surfactant, glidant and lubricant. It has a database on excipients. Afterwards, the Zeneca 
expert system predicts the tablet properties that the suggested formulation will have. Then 
the user enters the measured tablet property results like disintegration time etc. The Zeneca 
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expert system then compares the predicted results to the observed ones and accordingly it 
gives advice that the user can accept/reject. According to the user input in response to the 
advice, the system suggests formulation changes. This iterative process, of suggesting 
formulation, feed the observed tablet properties, give advice and suggesting a new 
formulation, is repeated fill the desired formulation is achieved. 
The Cadila expert system (Ramani et al., 1992) is written in Prolog. Prolog is a 
programming language specialized in the field of artificial intelligence and as such 
programming expert systems is one of its domains (Bratko, 1990). The system selects the 
appropriate excipients according to facts like interactions between drug and excipients. 
There is a rule embedded in this system that all formulations must contain one binder, one 
disintegrant and one lubricant. Excipients related to other functional groups are added if 
necessary. The user can accept or reject the purposed formulation. In the latter case the 
system will suggest another formulation. The Cadila expert system has no process of 
formulation optimisation. 
Podczeck (1992) developed a knowledge based system for the development of tablets. 
Physical, physicochemical and pharmaceutical measuring methods were used to 
characterise 15 drugs in terms of their pharmaceutical behaviour. Each of these drugs was 
n-dxed with several excipients and the properties of these drugs in the mixtures were 
measured. The relationship between drug properties and the behaviour of mixtures of drug 
substances and excipients was done using canonical analysis, which is a multivariate 
statistical method. Hogan et al. (1996) also used this type of statistical analysis and the 
capsule data from their article was used in this thesis. The relationships found were 
calculated as facts and the rules of knowledge based system. The expert system was 
validated successfully using another set of 5 drug substances. 
The Galenical Development System, Heidelberg (GSH) has been designed for the 
development of direct compression tablets, hard shell capsules, aerosols and intravenous 
injection solutions. It uses functional groups for the excipients and has a database with 
important information like compatibility of the excipients. It uses functional groups also for 
the chemical and physical properties of the active ingredients, manufacturing processes and 
other types of data. The desired properties of the formulation are set for the GSH and the 
system suggests a formulation according to a rule-based mechanism. If the suggested 
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formulation does not satisifies the desired properties the development continues and the 
system suggests another formulation. This system has a back-tracking mechanism to go 
back to the previous step or abort. The programming language of this expert system is 
SMALLTALK V. More details about this expert system can be found in the book 
'Intelligent Software for Product Formulation' (Rowe & Roberts, 1998). There are two 
articles about this system (Stricker et al. 1991 & 1994) but these are in the German 
language with no translation available through the British library. 
To summarise the evolution in methodology, in regression field there was an evolution from 
equations that are usually of second order type without variable selection to final equations 
that passed variable selection processes like stepwise regression. This evolution is not seen 
in a chronological order. For example, Hussain et al. (1991) did not do variable selection 
although other researchers like Bohidar et al. (1979) did it before. In the field of ANN it 
can be seen that as more and more studies are performed more parameters are varied in 
ANN, like changing criteria to stop training as the error goal or the number of iterations. 
Parameters that concern ANN topology like the number of hidden neurons and the 
connections between the neurons inside ANN were also varied. Other parameters that were 
mentioned are the type of activation function in the neurons of the hidden or output layer. 
Optimisation methods have evolved from graphical methods (Schwartz et al., 1973) to 
numerical optimisation methods (Takahara et al., 1997a & 1997b). Expert systems were 
discussed in the final stage since they are new to pharmacy and since they could incorporate 
regression, ANN and optimisation methodologies. 
1.7.3 Present study 
This part will be a brief summary of objectives and how this study differs from previous 
ones. Also, there will be a brief explanation of the Expha expert system contribution. It will 
emphasise points already mentioned in the review of previous studies. 
This study attempts to investigate rigorously applications of regression analysis and ANN 
to the formulation and manufacture of solid dosage forms. Specificially it will use data from 
well-designed experiments (full factorial) of manipulating tablet formulation and process 
variables. On the other hand, it also will use limited data of manipulated capsule 
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formulation variables. The prediction of ANN and regression models will be compared 
using extensive statistical analysis that vvill focus on various aspects. There is an attempt to 
develop an expert system that helps novice formulators in formulation and for educational 
purposes for undergraduate and postgraduate students in pharmaceutical sciences. It vAll 
have rules, a database and also modelling vAth optimisation facilities. 
The work which is presented here is different from previous ones (i. e. Hussain et al., 1994; 
Murtoniemi et al., 1994a & 1994b) in several points. Several regression models were used 
here whereas most use just one regression model. This study used different methods of 
training ANN while others used just one method of training ANN. This study used other 
learning techniques apart from backpropagation while others (excluding Bourquin et al. 
1997b who also used a Kohonen network) used just backpropagation for training. After the 
derivation of ANN/regression models, and generation of the prediction results the study 
does not just present the results in terms like relative error in percent, but also used 
statistical techniques to see if the difference in the predicting ability is statistically different, 
a task that other studies have not done. 
Today the advanced pharmaceutical formulator who is up to date with the software can use 
separate systems to aid him in formulation. An approach is using an expert system like 
PFES (Rowe, 1997) which suggests a formulation; after creating the formulation the results 
of the response variables are fed back to obtain a better formulation. The process of trial 
and error continues using the expert system suggestions till a satisfactory solution is found. 
A second approach is to use the expert system just for the initial formulation and then on 
the basis of this formulation conduct designed experiments and use ANN/Regression for 
modelling. These experiments are combined with oPtimisation tools that are within 
commercial packages like CAD/Chem (Colbourn & Rowe, 1996). One can also invent the 
initial formulation and design experiments and modelling of data with statistical tools like 
regression and ANN available on commercial programs. Part of the data modelling 
software available on the market has also features that assist in the final stage, which is 
optimisation of a formulation. In the Expha expert system the ANN/regression models are 
incorporated with a pharmaceutical database for decision making in the formulation 
process. This approach of using various modelling and optimisation techniques, which the 
user can control, in combination with heuristic rules applied to the database, creates a more 
powerful decision tool than each one of the methods alone, and this was not done before. 
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This work helps the formulator abandon the passive part of using an expert system, instead 
it helps in knowing what the expert system consists of There is no process of building an 
expert system and implementing it from the expert to the software engineer and then to the 
programmer (which is probably best from the management point of view of getting the best 
expert system in the minimum amount of time). The systems built in the latter manner are 
protected and are not transparent and so the formulator has difficulty in using them from an 
academic point of view. They were built more as boxes that give solutions sometimes with 
the reasons for choosing the solution but as to how the system generated this solution is 
unclear. 
Expha can help in learning and training of novice pharmaceutical researchers in the 
pharmaceutical formulation field. It can give the students the fundamentals of formulation 
development. It can educate them to try different models. And give them tools also to judge 
which is better. This process will force them to delve into statistics, and their use of this 
will enhance their judgment ability as researchers. It can also be of use to pharmaceutical 
researchers in industry as a tool for developing new and improving old formulations. 
If the people using these systems want to delve into the world of database systems this 
work can elucidate this subject by examining Expha which is a transparent expert system. 
Altematively they can decide that they want to analyse their knowledge and to implement 
their own heuristic rules. But before that they will have to create their own relevant tables 
of data. All this analysis of their decision making, and the data they use, will cause them to 
understand better their formulation problems and hopefully solve them better. 
1.8 The structure of the thesis 
Chapter 2 is the Background chapter, the following three chapters relate to the subject of 
building ANN/regression models and doing comparison between the best ANN and 
regression models. Chapter 3 is based on experiments with a full factorial statistical design. 
The following chapter deals with improving ANN modelling to this data with more 
emphasis on robust comparison between ANN and regression. A second set of data utilised 
had significant gaps in the mapping of the response space. Hence, Chapter 5 is about 
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modelling of limited data. Chapter 6 presents the subject of multiobjective optimisation and 
uses the experimental data used in Chapters 3&4. In order to demonstrate how ANNI 
regression models are used through the process of data collection and decision making in 
the field of tablet formulation, they were incorporated into an expert system. This is dealt 
with in Chapter 7 as well as the incorporation of database and heuristic rules in the Expha 
expert system. Finally, Chapter 8 presents a brief summary and the main conclusions 




This chapter begins with a description of tablet technology concepts such as formulation 
considerations and stability studies. Some of these subjects like the flow of powders also 
apply to capsules. After the domain of the problem is described, the modelling techniques 
to solve tablet problems follow, beginning with regression and then by background on 
ANN. The section on ANN will present the basic principles of ANN to give a better 
understanding of them. The backpropagafion algorithm that is the most common ANN 
training method will be presented with variations to this algorithm. Radial basis function 
(RBF) ANN will be presented since in certain cases these are superior to ANN trained by 
backpropagation as is shown later in this thesis. Finally, expert systems, technology that 
sometimes incorporates the modelling techniques, vAll be discussed briefly. 
2.2 Tablet technology 
Tablets are the most popular dosage form. Tablets gained their popularity for several 
reasons. They are light and compact so are very easy to carry in a bag, for example (thus 
enhancing patient compliance), and have low transport cost from the factory to the patient. 
Another reason there is good compliance with tablets is that each tablet is a unit dosage 
form. In that respect, they are usually designed so that the patient takes one or two tablets 
as and when necessary, e. g. take one or two paracetamol tablets in a case of headache or 
one tablet of Aspirin! every day. Tablets are a solid dosage form and as such are 
considered quite stable relative to the liquid dosage forms. Tablets are also less prone to 
microbial contamination relative to liquid dosage forms. To meet pharmacological or 
market needs their performance can be manipulated, for example change of dosage from 
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two conventional release tablets a day to one sustained release tablet a day, in order to 
enhance patient compliance whilst maintaining the desired pharmacokinetic profile 
necessary to achieve adequate pharmacological action. A major advantage of tablets is their 
low production costs. Nevertheless, tablet manufacturing can be a very challenging task. 
For the success of tablet manufacturing there are demands from the physical characteristics 
of the powder and also from the tablet press design. The tablet manufacturing machines 
today can work very fast, and this high speed could cause uniformity of weight problems. 
For uniformity of weight to be consistent the bulk powder poured into the die should 
always be of the same volume and homogeneity. The tablet should comply with several 
characteristics (responses) that are sometimes contradictory in their nature, e. g. the tablet 
should be strong enough to endure its travelling from the manufacturing site to the client 
and also to dissolve fast enough in the body. 
The manufacturing process affects the tablet formulation whether this is granulation with 
water/solvent or direct compression. The process selection is dependent upon the drug 
characteristics such as sensitivity to heat and moisture, the flow characteristics of the 
mixture (drug/s plus excipients) and if there is a tendency for segregation. Granulation is 
required to remove dependency on physico-chemical characteristics of drug, improve flow, 
improve compressibility (enable the tablet to compact easier), reduce potential for 
segregation, increase density and improve worker safety by reducing dust hazards. There 
are two main granulation methods, dry and wet granulation. 
In a dry granulation method two processes are commonly used. In the first called slugging 
the powder mixture is blended, then a heavy-duty tablet machine makes very large tablets 
(slugs). The tablets are broken down and screened and the mixture is placed in a regular 
tablet machine. In the second method, roller compaction, the mixture is placed inside a 
hopper, then a rolling auger force feeds the powder through two pressure rolls and the 
compacted material is due to the roller compaction. This compacted material, as in the first 
method, is milled and goes into a regular tabletting machine. The process variables that can 
be monitored in the latter process are roll pressure, roll speed, auger speed (powder feed) 
and roll profile. 
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In a wet granulation method there are two types of manufacturing, there is a traditional 
process and a modem one. In the traditional process there is a mixing stage in a planetary 
mixer for 30 to 45 minutes, followed by granulation for 15-45 minutes. The wet mass is 
then screened, a process that takes about half an hour to one hour. This is dried on special 
trays in an oven for about 16 hours then the granules are dry screened, a process that takes 
about half an hour. In the modem process using a high speed granulator with a fluid bed 
drier the mixing stage takes from one to five minutes, granulation from 2 to 5 minutes and 
the drying stage takes from half an hour to one hour. It is also possible to complete the 
process in two to three hours using a fluid bed granulator. Wet granulation can improve 
mixing of potent drugs or colours by incorporating the drug or the colour in the binder 
solution. Since the wetting is much better in wet granulation, dissolution rate in wet 
granulation can be much better than in direct compression. The disadvantages of wet 
granulation processes are that they are lengthy, costly and require the drug to be heat and 
solvent stable. After the granules are made, it is beneficial to test the granules in order to 
trace problems before the tabletting stage. In-process control (IPQ tests are also becoming 
a requirement by the regulatory authorities. The granule parameters that can be tested are 
shape, size, size distribution, densityý surface area (related to porosity), consolidation and 
compaction properties of the granules, strength, friability and flow properties. 
In a direct compression process, after the powders are mixed there is the tablet 
compression stage. Some pharmaceutical companies encourage direct compression 
processes in their tablet development guidelines because of the lower costs and easier 
process validation compared to the granulation process. The selection of process is directly 
related to the selection of excipients and drug form, e. g. paracetarnol DC could be in the 
form of paracetamol coated with PVP (combination of paracetamol 96% and 4% PVP can 
be bought from ATABAY) to enhance its compactability and flow properties, so it can be 
used in a direct a compression process. 
After the tablet is made there are several problems that could arise. Poor weight uniformity 
can be caused by poor flow of the powder used in the tablet compression machine. 
Inappropriate mixing can cause poor content uniformity. Mixing has its own methodology 
and it is not a simple subject mixing for too long a time is also not good. The tablet may be 
weak (hardness test) which may be caused by an inappropriate use of binder. The tablets 
could be friable, meaning there might be problems in the transport from factory to the 
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patient and that coating of the tablets will be beset with major problems (if there is a 
ffiabiltiy problem before the tablet coating stage). 'Picking' (explained later) could be 
caused by lack of antiadherents. 'Capping' and 'lamination' could be caused by: elastic 
recovery, residual radial forces, presence of moisture, air entrapment, or machine problems 
like non-homogeneity of the force transmitted to the powder causing different densities in 
different areas of the tablet, a wear ring in the tablet machine die or damaged punches. 
Where there is a problem with the dissolution rate, it might be beneficial to examine the 
disintegration rate of the tablets. For tablets that do not disintegrate easily this may be due 
to the tablet hardness being too high or the tablets becoming a sticky mass in the presence 
of water. The appropriate choice of disintegrant and/or binder should solve these problems. 
For cases where there is no disintegration problem, the low rate of dissolution may be 
caused by too much lubricant (since most lubricants are hydrophobic) impairing drug 
dissolution. A sparingly soluble drug might exhibit low dissolution rate. Use of wetting 
agents can aid in solving this problem. As is demonstrated in this section, the key for 
solving many tablet problems is the appropriate choice of excipients. Hence, the use of 
excipients will be discussed in the following sections. 
The drug is mixed with several other ingredients to make a tablet. These ingredients termed 
excipients help the tablet perform as specified. The excipients are divided into several 
groups according to their role. One excipient can belong to several groups since it has 
several roles and for each one of the excipient roles there is a different recommended 
concentration. The tablet does not have to contain all the excipient groups. On the contrary, 
the simpler the formulation the better, as more ingredients can cause more problems. No 
one excipient group must be included. Even the most common groups like disintegrants are 
not always required as in cases where both drug and tablet are easily dissolved in body 
fluids. A description of several important excipient groups: diluents, binders, disintegrants, 
lubricants, glidants and antiadherents follows. Excipient groups with specialised funcfions 
like antioxidants for ensuring drug stability or wetting agents for improving drug solubility 
(influence dissolution rate and bioavailability) will not be discussed. Other groups that will 
not be mentioned are absorbents, colours and flavours. 
Ile most important ingredient in the tablet is the drug. 71be larger the amount of drug inside 
the tablet is the more dominant the drug properties are and should be considered. One of 
the important drug characteristics is its crystal form. It is possible to select a crystal form 
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that contains many defects rather than a perfect crystal. The advantage of the former form is 
better dissolution rate but the disadvantage is reduced stability. In a scaling up processes 
there are drugs of which crystal characteristics can change, i. e. can undergo polymorphism. 
Different polymorphic forms have different structures in the crystalline state, they can have 
different solubility i. e. they can have different dissolution rate. When the pharmaceutical 
formulator knows there is a tendency for polymorphism, the process involved should be 
taken into consideration as well as the selection of excipients. It is possible, by changing the 
shape of the particles, to influence mixing and tabletting processes. The processes involved 
in the production of tablets, like drug micronisation, could also influence the dissolution 
rate. The determination of the drug solubility is a very important step in tablet development. 
In order for the drug to be active it has to dissolve in body fluids and then be absorbed. To 
measure the drug's intrinsic dissolution rate the drug is compressed close to zero porosity 
in a special die. The die is immersed in solvent and the drug concentration as a function of 
time is measured. This measurement can estimate if dissolution is likely to be a problem 
and the appropriate excipient(s) required, e. g. wetting agents to help overcome a 
dissolution problem. Before adding any excipient to the drug it is common practice to test 
how the drug interacts with the excipient. Placing them together in an incubator with 
elevated temperature and humidity for accelerated compatibility study does this. 
There are a variety of purposes in adding diluents. For example the drug dose could be 
small -5 mg. It is not easy to handle such small tablets so it is necessary to add material 
that will increase the tablet volume. Ile appropriate choice of diluent for the formulation 
must be compatible with the other tablet ingredients. For example calcium salts are not 
suitable diluents for tetracyclines since they interfere with the absorption. Another 
interaction is between arnine bases or salts with lactose or alkaline lubricant. This latter 
interaction results in tablet discoloration. Lactose is one of the popular diluents. It is 
important to note that different types of lactose have different properties. Carbohydrates are 
also popular diluents since they are not toxic, have reasonable taste, reasonable dissolution 
profile and the most importantly they enhance tablet cohesiveness (so act as binders). 
Excipients that are water-soluble and particularly diluents (since they constitute a large 
proportion of the tablet) are an important factor for good dissolution. Water content is an 
important diluent parameter that can influence drug stability, e. g. in preparing Aspirin" 
tablets it is best that the diluent contains no moisture since acetyl-salicylic acid reacts with 
water. Two other criteria for diluent selection are the production process and diluent 
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strength characteristics. The latter criterion is illustrated in plots of crushing strength as a 
function of applied force. 
Binders are used for adding cohesiveness to a tablet, so the powder upon compression 
would became a strong compact. It is important that the tablet is not too strong since this 
can influence drug dissolution from tablet. The primary criterion for choosing a binder is its 
inertness with the other tablet ingredients (compatibility). Secondly, the cohesiveness ability 
since without enough cohesiveness a tablet would not be formed. A third reason is the ease 
of binder use in the production process. 
The purpose of a disintegrant is to facilitate tablet breakage into smaller particles upon 
contact with body fluids. There are six basic groups of disintegrants: starches, clays, 
celluloses, algins, gums and miscellaneous. Disintegrants work by several mechanisms. 
The first group is of disintegrants that propagate capillary effects (water uptake by capillary 
forces), materials that belong to the group are starches and some forms of microcrystalline 
cellulose like Avicel. The second group is of disintegrants that swell. Ile problem is that 
some of the excipients belonging to the second group form a wet mass causing tablet 
swelling (e. g. powdered gum like tragacanth), but since it is also good binder, a 
concentration above 5% is not recommended. The third mechanism belongs to the gas 
producing disintegrants. These are good when fast disintegrafion is needed. In the 
production process involving this third type of disintegrants, it is necessary that in the 
tabletting; room the relative humidity is low. In this process it is also necessary to add the 
disintegrant just before tablet compression to avoid moisture uptake by them. Their 
composition is similar to that of effervescent tablets. The most cornmon is a mixture of 
citric acid with tartaric acid with carbonates or bicarbonates. 
There are also two other types of disintegrant mechanism that are not so popular. The first 
is a disintegrant of the enzyme type. They work by acting on specific binders that are used 
in wet granulation process. The reaction between the enzyme and the binder in the presence 
of body fluids generates the tablet disintegration reaction. The second type of disintegrants 
is the melter disintegrants. The tablet ingredients are 'locked' inside these disintegrants. 
Since they have low melting points, at body temperature they become liquid and the 
contents are poured out inside the body. 
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It is recommended that the disintegrant is both inside the granules and outside it, i. e. 
intergranular and extragranular. As the portion of disintegrant increases in the intragranular 
part relative to its extragranular part the tablet becomes harder. Addition to the 
extragranular part is good for fast disintegration rate whereas adding to the intragranular 
part is important for breaking each granule into fine particles. 
The next excipient that will be discussed is the lubricant. Most of the lubricants are 
hydrophobic so it is important to put disintegrants that are hydrophilic like starch in the 
extragranular part. Combinations of disintegrant and lubricant that are added before 
production are called running powder (Lieberman et al., 1989). This simultaneous addition 
prevents a possible pitfall, since the lubricant could coat the disintegrant preventing water 
from penetrating thus reducing the effectiveness of the disintegrant. 
The lubricant's role is to reduce friction between the powder and the die wall. Lubricants 
enable the transmission of tablet machine compression force and also help reduce the 
ejection force. There are two types of lubricants, the fluid and the boundary type. The first 
type acts by the creation of separation between the two surfaces that move past one another, 
i. e. between the metal surface of the machine and the powder surface. Mineral oil is an 
example of this type of lubricant. The second type act by adhering to the tablet press metal- 
surfaces in the die using the polar part of the molecule, e. g. magnesium stearate. The first 
type is considered inferior relative to the second one since without the polar portion its 
adherence to the metal surfaces of the die wall is poor. As a guideline, lubricant mixing 
time and lubricant concentration should be the minimum possible. This is because as the 
amount of lubricant inside the tablet increases there is more chance the lubricant would 
weaken the tablet or impair the dissolution process (most lubricants being hydrophobic). In 
the production process it is worth monitoring carefully the n-dxing time, mixing speed and 
batch size since they all influence the lubricant's performance. With respect to tablet 
dissolution it is preferable use soluble lubricants but their lubrication efficiency is less, 
relative to the hydrophobic ones. Sodium lauryl sulphate is an example of a soluble 
lubricant. Since it is a weak lubricant it must be added in higher concentrations than the 
hydrophobic ones. Sometimes, combinations between hydrophilic and hydrophobic 
lubricant give the best balance with respect to lubricity, tablet hardness and disintegration 
time, e. g. starch is added to the lubricant in a range of 1: 1-1: 4 (Lieberman et al., 1989). 
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Glidants are used to enhance the powder flow and also help in the particle arrangement 
inside the die before the compression stage. In addition, glidants help to prevent segregation 
due to excess vibration. They act by reducing interparticulate friction. Uniformity of weight 
property is directly related to the consistency of flow since the same amount of powder 
should enter the die for each tablet. If upon addition of glidant the flow is still poor, it is 
possible to force feed the powder into the tabletting machine. Com starch is an example of 
a glidant that changes flow properties with changes in its concentration. At low 
concentration it is used as glidant, at concentrations above 10% it does the opposite by 
reducing powder flow. Another characteristic it has is that it also acts as a disintegrant. As 
mentioned in relation to lubricants, high concentrations are not recommended, e. g. a high 
concentration of a hydrophobic glidant like talc has a bad influence on the dissolution rate. 
Tale, starch and most of the lubricants belong to the antiadherents group. In certain cases 
although there is a lubricant in the formulation it is necessary to add materials from this 
group. This is because sometimes the powder adheres to the punches or to the die wall, that 
can be seen in a phenomenon termed 'picking' in the tablet, giving the tablet rough 
surfaces. In such a case materials of this group should be added or there should be an 
increase in lubricant concentration if it belongs to this group. Formulations containing high 
concentrations of vitamin E need antiadherent since they have a tendency to 'picking' 
(Lieberman et al., 1989). Usually, antiadherents are hydrophobic but there are also water 
soluble ones like DL-Leucine that are suitable for tablets prone to 'picking' and dissolution 
problems. 
After the formulation ingredients are chosen, and the powder is ready for compaction it is 
important to test powder flow properties. As mentioned earlier the powder flow is very 
important for the uniformity of weight parameter and this problem is very relevant to 
today's world because very fast tabletting machines are in use today. Usually 
pharmaceutical powders are cohesive, so they tend to move together as one mass like flour 
or wet sand. The aim is that they will flow as freely as dry sand. There are a number of 
factors that affect powder flow and cohesion like particle size, shape and density as well as 
interparticulate forces, moisture and temperature. There are a number of tests that are used 
for prediction of powder flow. It is possible to measure angle of repose dynamically or in a 
static manner. In a test of angle of repose (static) there is a measured angle when a cone of 
powder is poured onto a flat surface. In an angle of spatula test the angle measured is the 
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one formed when material is raised from a flat surface out of a bulk pile. Another test of 
powder flow is flow through a circular orifice. In this test the rate of powder flow through 
the orifice is measured. Bulk density measurements could give estimates of flow of 
material. One of these measurements is Carr's compressibility index. In this test the 
powder is poured into a vessel and bulk density is calculated by measuring the powder's 
volume and weight. After standardizing the tapping procedure (Lachman et al., 1986), 
which can be done using a 'Jolting Meter', the tap density is calculated. From the latter two 
calculafions Carr's compressibility index is calculated as: 
(tapped density - bulk density) / tapped density 
Multiplying by 100 will give the result in percentage terms. 
Hausner's ratio is calculated as: 
tapped density / bulk density 
And again multiplying by 100 will give the result in percent. 
Now that the tablet is ready and the tablet properties meet the specifications, the most 
expensive and time-consuming step still remains to be done, the stability testing. A drug 
should be stable through all its shelf life period. The drug can decompose into inactive 
ingredients, active metabolites or toxic materials. In an era of very tough competition 
between the pharmaceutical generic companies over the one who will mimic faster drugs 
the patent of which has expired, it is not practical to wait three years in room temperature 
conditions to see if the development succeeded. It is also important for the NDA 
companies--just because they waited too long for long term stability studies-because 
another company could enter the market faster with a drug for the same indication and be 
the first on the market. All modem pharmaceutical companies hence do accelerated stability 
studies with the use of several incubators under different environmental conditions. After 
the experimental manufacturing of the tablets they are packaged (e. g. in blisters) and placed 
in appropriate incubators and are withdrawn for testing with strict regimen. The regulatory 
authorities usually allow manufacturers after storing drugs for 6 months at 40*C and 75% 
relative humidity a permitted shelf life of three years if the tests on the tablets are 
satisfactory. But the manufacturers must still monitor the stability of the drug through all 3 
years at room temperature. 
There are not many studies on the kinetics of drugs in the solid state. The kinetics of 
benzoic acid derivatives (belong to the domain of pure solids kinetics) was studied by 
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Carstensen and Musa (1972). The decomposition curve of aminobenzoic acid was found to 
be sigmoidal. Hence, the rate order of the decomposition changes according to the 
decomposition phase. In the case of an-ýnobenzoic acid, after the liquid begins to form the 
reaction becomes first order one, as the stability kinetics of drug in solution. Tablets could 
have even more complex kinetics since there are also possible interactions with excipients 
in the formulation. An example of how to calculate stability of drug in solution follows. It is 
given here since the first order kinetics described here is also assumed in Expha calculation 
(explained later) regarding the stability of the drug in the granulation process. 
If one measures the amount of drug in aqueous solution, in each incubator, at different time 
points, a plot of concentration of drug on the y-axis against incubation time (in hours) on 
the x-axis is obtained. For each incubation temperature a regression trend line could thus be 
plotted between the experimental points, this plot is shown on Figure 2.1. Obviously, as the 
incubation temperature increases the slope of the line is greater. The slope of the line is 
defmed as the decomposition constant k. Now it is possible to plot an Arrhenius 
relationship that is log k (k as measured from Figure 2.1) on the y-axis against reciprocals 
of the absolute temperature (multiplied by 106) on the x-axis. Regression trend line is 
drawn between the different log k for each incubation temperature and this line is 
extrapolated to 25"C as in Figure 2.2 (see Martin et al., 1983 for stability issues discussed 
here). The extrapolation to room temperature stands on the assumption that the 
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Figure 2.2: Arrhenius plot for predicting drug stability at room temperatures. T is the 
absolute temperature. 
2.3 Regression analysis 
Compaction Force (kN) 
Regression analysis is a method of finding an equation that best describes the data. 
y= a*x +b is an example of a regression analysis equation. y is the measured 
dependent variable (response) and x is the independent variable. Residual (error) is the 
difference between the observed value and the predicted value by the regression line. The 
sum squared error (SSE) is defined in the following equation: 
, md)2. SSE =Z (YpmdicW -Y obm The value in parenthesis is the residual. The ideal regression 
equation line is the one that its sum of residuals is equal to zero with the minimum SSE. 
From the above it is obvious why the regression line is also called the least square line. 
Figure 2.3 shows the change in tablet hardness as a function of compaction force. The 





Figure 23: Schematic plot of tablet hardness as a function of compaction force. The line is 
a simple linear regression line. 
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T-1 * 106 
It is also possible to build a complicated polynomial with several coefficients instead of the 
simple regression line. Figure 2.4 shows regression polynomial for the same data as in 
Figure 2.3. It can be seen that as opposed to the simple linear regression line presented in 
Figure 2.3 the regression line of Figure 2.4 fitted the data perfectly with no errors at all. 
The question that arises is which one of the models is better? 
ollý 
ti) 
Compaction Force (kN) 
Figure 2A Schematic plot of tablet hardness as a function of compaction force. The line is 
a polynomial regression line. 
It is possible to calculate a very important parameter that is called the coefficient of 
determination denoted by r2. If there are several independent variables the coefficient is 
called the multiple coefficient of determination and is denoted by Rý. So the term multiple 
is added according to the number of independent variables. The multiple coefficient of 
determination is calculated as Rý =I- (SSE / SS). 
SS is the sum of squares of the difference between the observed values and the mean 
values. The same calculation applies for the coefficient of determination (ý). If SSE is 
almost equal to SS then the expression in parenthesis will approximately be equal to I and 
Rý will approximately equal to 0. If SS is much bigger than SSE then the expression in 
parenthesis will approximately equal to 0 and Rý will approximately equal to 1. What is the 
meaning of the R2? If the value of Rý is 0.9 then 90% of the sample variation in y can be 
explained by using the equation to predict y. 
How does one know that the regression equation is good for prediction? By definition if the 
number of coefficients is equal to the number of cases the value of Rý is equal to I and it 
can be stated that 100% of the sample variation can be explained by using x to predict y. 
But this model is usually bad for predicting. The regression line in Figure 2.3 of the simple 
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model of a straight line probably predicts better then the complicated model of Figure 2.4 
although its W is much less than the Rý of the more complicated model. The complicated 
model memorises; the data as opposed to the more simple equation that probably learns the 
data. In other words, the more complex model can predict perfectly what it was developed 
with but cannot predict any other data points it has not seen. Figure 2.5 shows the change 
in W and in validation set error as a function of the number of coefficients in the regression 
equation. It can be seen in Figure 2.5 that as the number of coefficients goes up the Rý goes 
up, this happens since the SSE goes down. When a test is applied to check the predictive 
ability of the regression equation (in the form of measuring the validation set error), it can 
be seen in the bottom plot of Figure 2.5 that from a certain number of coefficients there is a 
deterioration in the predictive ability. Hence, the number of coefficients should be 
monitored carefully. The appropriate monitoring can be done with the aid of various 
techniques for the selection of coefficients. 
R2 
Validation set error 
Figure 2.5: The change in Rý (upper plot) and in validation set error (bottom plot) as a 
function of the number of coefficients in the regression equation. 
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Regression is a technique used in numerous research fields and the statistical inferences 
derived from this can be very interesting. Recalling the example in the introduction, a study 
was conducted by taking interviews with approximately 1000 women. The 2 variables 
measured in the study were financial reward at age 40, which was the dependent variable, 
and premarital pregnancy as the independent variable. The article concluded that couples 
beginning marriage with the bride already pregnant faced lower income and living 
standards and 22% fewer assets than couples with no premarital pregnancy. The paper 
concluded hence, a cause and effect relationship, but it may be that the socio-economic 
level of the women contributed to their premarital pregnancy and less money at the age of 
40. The data that they collected is called observational data. In observational data it is not 
possible to control the x values and one cannot draw a cause and effect relationship 
although the statistical tests are significant. In experimental data the independent variables 
are set in advance and it is possible to draw a cause and effect relationship. For example, in 
a set of experiments only compaction force was changed and the response measured was 
hardness. It could be stated that change in the compaction force caused the tablet to be 
harder. 
2.4 ANN 
There are a large number of texbooks, which provide a good introduction to ANN field. 
(Nelson & Illingworth, 1991; Xeksander & Morton, 1992; Haykin, 1994; Beale & 
Jackson, 1994; Bishop, 1996). The most readable of these are those of Nelson & 
Illingworth and Beale & Jackson. However, Nelson & Illingworth's book is quite 
superficial that gives just a 'feel' to ANN, since it is a brief course not intended for people 
with a scientific background. Beale & Jackson's book gives a more robust foundation to 
ANN without delving into complicated mathematics. This introduction to ANN is based in 
part on these books. The information here is also based on Hines (1997), Hagan et al. 
(1996) and Demuth & Beale (1998). The book by Gallant (1993) describes an expert 
system that incorporates ANN, and this concept of incorporating ANN into expert systems 
was also used in this study. 
An ANN is a mathematical model that uses as its basic component the model of the neuron 
in the brain. This basic unit in ANN is called a perceptron (Hagan et al., 1996). The neuron 
in the brain receives its inputs from other neurons and so does the perceptron. The strength 
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of the input from the other neurons depends on the synaptic strength. In ANN this synaptic 
strength is called the weight of the connection. On receiving enough stimulation, the neuron 
in the brain 'fires' and feeds its output to other neurons that are connected to it. Similarly, 
the perceptron receives a signal and according to its activation function sends its output to 
other connecting neurons. 
Figure 2.6 shows ANN with a single neuron in action. The goal is to train ANN so that 
when input "xi" is presented it will generate output of "yI , b. " and when input "X2" 
is 
presented it %krill generate Output Of IIY2 obs". In Figure 2.6 there is ANN with 
just one 
neuron. The value of the single input unit is multiplied by the weight denoted by the letter, 
"W". To allow more flexibility in the system a bias value is introduced denoted by the letter 
"B". The bias summed with the value of the input unit multiplied by "W" produces the 
calculated "X" value. The bias is always multiplied by I and generally there is a bias in 
ANN. The bias can be considered just as having another weight attached to an input unit 
with a constant value of 1. So the ANN could be seen as one with 2 input units and 2 
weights. The calculated "X" value enters into the activation function of the perceptron 
which outputs the calculated "y, . 1" value. In the next iteration "X2" is the 
input value and 
the output of the ANN is "y2 . 1". 
fly, b. " and "y2 b. " are the desired outputs to the inputs of "xl" and "X2" respectively. The 
difference between the observed and the desired output of the ANN is the residual. The 
Sum Squared Error (SSE) is the sum of the squared residuals. The SSE in Figure 2.6 is 
defined as: 
SSE = (y, Obs _ Y, C"1)2 
+ (Y2 Obs _ Y2 C31)2. 
By adjusting the weights ANN can minimise the SSE. Looking at the ANN from Figure 
2.6 there are two weight variables to be optimised: "B" and "W", the optimisation process 
aim to find the values of these variables that would give the lowest error (minimum SSE). 
The process of minimisation of the SSE by the ANN is called the learning/training process. 
A learning rule (also known as training alogorithm) is a procedure for modifying the 
weights and biases of a network. Backpropagation is a training algorithm that is commonly 
used to adjust the weights in a multilayer network. In this learning method the weights 
adjustments are propagated backwards from the output neurons to the input neurons. 
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Inside ANN with a Single Perceptron 
Yl Cal Yl obs 
Y2 cal Y2 obs 
SSE = (YI obs _YI cal)2 + 
(Y2 
obs - Y2 cal)2 
Figure 2.6: Inside ANN of a single neuron. "xi" and "X2" are the input values. 
Abbreviations: "In" is input unit and "out" is output perceptron. The sum x, -W+B X) is 
entered to the perceptron into its activation function "ftX)" and the output is "y, The 
required output is "y, &,, ". The same calculation is repeated on 19X2". In the training process 
"W" (weight) and "B" (Bias) are adjusted in order to minimise the SSE. 
2.4.1 Learning by backpropagation 
This section explains the backpropagation algorithm for ANN training. Backpropagation is 
one form of supervised learning as opposed to unsupervised learning. Unsupervised 
learning does not require any information regarding the target output. The unsupervised 
Hebb rule is demonstrated in the following equation: 
W(new) = W(old) + CC lkq Pq 
Where W(new) are the new weights. W(old) are the old weights to be updated. cL is the 
leaming rate and a., p. are output and input pair for a given q data point respectively. The 
superscript T is denoted for transposition of the input vectors from rows to columns to 
enable multiplication with output vector columns. It can be seen from the equation that 
when the input is positive and the output of the ANN is positive the new weights are 
bigger. The change in weights is proportional to the size of input and output vectors. In the 
brain when one neuron excites an adjacent one (input to the neuron) the efficiency of 
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excitation with more and more stimulus is increased, this is done by a physical mechanism 
between the cells in the brain. There is evidence that some brain cells do behave according 
to this Hebbian learning pattern. It can also seen from the equation that if both input and 
output pair are negative there is a proportional increase in the weights. For opposite signs 
of input and output vectors there is a decrease in weights. There are many other 
unsupervised learning algorithms for use with ANN that can help in learning the input 
patterns. In supervised learning there is positive feedback for desired response and negative 
feedback for undesired response. So in supervised learning the target values must be taken 
into account in comparing them to the actual values that the ANN outputs. The delta rule is 
a variation of Hebbian learning rule for supervised lean-dng. The rule takes the form of the 
equation: 
W(new) = W(old) + cc (tq- aq) pqT 
Where all the parameters are like the previous equation except the tq Which is the relevant 
target vector of q data point. The delta rule got its name from the difference between 
desired and actual output. It is also called Widrow-Hoff algorithm (Widrow & Hoff, 1960) 
after the researchers who developed it. The delta rule is used to minin-ýise the SSE and is 
precursor to the backpropagation algorithm which will be presented now. 
Like the Widrow-Hoff algorithm the backpropagation algorithm also aims to minimise the 
SSE. The function that the training process tries to minimise is called the performance 
function. Looking at the ANN from the previous example there are 2 variables to be 
optimised the bias B and the weight W. The aim is to find the values of these variables that 
will give the lowest error (minimum SSE). Suppose one wants to plot the error function of 
the surface. First put values of 4,4 for both W and B. The ANN is trained with these 
values and the SSE for data point (4, -4) is calculated (SSE = 0.2, see Figure 2.7). Then at 
specific interval the next point is selected and using the ANN its SSE is calculated. In the 
same way thousands of points can be calculated by taking different values of W and B and 
the result is shown in Figure 2.7. On the right there is a contour plot of the error surface 
and on the left is the error surface. The height of the surface is the SSE. The aim is to get to 
the lowest SSE. At the point of lowest SSE the weight and bias are at their appropriate 
values and the ANN has learned. Backpropagation tries to minimise the error by gradient 
descent. A simple analogy is a ball with no inertia that represents the network rolling 
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around the error surface. The ball always rolls in the steepest direction until it stops at the 
bottom of a valley, which is the error minimum. The network path (called trajectory) 
crosses the contour lines at approximately 90 degrees in a method called steepest descent. 
As an example of minimisation path, one can look at Figure 2.7 and see the starting guess 
(-2, -2). The optimisation path moves according to the law of gravity, in the manner 
described earlier till it reaches the minimum point. It stopped there since it cannot go down 

























Figure 2.7: Minimisation pathway starting from the point -2, -2. The weight (W) and bias 
(B) are changed at each iteration until the minimisation leads to the minimum point. 
Figure 2.8 illustrates a multilayer ANN with one hidden neuron and one output neuron. 
This ANN will be used to demonstrate how ANN trains in a backpropagation. The input to 
the network is p and the goal is to train the ANN to generate output of t when presented 
with this input. The input to the hidden neuron in the first layer can also be seen as the 




if II%I %Ikx x 
Ile ANN weights and biases are: 
Weights: wl(O) =I wý(O) 2 
Bias: b'(0) = -1 b 
2(o) 
-2 
The superscript represents the layer, and the number in parenthesis represents the iteration, 
e. g. iv'(O) is the weight to the first layer in the first iteration (the counting of the number of 
epochs for ANN begins with 0) 
a2 
Figure 2.8: Inside feedforward backpropagation ANN with two neurons. The input value 
to the ANN is p=2. The sum n' = wl *p+ bl is entered to the neuron's activation 
functiony(W) and the output of the hidden neuron is a'. The sum n2 = iv2 * a2 +b2 is 
entered to the output neuron's activation function/0) and the output of the ANN is a2. 
The output of the ANN (a2) is compared to the desired (t) output and the error term t- a2 is 
calculated. The sensitivities, which take into account the derivatives of the activation 
function and the error term, are propagated back and the weights and biases are adjusted 
accordingly. 
The parameters so far were important for calculating the forward pass of the ANN. The 
activation functions are important for calculating the forward pass and their derivatives are 
important for the backward steps of adjusting the weights. The learning rate is an important 
parameter of the backward steps. Here are additional parameters that are important for the 
learning process of the ANN: 
Learning rate: a=aI 
Activation function of the first layer: 
en - e-» '(n) 
en + e-" 
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en - Cm (em - e-") + 
ex + C-A 
=I- 
e" - e-n =I- 
(dy. 
+2 + -, 
2 dii dn 
(em 
+ e-m (em + e-R em + e-m em +e -M 2 e "He 
Activation function of the second layer: 
f'(n) =n 
Its derivative is: 
=d (n) di i cbi 
Calculation of the forward pass to generate the ANN output: 
nl(O) = iv'(Oý p+ bl(O) = (1) (0.5) + (-J) = -a5 
a (0) =. / ýý )= -0.46212 2(o) 
n2ro) = iv (0) al(O) +b= (2)(-0.5) + (-2) = -3 
and the output of the ANN is: 
a2(0) =. f (W) = -3 
The error term of the network is: 
c =(1-a2) = (0.9 - (-3» = 3.9 
Calculation of the new weights and biases of the ANN: 
For abbreviation, the calculation. of the derivatives for the first and second activation 
functions will be denoted as F4 and 172respectively. 
12 2=0 78645 
, F; 
4=1-(a')2=J-(-0.462 
T, 2 =I 
In backpropagation the sensitivities (denoted by s) are propagated back: 
s2 = -2 F2 c= (-2) (1) (3.9) =-7.8 I= pi 2 S2 =0 78645 2 s 7.8 = -12.269 IV )() 
Now that the sensitivities for the first and second layer were calculated the weights and 
biases can be updated: 
iv2(I) =iv2(O) - as2al =2-(0.1)(-7.8)(-O. 46212) = 1.6395 
wl(1) = w'(O) -a s' ao =1- (0.1)(-12.269)(0.5) = 1.6135 
b21 20 s2 = () =b ()-a -2 - (0.1)(-Z8) = -1.22 
bl(1) = (0) -a s2 = -1 - (0.1)(-12.269) = 0.2269 
In more complex ANN topologies the calculations of the forward and backward 
backpropagation use matrix algebra, but the calculations are in exactly the same manner. 
The backpropagation calculations will henceforth be presented in a general form using 
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am+' = r+l (Wm+l in +b'+') for m 0,2,..., M-1 
Where m is the layer number and M represent the output layer. 
The calculated output of the ANN is a= am. 
Backward Propagation 
The sensitivities are propagated back and they take into account the derivatives F(n) and 
the error term (t-a). 
sm = -2e(nm) (t-a) 
sm= Fcn(nm) 
(wm+I)T Sm+I for m= M-I,..., 2,1 
Where the superscript T in (Wm+I)T represent the transposition of the matrix such that the 
columns of W'+' become rows in (Wm+I)T and the rows in W'+' become columns in 
(W m+I)T . This operation 
is important for the matrix multiplication. 
Weight & bias update 
Finafly the weights and biases are adjusted with a leaming rate. 
Wm(k+, ) = Wm(k) _ (X Sin 
(am-I)T 
b'(k+l) = bm(k) - cc sm 
2.4.2 Heuristic variations on backpropagation: momentum 
and adaptive learning rate. 
The adding of momentum and/or adaptive learning rate can improve performance and 
convergence speed of backpropagation. Momentum helps in overcoming barriers by 
jumping over local minima. It causes the algorithm to go faster in the trajectory direction. 
Momentum acts to screen out the noise and with only the general/average trend left, it is 
like a filter. Due to the filtering property of momentum it can help ANN to relate not just to 
the current gradient but also to recent trends in the error surface. As the momentum term 
gets larger it filters more noise. As the trajectory becomes smoother the weight changes are 
less drastic and fewer oscillations can be detected in a plot of SSE versus the number of 
iterations. The implementation of the momentum term is done at the stage of updating the 
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weights and biases. Adding the momentum term changes the equations for updating the 
weights and biases to: 
AW'(k+ 1) y AW'(k) - (I - y) a s' (a'I)T 
Ab'(k+ 1) = Ab(k) - (I - y) cc s' 
where y is the momentum term. 
The momentum term takes values between 0 and 1. If the momentum takes the value of I 
the right side of the equations above became 0, and there is no change in the weights and 
biases. If the momentum takes the value of 0 there is no momentum and the weights and 
biases are updated as in regular backpropagation. 
Figure 2.9 shows a more intuitive explanation of momentum in backpropagation. The 
demonstration of the backpropagation path is of ANN with only one input unit, one neuron 
and one weight. On the x-axis is the weight of the neuron and on the y-axis is the SSE. The 
ball always rolls in the steepest direction (the derivative of the activation function 
demonstrated earlier), according to the law of gravitation, until it stops at the bottom of a 
valley; this is the error minimum. In order to avoid getting stuck in local minimum the 
momentum term is added and if large enough the ball jumps over the local minimum to fall 
into global minimum, hence reaching the lowest error. If the momentum is too low it will 





Figure 2.9: The green ball will fall, according to the gravitation laws, to the local minimum 
but with the aid of the right amount of momentum it could reach the global minimum. 
Learning rate is the size of the steps that an ANN takes in the error surface. If it is too small 
it will take a lot of steps for the ANN to arrive at the error minimum. The learning rate 
required is the one that produces large steps so the ANN learns quickly, and yet small 
enough to produce short steps when needed. The solution to the problem is a variable 
learning rate. A variable learning rate is used when there is a need that the size of the steps 
will take into account the error surface. When the surface is flat it is preferable the step size 
is large. When the surface is steep there is preference for a small learning rate. Figure 2.10 
illustrates the backpropagation path of ANN with single neuron with one weight and one 
bias. On the left is an illustration of adequate learning rate and on the right an illustration of 
a learning rate that is too large. It can be seen that the large step does not allow the ANN to 















Weight = 1.6129 
Figure 2.10: On the left picture is ANN with adequate learning rate and on the right is 
ANN with learning rate too large. 
The two questions to ask therefore are: 
How can one know the effor surface? 
How much change can there be in the step size? 
There is a common algorithm for variable learning rate (Hagan et al., 1996) that has 3 rules: 
1. When the SSE increases below a specified value of ý (usually one to five percent) then 
the weight update is accepted and the momentum (if used) and adaptive learning rate are 
unchanged. 
2. When the SSE increases by more than ý then the new weights are discarded and the 
learning rate is multiplied by value O<p< I and the momentum term is set to 0. 
3. When there is a decrease in the SSE then the new weights are accepted. The learning rate 
is multiplied by Tj> I- If the momentum (y) was previously set to zero, it is now set to its 
original y value. 
So the learning rate is dependent upon 3 new parameters ý, p, and -rj. If momentum as well 
as adaptive learning rate is in use then the algorithm is dependent upon 5 parameters, 
whereas simple backpropagation was dependent on just one parameter of cc, the value of 
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Weight = O. J57497 
the learning rate. There are numerous algorithms of variable learning rate, e. g. one that has 
different learning rate for each variable (weight or bias). In this algorithm if there is a 
change in the weights in the same direction as in the previous several iterations then the 
learning rate increases, if the change in the weights alternates then the leaming rate 
decreases. This study uses the simple form of variable learning rate as described in the first 
example, rather than a complex one. There are two reasons for doing the simple heuristic 
variation and not the complex ones. The first is to reduce the sensitivity of the algorithm 
performance to changes in the learning parameters. The second is to reduce the probability 
of not converging to a solution that simple backpropagation will find. 
2.4.3 Radial basis function ANN 
Radial basis function (RBF) ANN is different from ANN of the usual multilayer perceptron 
(MLP) type. This section will explain how they differ and how they work. The output layer 
neurons of RBF ANN performs a linear transformation in the activation function, but their 
weights are usually adjusted according to least-square algorithm and not with 
backpropagation as in 1ýEP. The hidden layer neurons are radial basis function neurons. 
Each one of them does local mappings to the inputs. So, RBF ANN does local mapping 
whereas MIP does global mapping to the inputs. Figure 2.11 shows how they map 
differentially their input data. 
0 
0 
0 0 ', --0 oz 
RIBF ANN Mapping 
Figure 2.11: Multilayer perceptron (MLP) global mapping on the left figure, versus radial 
basis function (RBF) ANN local mapping on the right figure. 
Each RBF neuron has its own receptive field. Figure 2.12 shows the receptive fields in the 
input space of each RBF neuron. 
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MLP Mapping 
Radial Basis Function Neurons 
Figure 2.12: Receptive fields of each radial basis function (RBF) neuron. 
The activation function of RBF neuron is a Gaussian one. This means that the closer the 
input is to the centre of the receptive field the more the output of the RBF neuron. The 
output of RBF neuron is calculated according to the following formula: 
gj(X) = exp[(-X-ýLj) 
2/0j2 I 
Where x is the input vector, A is the centre of the receptive field, oj is the width of the 
receptive field and gj(x) is the output of neuron number j. 
An important parameter to choose is the width of the receptive field. The receptive fields 
should overlap, but they should not be too big, to prevent them from being highly active for 
a single input. In this study the width of the receptive field is termed as spread constant. 
This study tried numerous spread constants and the change in them influenced immensely 
the generalisation ability of the ANN. 
There is another important parameter and it is the number of RBF neurons. Two methods 
of choosing them were selected. One of them is that there are as many RBF neurons as 
there are input vectors (it is a vector since it could be composed of more than one 
independent variable). The second one is that neurons are added to the ANN until the sum 
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Receptive Fields 
squared error falls below an error goal or a maximum number of neurons has been reached. 
The second method showed better results in this study. To summarise, the steps used to 
train RBF ANN according to the latter method were: 
1. The ANN is simulated. 
2, The input vector with the greatest error is found. 
3. A RBF neuron is added with weights equal to that vector. 
4. The output layer weights are adjusted to minimise error. 
This study will show RBF neurons predicted better, part of the responses. Like regression, 
their training time is much shorter than MLP (but not as short as regression) and they will 
always repeat their results. 
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2.5 Expert systems 
Expert systems are used in many fields like: electronics, geology, engineering, chemistry 
and medicine. They are utilised in pharmacy in general and also specifically in the domain 
of pharmaceutical product formulation (Rowe & Roberts, 1998). Rowe explains in his book 
the basic principles of expert systems in general. He surveyes a number of expert systems 
in the product formulation field. He explains which technologies were incorporated in the 
expert systems like ANN and genetic algorithm. He also gives the background to these 
technologies. Bohl (1990) brings detailed examples of solving formulation problems. When 
he discusses expert systems he focuses on subjects like building regression equations and 
solving multiobjective optimisation problems. These two books on product formulation 
using expert systems approach the subject from completely different angles. It is quite 
common that books or articles discussing expert systems used in solving the same problem 
seem so different from each other. The reason for the latter point stems from the fact that 
expert systems are such a broad subject that has numerous definitions. One of them was 
presented in the introduction. Main issues regarding expert systems (Giarratano & Riley, 
1994) are given in the following paragraphs. The aim of this section is to give the reader a 
'feel' for expert systems. 
Characteristics of expert systems: 
I. The quality of expert system advice should be better than or equal to a human expert in 
the field. 
2. The response time of an expert system should not be too long. 
3. Reliability - the expert system should not crash frequently otherwise people will not want 
to use it. 
4. Explanation - it is important the expert system explain its decisions. It is hard to accept 
answers that can not be explained. It is also a way to track errors. 
5. Flexibility - the expert system should have facilities to update the expert system 
knowledge. 
The technology of ANN is considered as a milestone in the development of expert systems 
and these terms (ANN and expert systems) are quite often related. Bohl (1990) describes 
an expert system for formulation of cupcakes with the use of regression. Hence, ANN and 
also regression are technologies that are used in expert systems. 
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One important expert system is MYCIN (Gallant, 1993). This system diagnoses illness and 
suggests a remedy from the medical domain of bacterial infections. It was a milestone in 
the field of expert systems because for the first time the knowledge base was separated 
from the inference engine. Emptying the knowledge out of MYCIN created Expert-System 
shell called EMYCIN; the added E stands for essential or empty MYCIN. 
There are computer languages like Prolog (Bratko, 1990) that are more suited for the 
creation of expert systems than the common languages, like Fortran, which is more suited 
to numeric calculations. The selection of computer language for the creation of the expert 
system is an important decision in expert system development. 
Expert systems usually have some typical components. They have a user interface in order 
for the user to interact with the system, a help or advice facilities that will explain the expert 
system decisions, and a database of facts that could include properties of excipients as well 
as other relevant data on the tablet formulation domain. 71be other two componenets are an 
inference engine - the computer has to apply rules in response to database data, and a 
knowledge acquisition facility - the user must have the ability to enter knowledge to the 
system. For example, relevant to this study, it must have the ability to enter new excipients 
and their properties into the database. 
Expert systems possess many advantages. They increase availability - an expert system can 
be put on many computers and used by many people simultaneously whereas a human 
expert is not always available. Once they are put on many computers the knowledge is 
already in them so costs are reduced since there is no need to pay consulting fees. The 
human expert may die and their knowledge vanishes whereas storage on computer makes 
the knowledge more permanent. Lai et al. (1996) programmed an expert system with the 
knowledge of several experts on capsule formulation. Several experts involved in 
developing an expert system can create a more powerful expert system than one expert can. 
Expert systems are more reliable than human experts are, they could sometimes generate a 
better solution than the human expert whose knowledge was put into the system. For 
example, in cases where there are stress conditions on the human experts that prevent them 
from thinking clearly about the problem (the input to the expert system was not given under 
conditions of stress). Providing the same explanation regarding a decision several times to 
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many people is a task that involves tedious repetition. On the other hand an expert system is 
never fired of giving explanations. Expert systems can be used as an intelligent tutor that 
explains expert knowledge. Expert systems can be used as a database from which the 
knowledge within can be retrieved easily; e. g. the user can ask the expert system about 
relevant excipient properties instead of retrieving the information by searching in many 
books/articles. Hence, it reduces literature search time. Fast response - e. g. in coating of 
tablets, if human expert is asked about adjusting coating process parameters according to 
problems arising in the process (troubleshooting), he/she can think about this without any 
critical time constraint and the expert knowledge will be entered into the expert system. If 
the expert encounters the problem on site a decision on the solution may be too late/slow. 
On the other hand the expert system could give a fast answer that would save the batch 
whilst in the coating phase. 
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3. Application of Artificial Neural 
Networks and Multivariate Regression to 
Solid Dosage Form Optimisation 
3.1 Introduction 
This chapter deals with the development and application of arfificial neural networks 
(ANN) and multivariate regression analysis to pharmaceutical formulation. It is based on a 
study of tablet formulation and process variables. The data for this study was taken from 
Patel (1996). 
Four problems were exan-dried in this study. Is it possible to predict the best ANN 
methodology based on ANN trained on all data? This method of screening used by others 
(Hussain et al., 1994) could reduce the time required to perform validation experiments on 
each ANN topology. But still this method has to be checked for its validity. The second 
issue examined the significance of the validation method employed. As different studies 
have employed different validation methods it is important to examine whether the chosen 
validation method influences research results. As an example, Murtoniemi et al. (1994a & 
1994b) chose a validation set of five samples (using only some of the samples) whereas 
Hussain et al. (1991) chose the leave-one-out validation method (using all the samples). 
The third issue tackled the subject of comparing the predictive ability of ANN versus 
regression. It is important to examine if the new ANN methodology (Hussain et al., 1991) 
gives an advantage over regression methodology (Schwartz et al., 1973), since the 
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methodology used influences not just the predictive ability of the model but also the 
performance of the optimisation step. The latter stems from the fact that the optimisation 
step relies on the model generated. This problem has been tackled many times before 
(Murtoniemi et al., 1994a & 1994b; Hussain et al., 1991). However, this study attempts to 
do it in a more rigorous way, no work has been reported using leave-one-out experiments 
on so many topologies and none trying so many regression models. The fourth question that 
was examined is if scaling of ANN is a real necessity and if so which scaling method is 
preferable. If scaling influences substantially the predictive ability it is worth testing it since 
improving the predictive ability means better optimisation hence, less experiments, less 
development time and more money saved (which is true for every technique that improves 
predictive ability). 
The chapter begins by introducing the methodology followed by the results in 4 
subsections. The first presents results of ANN trained on all data as a tool to predict the 
best topology. In this the error for each topology is used to determine the best topology 
chosen. This screening experiment, using all the data could eliminate the computation time 
required to perform validation experiments on each topology. The second and third result 
subsections give the results for ANN and regression predictive ability, using two different 
validation methods. These subsections address the subjects of comparison between ANN 
and regression performance, also as to whether there is influence by the validation method 
employed. The final part of the results explains the scaling methods employed for ANN. 
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3.2 Methods 
The experimental data utilised was from laboratory experiments conducted by Patel (1996). 
Screening experiments were done. Two methods of partitioning the data for training and 
validation sets were employed, In ANN different training methods and topologies were 
tested. In regression different variable selection methods were employed. Ile data were 
scaled and the method of evaluating the prediction ability was by calculating the average 
percentage deviation (this is the same as the relative error in percent). 
Tablets containing 500 mg of paracetamol were formulated using directly compressible 
paracetamol, croscarmellose sodium, type A (Ac-Di-Solý) as disintegrant, magnesium 
stearate as lubricant, and made up to 600 mg of tablet with lactose as diluent. In generating 
the experimental data the compaction force, percent lubricant and percent disintegrant were 
manipulated. The levels were 6,12 and 20 kN for the compaction force; 0.25,0.5 and 1% 
for the lubricant; 1,2 and 5% for the disintegrant. Table 3.1 presents these independent 
variables values. The appropriate responses were measured in order to build a model that 
should allow the prediction of dissolution rate, disintegration time, hardness, tensile 
strength, two friability tests, thickness and mean weight. These response values are 
presented in Table 3.2. The manipulation of the independent variables was based on a 
factorial design. Factorial design is an experimental strategy in which factors are varied 
together, instead of one at a time (Montgomery, 1997). However, the compaction force 
could not be absolutely fixed, but the actual value was monitored, and these values were 
used in the calculation of the regression and ANN models. The compaction force was 
nominally set at 3 different levels. The other independent variables were fixed at exactly 3 
levels. In total 27 experiments were conducted by Patel (1996). For every formulation, 20 
tablets each, were checked for tablet weight, thickness and hardness. Tensile strength data 
for the sample tablets were obtained from the tablet thickness and hardness. Two friability 
tests were conducted: impact friability and erosion friability. The friability tests were 
triplicated using 5 tablets in each trial. Disintegration time data were obtained using 6 
tablets per formulation. Dissolution rate data were obtained using 3 tablets per formulation. 
In all data analysis the average values of these measurements were used. Tensile strength 
was the only response that was not measured directly, but calculated in a manner explained 
in the next section. 
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The tensile strength measured was diametrical tensile strength denoted by cr. It was 
calculated using the equation (Lieberman et al., 1990): 
2F 
G- D 
whereas F is the maximum force to cause tensile failure (fracture). D is the diameter and t 
is the thickness. As an example, the radial tensile strength calculation of one sample out of 
20 in case number 5 was: 
(2 x 9.81 rn secý x 3.39 kg x 1000)/(12.1 mm x 5.65 mm x n) = 309.84 kN m*2 
whereas 3.39 is the tablet hardness, 9.81 is the accelaration constant (g) and is used for the 
trasformafion to units of force. The multiplication by 1000 in order that the units will be in 
kN. 12.1 mm is the diameter and 5.65 mm is the tablet thickness. 
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Table 3.1: Independent variables manipulated 
Case Lubricant (%wtw) Disintegrant (%wtw) Force (W) 
1 0.25 5.00 6. 
2 0.25 2.00 6.44 
3 0.25 1.00 6.22 
4 0.50 5.00 5.94 
5 0.50 2.00 6.00 
6 1.00 5.00 5.73 
7 1.00 1.00 5.96 
8 0.25 5.00 11.82 
9 0.25 2.00 13.98 
10 0.25 1.00 12.12 
11 0.50 5.00 11.27 
12 0.50 1.00 11.48 
13 1.00 1.00 12.12 
14 0.25 5.00 20.45 
15 0.25 2.00 19.38 
16 0.25 1.00 20.21 
17 0.50 5.00 19.94 
18 0.50 2.00 19.68 
19 0.50 1.00 20.18 
20 1.00 5.00 19.35 
21 1.00 2.00 19.65 
22 1.00 1.00 19.71 
23 0.50 1.00 6.26 
24 1.00 2.00 6.13 
25 0.50 2.00 12.42 
26 1.00 2.00 12.05 
127 1 1.00 5.00 11.17 
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Table 3.2: Responses measured. 
Case Mean Weight (mg) Thickness (mm) Hardness (kg) Tensile Strength 
(kN/M2) 
1 598.9 5.43 3.71 353.31 
2 600.9 5.49 4.05 380.87 
3 610.0 5.55 3.97 369.31 
4 599.1 5.56 2.74 253.77 
5 619.0 5.67 3.44 313.21 
6 594.3 5.54 2.52 234.99 
7 632.1 5.75 3.11 278.91 
8 588.7 4.88 7.52 795.40 
9 607.2 4.91 9.20 966.96 
10 609.1 5.02 7.42 763.08 
11 606.2 5.06 6.25 637.41 
12 618.8 5.15 7.04 705.41 
13 594.7 5.17 6.99 697.36 
14 593.7 4.62 12.39 1385.41 
15 600.5 4.70 11.79 1294.09 
16 619.5 4.83 12.54 1339.53 
17 594.0 4.65 10.64 1180.66 
18 600.3 4.72 10.56 1156.43 
19 612.5 4.79 7.52 810.80 
20 591.1 4.64 9.56 1062.81 
21 626.3 4.91 10.32 1086.33 
22 625.6 4.88 10.87 1150.93 
23 617.9 5.63 3.38 310.11 
24 622.5 5.67 2.97 270.07 
25 606.2 4.99 7.45 771.80 
26 628.0 5.17 6.92 690.09 
127 1 621.51 5.19 , 6.18 , 614.34 
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Table 3.2 (cont. ): Responses measured. 




1 1.66 2.21 115 36.22 
2 1.46 1.96 102 55.27 
3 1.71 2.03 65 73.38 
4 2.02 2.59 128 25.72 
5 1.66 2.19 102 58.45 
6 2.10 2.79 116 30.37 
7 1.86 2.50 58 133.47 
8 0.77 1.04 24 46.89 
9 0.68 0.91 22 72.30 
10 0.81 1.18 33 65.10 
11 0.90 1.12 39 98.15 
12 1.03 1.06 34 62.65 
13 1.01 1.05 49 89.75 
14 0.50 0.67 58 72.48 
15 0.51 0.73 50 75.67 
16 0.51 0.69 93 56.79 
17 0.69 0.65 59 62.35 
18 0.65 0.78 61 54.15 
19 0.61 0.71 93 39.89 
20 0.72 0.81 59 72.82 
21 0.62 0.91 78 59.48 
22 0.66 0.85 98 46.59 
23 1.71 2.36 58 77.18 
24 1.94 2.52 71 107.11 
25 0.78 1.14 31 77.45 
26 0.93 1.14 42 97.35 
27 1 0.92 , 1.20 46 , 94.76 
88 
Screening experiments using ANN were done using all the 27 data points to train various 
ANN topologies. The sum squared error (SSE) and the mean relative error (MRE) for each 
topology were recorded. 
The data was partitioned into a training set (used for building the model) and a validation 
set (this process is called cross-validation) as follows: 
Five data sets were selected randomly for validation and the remaining twenty-two data sets 
for building the model. 
The second method was jacknifmg. Jacknifmg is the leave one observation out at a time 
approach (Mendenhall & Sincich, 1996). This method is also used to find influential 
observations in regression. There were 27 cases in our study, each time one observation 
was taken out and used for validation. The other 26 cases were used for building the model. 
This process was repeated 27 times, so in the end all the data was used for training and for 
validation. 
ANN experiments were repeated 4 times using the first method of partitioning the data (4 
times x9 topologies = 36 networks to run) using different activation functions. The 
activation functions that were examined were: 
1. Hyperbolic tangent sigmoid transfer function. 
2. Log sigmoid transfer function. 
3. Linear activation function. 
Combinations used were (the first number is for the hidden layer neurons, the second is for 
the output layer neurons): 
a. I and 1. 
b. 2 and 2. 
c. 2 and 3. 
d. I and 3. 
The last combination, which is hyperbolic tangent sigmoid transfer function in the hidden 
layer and linear activation function in the output layer, was regarded as the reference ANN. 
The activation function chosen was then employed in the second method of partitioning the 
data. All ANN were run for 100,000 epochs. Each epoch consisted of all the training set, 
and the weights were adjusted after each epoch. Ile latter method of updating the weights 
is called batch training, and is different from incremental training in which the weights are 
updated each time input is presented to the ANN. 
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The polynomial regression equations were derived using stepwise regression or backward 
elimination as methods of variable selection or without any variable selection at all. The 
process of finding the final equation is done by first choosing the order of the model and the 
interaction terms and after that employing the method of variable selection. Twelve models 
were derived for each method of partitioning the data. The different models are described in 
the Results & Discussion section. In the first method of partitioning the data (simpler than 
the second one, thus used here for demonstration purposes) from each model 8 different 
polynomial equations (8 response variables) were derived using the least squares method, 
e. g. a first order model with no interaction terms, y =-- aj*xi + a2*x2 + a3*X3. Eight equations 
were derived using this model, one for each response variable. The values of the 
coefficients a,, a2 and a3 thus differentiate between the equations. 
The method of evaluating the prediction error was by calculating the MRE (MRE = 
I/n * I: ABS[(t-o)/tl). The NM is computed by taking the absolute value (ABS) of the 
difference between the desired target output that is the observed value (t) and the attained 
output (o) as a fraction of the desired target output (t), and summing across all trials (Z). 
The sum is divided by the number of trials (n) to get a mean value (Masters, 1993). In this 
thesis all N4RE values are presented in percentage (multiplied by 100) unless stated 
otherwise. 
The different scaling used is best explained using the simple ideas of matrix manipulation. 
Define P as a matrix of all data input. Each column y in that matrix thus represents one 
input variable, whereas each row x represents the 3 input scalars for a specific data set. In 
the same way we define T as a matrix of outputs. Each column y in that matrix represents 
one output variable, whereas each row x represents the 8 output scalars for a specific data 
set. The scalar value of each one of the 27 members of a column is represented by y. 
Scaling the data for the ANN was done using 4 different methods: 
1. Set the highest value in y to be 0.9. This is done by finding the maximum value in each 
y. And the operation y,,,,, -"' Yold / max(y) * 0.9 for the appropriate max(y) scalar value 
according to the relevant response. Where max(y) is the maximum value of each output 
variable (i. e. one maximum value for each response). 
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2. Set the values between 0.1 and 0.9. The values max(y) and min(y) are the maximum and 
minimum of y respectively. Define A.. = 0.9 and A. i,, = 0.1 as the ANN practical limits. 
Define r= (A. - A. i. ) / (max(y)-min(y)). The translation of each y value in the column is 
done using the following formula: y,,,, =r* (y. 1d - min(y)) + Ai,, (Masters 1993; Smith, 
1993). 
3. We can scale each y by subtracting its mean (denoted by mean(y)) and dividing by its 
standard deviation (denoted by std(y)). The formula is: y,,,, 2-- (Yold - mean(y)) / std(y). The 
mean and standard deviation were estimated from each vector y. Ibis method (zscore) 
ensures that 2 researchers using different units for the same measurement will get the same 
results (Masters, 1993; Bishop, 1996). 
4. Methods 2 and 3 can be incorporated to one formula: 
Yncw =r* ((Yold - mean(y)) / std(y)- min(y)) + A, ý, 
=r/ std(y) * Yold + (A,, ý -r* (mean(y) / std(y) + n-dn(y)) (Masters, 1993). 
There were also ANN run without any scaling on the data (Method 5). ANN were trained 
using the leave one out method for validation and using the Levenberg-Marquardt 
algorithm in the backpropagation. The neurons of the hidden layer had a hyperbolic tangent 
sigmoid transfer function and those of the output layer had a linear activation function. A 
hundred epochs were run on each topology. The 9 different topologies examined were 
composed of I to 9 neurons in the hidden layer. The total number of ANN trained was thus 
234 (i. e. 27x9) for each scaling method. To generate these predictions 5 steps were 
involved: scaling of input and output data, run ANN, simulate ANN, unscale ANN 
predictions and errors calculations. 
For ANN, the software for programming ANN algorithms employed was MATLAB40 with 
Neural Network Toolbox. SPSSO version 7.5 was used for the regression analysis 
procedures. The hardware employed was an EBM compatible personal computer (Pentium 
H, 150 MHZ/32 UB RAM). 
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3.3 Results & discussion 
3.3.1 Screening experiments 
For all the topologies that were considered the sum squared error (SSE) and the mean 
relative effor (MRE) are tabulated in Table 3.3. Ile column on the left ("Model") shows 
the ANN topology, from one to nine hidden neurons. The two columns on the right show 
the SSE and NME error values. The data of Table 3,3 is plotted in Figure 3.1. On the y-axis 
is the error term that is NME or SSE and on the x-axis is the number of hidden neurons. 
Table 3.3: The dependency of the SSE and NIRE on the number of hidden neurons. 
Model SSE MIRE 
318 2.3231 15.8815 
328 0.9672 10.1564 
338 0.6455 8.3344 
348 0.5321 6.9497 
358 0.3648 6.1582 
368 0.3306 5.5620 
378 0.3299 6.4498 
388 0.2263 4 8715 




















Figure 3.1: The two graphs above show the dependency of the SSE and MRE on the 
number of hidden neurons. 
The reasoning of taking two error measurments is that in previous studies, the error was 
measured by two different methods. Previously the root mean square error and the SSE 
have been employed (Hussain et al., 1994; Jogarao et al., 1995), which are essentialy the 
same, whilst I have used other more distinct measures of errors. Both research teams 
conducted screening experiments for selecting the best topology before the validation step. 
Both used the time consuming (leave-one-out) validation test and saved time by the 
approach of not performing validation tests on all topologies. This study tried to identify if 
there was a correlation between the results of this approach to validation on all topologies. 
From the two graphs in Figure 3.1, the slope of the SSE/MRE reached a plateau after 6 
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performance. The next section will investigate if there is a correlation between the 
screening experiments to the validation ones. 
3.3.2 Validation experiments 
This section will describe the two validation experiments, the cross-validation and the 
leave-one-out validation method, but first the previous screening experiments vAll be 
discussed with connection to the validation results. 
As can be seen in Table 3.3 and in Figure 3.1, in the screening experiments, it was not 
possible to establish any correlation between the SSE or MRE to the topology that showed 
the best performance in the validation experiments. There was no correlation with any of 
the validation experiments. The reasoning for the latter statement is that the overall best 
ANN in the cross validation experiments was with 5 hidden neurons (see Table 3.4), and in 
the leave-one-out validation method the best ANN was with 3 hidden neurons (see Table 
3.7) whereas the screening experiments found the best ANN was with 6 neurons in the 
hidden layer. The results were quite surprising since the method of screening is commonly 
practiced by researchers in the field (as was mentioned before: Hussain et al., 1994 or 
Jogarao et al., 1995). 
The first approach used cross validation, splitting the data into two sets, 22 for training and 
5 for validation. The MU values of the validation sets for ANN and regression are shown 
in Tables 3.4 and 3.5 respectively. Looking at Table 3.4 and Table 3.5 the left-hand column 
is headed "Model". In Table 3.4 this heading stands for the topology of the ANN. For 
example, "348" means an ANN with 3 input 4 hidden and 8 output neurons. In Table 3.5 
the heading "Model" stands for the type of regression model. Columns two to nine give the 
MU for each of the responses monitored. The average MRE for all the responses is given 
in the column on the right. The average NIRE ranges from about 6% to a maximum of 
about 25% in the regression and ANN tables. MIZE of the best models for both the 
regression and ANN are given in Table 3.6. 
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Table 3.4: Average percentage deviation (MRE) between predicted and observed values 
for the ANN. The validation method is the cross-validation. The middle number in the first 
column represents the number of hidden neurons. The number in bold represents the best 
result from all topologies. Ile term "Model" indicates the topology, e. g. "348" means 
ANN with 3 input, 4 hidden and 8 output neurons. 
Model Weight Thickn. Hard. Tensile Er. Fr. Im. Fr. Disint. Dissol. Average 
318 2.05 1.98 14.47 19.17 7.58 7.77 59.92 30.29 17.90 
328 1.67 1.05 6.34 9.19 8.97 8.43 26.08 7.99 8.72 
338 1.84 0.68 2.41 3.30 11.63 11.24 25.38 20.37 9.61 
348 1.09 1.61 8.01 8.06 15.74 17.79 15.73 9.89 9.74 
358 1.51 1.01 4.42 4.25 7.69 10.95 8.39 16.97 6.90 
368 1.56 1.65 9.12 10.85 5.47 10.25 36.97 16.38 11.53 
378 2.12 1.74 11.68 14.21 6.24 7.63 17.21 20.67 10.19 
388 0.60 1.18 11.45 12.93 7.82 6.42 1833 ' 31.45 11.27 
398 2.68 , 1.56 , 25.38 
1 27.87 1 11.88 1 12.431 79 . 07 
1 40.71 1 25.2; 1 
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Table 3.5: Average percentage deviation (MRE) between predicted and observed values 
for the regression analysis. The validation method is the cross-validation, The number in 
bold represents the best result from all regression models. 
Model Weight Thickn. I Hard. Tensile Er. Fr. Im. Fr. Disint. Dissol. Average 
1 2.04 1.36 5.72 6.72 7.79 12.41 18.54 36.71 11.41 
2 2.94 1.80 3.26 6.19 10.55 10.98 25.06 13.09 9.23 
3 2.37 1.79 6.00 7.74 8.86 10.64 22.69 5.76 8.23 
4 2.04 1.10 7.36 6.63 7.79 11.34 23.19 4.79 8.03 
5 1.94 1.16 11.45 15.15 9.00 12.35 18.45 8.70 9.78 
6 1.82 1.06 9.31 8.08 7.79 10.82 17.75 20.05 9.58 
7 0.60 0.24 14.12 17.28 4.17 3.33 5.80 7.70 6.66 
8 2.04 1.06 9.31 8.08 7.79 10.82 17.75 15.99 9.10 
9 0.60 0.30 15.08 18.41 4.20 4.54 6.37 6.93 7.05 
10 1.1 1.60 12.55 11.37 33.24 31.77 60.70 17.94 21.36 
11 2.04 1.60 8.50 8.42 31.17 29.34 60.62 20.05 20.22 
12 1.56 1.60 8.69, 8.56 , 30.63 , 28.80 70.90 , 23.18 , 21.741 
Details of the models 
I. Reduced six order model by stepwise regression (excluded terms greater than x). 
Criterion for enter was p<0.05 (refer to section 1.3 regarding p-value) and for removal 
p>0.1. If none of the independent variables succeed to enter the equation the criterion 
was changed for p<O. I for enter and p>O. II for removal (p for enter must be smaller 
than p for removal). And if the problem persisted the values checked were p<O. 15 for 
enter and p>O. 16 for removal and so on in steps of 0.05. 
2. Third order model not included terms in the power of 3 (excluded x3 terms). 
3. Reduced third order model (excluded x3 terms) by backward elimination p>O. 1. 
4. Reduced third order model by stepwise regression (excluded x3 terms). Stepwise 
regression was done as in I- 
5. Second order model + interaction term- xj* X2 * X3- 
6. Second order model + interaction term- XI*X2*X3 reduced by backward elimination 
P>O. 1. 
7. Second order model. 
8. Reduced second order model by backward elimination po. 1. 
9. Reduced second order model by stepwise regression. Stepwise regression was done as 
in 1. 
10. First order model + interactions terms (XI*X2. XI*X3, X2*X3, XI*X2*X3). 
11. First order model + interactions terms (XI*X2, XI*X3, X2*X3. Xl*x2*x3) reduced by 
backward elimination. 
12. First order model. 
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Table 3.6: Average percentage deviation between predicted and observed values for the 
best models of regression analysis and ANN. The validation method is the cross-validation. 





















The MRE of the second validation method of the leave-one-out, are given in Table 3.7 and 
Table 3.8 for ANN and regression respectively. For both Tables 3.7 and 3.8, the left-hand 
column stands for the ANN topology and the regression model respectively. Columns two 
to nine give the MRE for each of the responses monitored. The average MRE for all the 
responses is given in the right-hand column. The best models for both the regression and 
ANN are given in Table 3.9. 
Table 3.7: Average percentage deviation (NIRE) between predicted and observed values 
for the ANN. The validation method is the leave-one-out. The middle number in the first 
column represents the number of hidden neurons. The number in bold represents the best 
result from all topologies. 
Model Weight Thickn. Hard. Tensile Er. Fr. Im. Fr. Disint. Dissol. Average 
318 1.9ý 1.93 12.50 15.14 10.41 8.89 49.23 38.62 17.33 
328 1.90 1.83 12.53 15.80 10.12 8.32 30.30 29.78 13.82 
338 1.74 1.48 9.37 11.54 9.08 9.08 20.86 25.60 11.09 
348 1.63 1.19 9.89 11.91 9.83 9.60 17.70 28.37 11.26 
358 1.71 1.38 11.17 13.67 10.87 11.18 15.07 28.91 11.74 
368 1.55 1.28 13.49 15.20 9.49 8.93 19.42 26.41 11.97 
378 1.76 1.49 15.78 18.70 9.20 10.88 17.22 31.22 13.28 
388 1.97 1.85 16.91 19.86 7.86 9,10 15.97 32.48 13.25 
398 1.74 
1 1.321 18.19 1 19.84 1 10.21 1 11.00 1 19.11 , 25.901 13.411 
Table 3.8: Average percentage deviation (MRE) between predicted and observed values 
for the regression analysis. The validation method is the leave-one-out. Details of the 
models are the same as in Table 3.5. The number in bold represents the best result from all 
regression models. 
Model Weight Thickn. I Hard. Tensile Er. Fr. Im. Fr. Disint. Dissol. Average 
1 1.2i 0.88 7.81 7.53 7.63 8.35 9.13 35.57 9.77 
2 2.97 1.63 15.15 15.99 12.03 7.42 13.73 31.36 12.54 
3 1.61 0.89 7.65 6.99 7.25 5.64 9.36 19.28 7.33 
4 1.28 0.88 9.82 8.92 7.63 8.35 9.36 33.05 9.91 
5 2.15 1.37 10.07 10.73 12.11 11.75 24.17 26.66 12.38 
6 1.29 0.88 8.53 9.14 7.63 8.99 19.90 23.45 9.97 
7 1.78 1.12 10.87 11.87 10.90 10.26 22.75 26.29 11.98 
8 1.29 0.88 8.53 9.14 7.63 8.99 19.90 22.05 9.80 
9 1.28 0.88 7.65 9.05 7.63 8.35 26.58 35.85 12.16 
10 1.84 2.15 11.70 10.54 30.56 33.90 65.21 30.20 23.26 
11 1. 
]28 
1.80 11.24 10.56 22.16 23.71 54.24 26.48 18.93 
12 . 08 1.08 1.54 8.49 , 8.70 , 20.12 , 21.57 , 48.39 , 31.87 , 17.72, 
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Table 3.9: Average percentage deviation (MRE) between predicted and observed values 
for the best models of regression analysis and ANN. The validation method is the leave- 
one-out. 



















As can be seen in the two validation experiments, different methods of validation gave 
different results. The leave-one-out method detected MRE that are greater in all the 
response variables (in ANN as well as in regression) than in the first experiment, using 22 
samples for training and 5 samples for validation. The high MRE in the leave-one-out 
validation method is partly due to outliers, partly to chance and partly to extrapolation that 
is unavoidable in the jacknife experiment. The data for validation in the first experiment 
was in the domain of the training data so there was no need for extrapolation. 
Generally, in the two validation experiments, predictions based on regression analysis 
method were better. The superiority of regression analysis was more obvious in the second 
experiment than in the first one. The second experiment is probably more important than 
the first one because it takes into account all the data for testing and for validation. 
The test was not equivalent because the ANN took into account all the relationships 
between the input variables and the output variables and did not simply focus on a single 
response variable as in regression. To conduct a fair test one should also model ANN with 
one output only, at the expense of losing ANN inversion capability as a multiobjective 
optimisation method (Zell et al., 1994) 
Whether using ANN or regression one can choose the topology/model (in ANN one 
optimum model for all response variables, and in regression one optimum method for 
deriving the regression equations) for prediction with an overall error higher than the best 
model but better for predicting the important parameters such as dissolution rate at the 
expense of overall predictive ability. For example, in the first experiment we can choose the 
topology with two hidden neurons and hence increase the overall MRE from 6.90 in the 5 
hidden neurons (the best model) to 8.72, but decrease the NRE for the important parameter 
of dissolution from NIRE of 16.97 in the 5 hidden neurons to 7.99 in the two hidden 
neurons. 
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Selecting the best overall model is important in ANN because it is possible to do 
multiobjective optimisation using one ANN. In regression the same method of selecting 
coefficients can be used for all responses but there is no advantage in using the same 
method since it would yield 8 different equations, one for each response. Hence, in 
regression there is no one model that captures all independent variables and responses that 
could be used in multiobjective optimisation. In either case it was not possible to say which 
ANN/regression model is the best from the two experiments because the answer changed 
when the method of partitioning of data was changed. Since it seems that the second 
method of partitioning the data Oacknife) was superior, putting all the data in an ANN of 5 
hidden neurons (best topology of the leave-one-out validation method), training the net and 
performing multiobjective optimisation seems to be the best method of optimisation. 
Multiobjective optimisation will be discussed later. 
The MRE of regression leave-one-out validation method presented in Table 3.8 show 
variable selection on third order polynomials gave the best models except for the response 
of disintegration time. Examination of the regression coefficients for modelling of the 
disintegration time response (details of the regresssion equations are given in Appendix A) 
show that the selected coefficients did not include terms greater than third order but 
included one x3 coefficient. The third order polynomials did not included these terms. These 
terms were included in a higher polynomial described in Table 3.5 (model 1). To see if 
there was a need in higher polynomial than a third order one, additional polynomial of third 
order that included x3terms; was build for modelling the disintegration time response and 
stepwise regression was done on this polynomial. It generated the same regression model 
as the one that was built, %krith higher polynomial model (model 1). Hence, it seems there is 
no need in modelling with polynomials greater than third order. Since all the best models 
are variations of third order polynomials there is a need to use polynomials greater than 
second order, which is the common approach (see Introduction). 
3.3.3 Scaling 
The scaling experiments are shown in Table 3.10. The column on the left represents the 
scaling method. Each scaling method is explained in detail in Section 3.2. Columns 2 to 9 
present the N4RE and the column on the right represent the average N4RE of all 8 
99 
responses. 
Table 3.10: MRE results when ANN were trained on scaled data according to methods I- 
4, whereas method 5 is without scaling. 
Model Weight Thickn. Hard. Tensile Er. Fr. Im. Fr. Disint. Dissol. Average 
1 1.4i 1.26 8.77 10.82 8.61 8.30 15.53 22.10 9.60 
2 1.47 1.17 9.49 11.63 8.95 8.42 16.18 24.01 10.17 
3 1.56 1.35 9.34 11.05 9.31 8.84 16.61 22.42 10.06 
4 1.47 1 17 * 9.49 1163 ' 8.95 8.42 















If ANN has an activation function that is linear in the output layer, scaling is not necessary 
(Masters, 1993), but as can be seen in the Results & discussion section, scaling improves 
prediction ability even in this type of ANN. In feedforward ANN there are no limits to the 
input values. Nevertheless, when there is in use training algorithms that minimise the total 
error of all outputs, like in this study, if the output variables are unequally scaled, those with 
larger variability will be favoured, as they will dominate the error sum (Masters, 1993). For 
example, it is obvious that the output variable dissolution rate (large variability) will 
dominate the error sum relative to the mean weight variable (small variability). If one scales 
the input variables to the same range the ANN does not have to learn. the magnitude of the 
input weights by assigning large weights to small variables and small weights to large 
variables. For cases where the algorithm imposes limits on the size of the weights the 
system could get stuck as a consequence of not scaling the input data. In the data of this 
study, the difference between the values of the input variables is of just one order, so this 
problem was not significant. Nevertheless, it seems reasonable to try scaling the data of 
both input and output variables to improve results. 
Looking at Table 3.10, scaling with method 5, the raw data vAthout any change, it is 
obvious that scaling is necessary from looking at the big average IýM related to this 
method. Method 1, that is the simplest one for scaling, seems to be the appropriate one for 
this set of data since it has the smallest average NIRE. Hence, this method was chosen in 
this study. Examination of the variability of the data scaled according to method 1, of the 
two output variables, mean weight and dissolution rate, will yield range between extremes 
of 0.838 to 0.9 and 0.173 to 0.9 respectively. ne gap between the extremes in the first 
case is 0.062 and in the second case is 0.73. So there is one order difference between the 
range (which is a measure of variation) of the two different output variables. But the 
neurons of the output layer adjusted the weights and learned this variability without any 
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problem. To summarise, as opposed to other studies that did not examine the scaling 
aspect, this study explored this technical issue and found it could be more important than 
optimising the different variables related to ANN (like topology). 
3.3.4 Getting and visualising the regression equation 
Looking in the first three cases in Table 3.1 & Table 3.2 one could see that in the 
independent variables only disintegrant level changed (the compaction force is more or less 
fixed). The disintegration time and dissolution rate of these cases shows that, as the 
disintegrant level decreases there is a decrease in disintegration time and increase in 
dissolution rate. This is for the lowest compaction force level and lowest lubricant level. 
Logically, quite the opposite is the expected trend (regarding drug dissolution). However, 
looking just at a few cases and trying to analyse them could be misleading so it is better 
generate a plot that will throw light on all the cases. Such a plot was generated in Figure 
3.2. From Figure 3.2 one could see that when compaction force is fixed to medium level 
increasing disintegrant concentration level by a factor of five from 1 to 5% causes just 
slight increase in dissolution rate. As opposed to this, for lubricant levels the trend is 
reversed at a certain level and there is not one continuous trend. Till a certain level adding 
lubricant causes the dissolution rate to deteriorate (a decrease in dissolution rate) whereas 
at a higher lubricant level, addition of lubricant reversed the trend. This is probably due to 
the fact that for lower levels of lubricant its dominant property that influences dissolution 
rate is its hydrophobicity and at higher levels it causes the tablet to be weaker hence in the 
presence of water the tablet dissolve faster. So it has micro and macro effects that act in an 
opposing manner on the dissolution rate response. Since visualising the data is of much 
importance as was discussed earlier, generating the regression equation (imperative in 
order to try predicting the experimental result optimise or visualise the data) and 
visualising the data according to the equation will be discussed in the next section. 
Tables 3.11 and 3.12 describe how in a stepwise manner the best regression equation for 
the dissolution, in the first experiment (cross-validation), was derived. In Table 3.12 it can 
be seen that the final equation gave a Rý value of 0.716, this means that 71.6% of the 
sample variation in Y can be explained by using X to predict Y (Mendenhall & Sincich, 
1996). Table 3.11 demonstrates each step in the stepwise regression variable selection 
method to arrive at the final equation (Y = 0.512 - 1.315*X2 + 3.805*X2*X3 + 0.455*x12 _ 
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0.860*X3 2* xj - 2.436*X3 
2* X2). Notice the significance level of the coefficients, as this is the 
factor used for their selection. Value of 0.019 for significance level means there is 
probability of 1.9% that the term (X3*X3*X2 in the last step) is zero (that the null hypothesis 
is correct). The global significance level is 0.001 means that there is probability of 0.1% 
that all the model coefficients are zero, or in other words, there is probability of 99.9% that 
at least one of the model coefficients is non-zero. 
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Table 3.11: The process of variable selection, which used the stepwise regression 




Unstandardized Coefficlen E 
Coefficients ts 
Model B Std. Error Beta t Sl 
ýwý 1 
(Constant) . 491 . 062 7.880 . 000 X2 -. 133 . 107 -. 268 -1.245 . 227 
2 (Constant) . 541 . 064 8.448 . 000 X2 -. 415 . 178 -. 839 -2.334 . 031 X2X2X3 . 459 . 239 . 690 1.921 . 070 
3 (Constant) . 739 . 095 7.745 . 000 X2 -. 743 . 202 -1.503 -3.685 . 002 X2X2X3 . 959 . 286 1.442 3.352 . 004 X3X3 -. 323 . 125 -. 624 -2.573 . 019 
4 (Constant) . 698 . 097 7.164 . 000 X2 -. 806 . 202 -1.631 -3.997 . 001 X2X2X3 -. 313 . 955 -. 470 -. 327 . 747 X3X3 -. 603 . 235 -1.166 -2.561 . 020 X2X3 1.534 1.101 2.257 1.392 . 182 
5 (Constant) . 714 . 083 8.609 . 000 X2 -. 809 . 197 -1.637 -4.117 . 001 X3X3 -. 548 . 161 -1.060 -3.410 . 003 X2X3 1.189 . 314 1.750 3.790 . 001 
6 (Constant) . 681 . 084 8.109 . 000 X2 -. 813 . 191 -1.644 -4.245 . 001 X3X3 -, 563 . 157 -1.088 -3.587 . 002 X2X3 1.206 . 306 1.776 3.947 . 001 x1xi . 116 . 082 . 232 1.406 . 178 
7 (Constant) . 616 . 083 7.434 . 000 X2 -. 814 . 175 -1.647 -4.659 . 000 X3X3 -. 275 . 198 -. 533 -1.390 . 183 X2X3 1.214 . 279 1.787 4.351 . 000 x1XI . 329 . 127 . 661 2.602 . 019 X3X3X1 -. 587 . 280 -. 793 -2.097 . 052 (Constant) . 565 . 077 7.306 . 000 X2 -1.332 . 278 -2.694 -4.783 . 000 X3X3 -. 160 . 184 -. 310 -. 870 . 398 X2X3 3.665 1.120 5.394 3.273 . 005 x1XI . 398 . 117 . 800 3.399 . 004 X3X3X1 -. 703 . 255 -. 950 -2.752 . 015 X3X3X2 -2.199 . 980 -3.007 -2.245 . 040 
9 (Constant) . 512 . 047 10.789 . 000 X2 -1.315 . 276 -2.660 -4.771 . 000 X2X3 3.805 1.100 5.600 3.460 . 003 x1xi . 455 . 096 . 915 4.737 . 000 X3X3XI - 860 * 179 ' - 1.162 -4.794 . 000 X3X3X2 436 -2 934 -3 332 -2.609 . 019 
a. Dependent Variable: DISSOL 
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Table 3.12: Summary of the models, which were examined in the stepwise regression 
methodology, for the derivation of the best dissolution equation in the first experiment. 
Model Summarý 






_ 1 . 2681 . 072 . 026 . 15850327 
2 . 472b . 223 . 141 . 14881554 
3 . 65711 . 432 . 337 . 13073345 
4 . 700d . 490 . 370 . 12745125 
5 . 6986 . 487 . 401 . 12425034 
6 . 735f . 540 . 432 . 12101302 
7 . 8009 . 639 . 527 . 11047635 
8 . 854h . 730 . 622 9.87E-02 
9 . 8461 . 716 1 . 628 1 9.80E-02 
a. Predictors: (Constant), X2 
b. Predictors: (Constant), X2, X2X2X3 
c. Predictors: (Constant), X2, X2X2X3, X3X3 
d. Predictors: (Constant), X2, X2X2X3, X3X3, X2X3 
e. Predictors: (Constant), X2, X3X3, X2X3 
f. Predictors: (Constant), X2, X3X3, X2X3, XIXI 
9. Predictors: (Constant), X2, X3X3, X2X3, XlXl, X3X3Xl 
h. Predictors: (Constant), X2, X3X3, X2X3, XlXl, X3X3XI, 
X3X3X2 
Predictors: (Constant), X2. X2X3, XlXl, X3X3Xl, X3X3X2 
Dependent Variable: DISSOL 
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As was demonstrated earlier, it can be useful to plot the data in order to understand the 
relationship in the system between the independent variables and the dependent variables. 
Figure 3.2 shows a plot based on the regression equation, the derivation of which was 
explained earlier in this section. Since there are 3 input variables and 8 response variables, 
it is very informative to see 8 plots, one for each response variable. The problem is that this 
is not possible since this requires plotting a 4-dimensional plot and that is not feasible. It is 
possible to describe the data in a 3-dimensional plot by fixing onc input variable at a 
specific value. Under experimental conditions it was not possible to fix the compaction 
force exactly to only 3 values but it is possible to derive regression equation and to fix the 












Figure 3.2: Plot of dissolution rate (mg/min) against disintegrant and lubricant levels 
(%w/w) whereas the compaction force is fixed to medium level of 12 kN. The regression 
equation being represented in this plot is derived from the training set of the first 
experiment. 
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Disintegrant (%wAY) Lub6carvt (%Y#w) 
3.5 Conclusions 
Generally, the ANN has been found to be slightly less effective than regression approach 
since regresssion predictions showed lower MREs for all 8 responses in the leave-one-out 
validation method. The validation results depend on the validation method and it is worth 
considering the method of validation since the model chosen is used for optimisation (if the 
model is not good the optimisation performed on this model will be useless). It is not 
possible to predict the validation results by screening experiments since there is no 
correlation between the best ANN topology found in these experiments to the ones found 
by the validation experiments. It is worth using polynomials greater than second order, 
which is the common approach (see examples of modelling with second order polynomials 
in section 1.7), since variations on third order polynomials generated the best regression 
models. Scaling should be done, and the scaling method is not a cardinal issue since ANN 
that were run on different scaling methods showed similar, but much lower errors than the 
ones generated by ANN that were run on unscaled data. An appropriate statistical test 
should be conducted in order to assess whether the difference in prediction ability between 
the two methodologies is statistically significant or insignificant. This statistical test will be 
done in the subsequent chapters. Another issue that has to be addressed is whether ANN 
predictions are inferior when it predicts eight responses simultaneously instead of one 
response for each ANN. It is possible that the reduced complexity of ANN will help it learn 
the data. The question that the pharmaceutical researcher, who wants to model the data 
from the experiments, has to ask is whether to spend numerous hours on building 
regression models for each response variable individually instead of wasting no more than 
an hour in total on testing several ANN models, each of which would give a prediction of 
all response variables. The ANN methodology costs just more computer time. Furthermore, 
it may be that ANN might prove to be better for problems with a more complex 
hypersurface. 
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4. A Rigorous Statistical Comparison of 
ANN & Regression Models 
4.1 Introduction 
There are several questions that the current study attempts to answer. Does an ANN 
simulate better if its complexity is reduced? The complexity is to be reduced by not 
modelling all the system at once but modelling with several ANN each one having only one 
output neuron. No worker has addressed this important question before. Another question 
that remains unanswered and that has not been addressed before was whether the 
difference in prediction between ANN and regression is statistically significant. No study 
has presented the prediction errors of regression versus those of ANN with a check to see if 
the difference between these prediction errors is significant. A rigorous statistical 
comparison between ANN and regression errors was conducted. The underlying data used 
for the statistical comparison between ANN and regression was the same as that used in 
Chapter 3. Knowing one method is better than the other, even if the difference is 
statistically significant does not mean it is preferable to use the more accurate method. The 
reason for this is that the accuracy of prediction might depend upon the response value. For 
example, it may be that ANN have lower average error than regression but it is preferable 
to use regression in the domain of response values where it predicts better than ANN. The 
same reasoning applies when asking the question, which method predicts better at the 
extreme values of the responses? This was also tackled in this chapter. 
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Why then is it important to test whether ANN is more precise than regression? In an 
analogy to the game of darts, the darts being thrown are the predictions. Ile closer the 
darts are to the target the more accurate are the predictions. The scatter of the darts 
represents the precision term. It is important since it might be that a method is more 
accurate but it is preferable to use the less accurate method that is more precise. For 
example, if the mean relative error value (URE) in one method is 12% compared to 10% 
with the more accurate method but in the latter method the predictions are much more 
scattered it might be better to choose the less accurate method. The less accurate method 
njight be preferable since there is less risk of getting a large prediction error. 
The question of whether the model is biased was also examined, For example, if regression 
equation yields predictions that are almost always greater than the observed value it is 
possible to trace this in the bias test. After tracing the problem the bias may be reduced by 
lowering the intercept term of the equation (i. e. y= a*x + b, b is the intercept term) to yield 
lower prediction values that are closer to the observed values. 
This study also focuses on a number of training methods to determine whether they offer 
any improvement on the commonly used methods. 
This chapter opens by explaining the various statistical methods for the comparison 
between ANN and regression. This is followed by a detailed section of Results & 
discussion that will include a summary of the results from the best ANN models compared 
to the results of the regression models developed in the previous chapter. Ibis includes all 
the comparison data between ANN and regression prediction ability. There will also be a 
description of optimisation of the error goal parameter (mean squared error criteria to stop 
training in ANN) for the dissolution rate response. 
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4.2 Methods 
ANN were trained using various algorithms, including different types of backpropagation 
methods as well as training methods that are not of the backpropagation type. The neurons 
of the hidden layer were of the hyperbolic tangent sigmoid transfer function and those of the 
output layer had a linear activation function. Topologies were varied from I to 9 neurons in 
the hidden layer. The validation method employed was the leave-one-out method. The 
number of epochs was also varied. Total number of ANN run was 27x9 = 243 (9 for each 
topology and 27 for each validation cycle) for each unique combination of training method 
and number of epochs. In the radial basis function ANN, the variables being manipulated 
were the spreading constant and error goal. 
The prediction sets of ANN versus regression were compared using various statistical tests. 
Each set was composed of 27 rows representing prediction for that case when excluded 
from the model (leave-one-out) and number of columns as the number of responses 
Both ANN & regression input and output data were scaled according to method I 
described in section 3.2. In this method the highest possible value is 0.9. 
A one tailed, paired Mest was conducted to test the hypothesis that the NM of ANN is 
smaller than that of regression. Although the West does not require that the sample comes 
from a perfectly normal distribution (Norusis, 1997) it is still necessary that the population 
resembles a normal distribution. Hence, examination of the data was done before the t-test. 
For examination of the normality assumption the relevant histograms were plotted 
overlayed with a perfect normal distribution line. There were also formal statistical tests 
that were conducted in order to help decide if the data for the t-test came from a normally 
distributed population. The higher the significance value of Shapiro-Wilk statistical test is, 
the higher the possibility that the distribution of the data is normal, since the null hypothesis 
of this test is that the population distribution is normal. This test has been tabulated for 
sample sizes :5 50 (Shapiro & Wilk, 1965). The paired t-test was used to test if the 
difference between the NM of ANN and regression was different from zero. It generated 
for each pair of ANN and regression columns, a new column of the differences between the 
MRE, and it tested if the mean difference was not equal to zero. Hence, the tests of 
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normality were done on these new columns of difference. 
Bivariate correlations were carried out using the data sets of the predicted values of ANN 
and regression and the observed response values. All 3 possible correlations between them 
were examined for each response variable separately. The correlation coefficients that were 
examined are based on the Pearson and Spearman's correlations. The first uses the actual 
data and the second uses non-parametric correlation coefficients in which the data is 
replaced by ranks. Both give values from -1 to 1. The closer these values are to I the less 
scattered the data is about a straight line, until at the value of I all the points are on a 
straight line with a positive slope. The same applies for -1 except all the data points lie on a 
straight line with a negative slope. 
For the comparison of precision between ANN and regression the F-test was conducted on 
the percent relative deviation (signed N4RE) data sets. 
There is the possibility of bias in the models. This can be tested by an examination of the 
signed residuals (observed minus predicted). A model is biased if most of its predicted 
values are significantly below or above the observed values. The null hypothesis that was 
tested is that the average of residuals is not different from zero. 
Sometimes one model is better in a certain response domain than the other. For example, it 
could be that ANN predicts better for high values of dissolution rate. This can be seen in a 
scatter plot of the difference between the absolute residuals (absolute value of the error 
term: observed - predicted) of regression minus those of ANN on the y-axis versus the 
observed value on the x-axis. Another scatter plot used was of the NIRE versus the 
response value. Two sets of points (one for ANN and one for regression) are plotted in a 
figure relating to one response. These plots give a good indication of dependency of error 
upon response values. For both types of scatter plots the data trend lines were plotted. 
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4.3 Results & discussion 
A large number of ANN were trained and the best model for each response was selected 
for comparison with the corresponding best regression model. Extensive comparison 
between ANN and regression was done, involving various statistical techniques. The topics 
covered by these tests were: which method has lower prediction error (for which t-test and 
bivariate correlation were employed); which method's predictions are more precise; which 
method is less biased; whether there is a connection between the predictive ability and 
response value for both ANN and regression. 
4.3.1 Summary of the best ANN models 
Table 4.1 presents the URE of the best ANN predictive models. The MRE of the best 
regression models were presented in the previous chapter. The first column represents the 
number of neurons in the hidden layer for the backpropagation ANN (columns 2-6) for 
RBF ANN it represents spread constant interval (which is explained later in this section). 
The upper row of headings from columns two to nine represents the response variable and 
the bottom one the training method. All the data in each column (9 values) are relevant for 
the specific training method. Some ANN parameters were also manipulated for each 
training method and the NIRE of the best one chosen for each column is in the table, i. e. the 
optimised number of epochs for the basic gradient descent ANN was 10,000, and for the 
other backpropagation ANN was 1000. For the radial basis function ANN the mean- 
squared error goal for the responses of impact friability, disintegration time and dissolution 
rate was 0.1333,0.1330 and 0.1320 respectively. The spread constant for these responses 
was 0.915,0.72 and 0.555 respectively. For the radial basis function ANN the left column 
represents number of interval (t) of spread constant (SQ, e. g. SC = 0.81 + 0.015*t, since 
the lowest NERE was with t=7 for the impact friability response the calculated spread 
constant is 0.915. The equations of the spread constant for disintegration time and 
dissolution rate are SC = 0.675 + 0.015*t and SC = 0.54 + 0.015*t, respectively. Hence, 
table 4.1 also demonstrates the sensitivity of radial basis function upon changing the spread 
constant (only sample data near the optimum spread constant is given). An example of how 
to read the data from the second column, for the mean weight response the best ANN 
model was simple backpropagation with basic gradient descent. The best topology had 5 
neurons in the hidden layer. 
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Table 4.1: Average percentage deviation (MRE) between observed and predicted values of 
ANN. The number in bold represents the best ANN model. 'Me left column represents the 
number of Iýdden neurons for the backpropagation training methods (columns 2-6) and for 
the RB ANN it represents the number of spread constant intervals of 0.0 15 (the base level 
differs for each response in columns 7-9). The headings in the upper row from columns 2 
to 9 stand for the responses of mean weight, thickness, tensile strength, erosion friability, 
impact friability, disintegration time and dissolution rate respectively. Ile bottom row 
represents the best learning algorithm to which all the data in the columns belong. 
No. Hidden Neurons 
(Backpropagation) / No. 
of Spread Constant 
Intervals of 0.0 15 (RB) 
Weight Thickn. Hard. Tensile Er. Fr. Im. Fr. Disint. Dissol. 
1 1.94 1.76 12.62 15.25 10.46 6.86 11.50 17.73 
2 1.65 1.68 11.87 15.15 11.61 7.08 14.15 19.91 
3 1.43 1.37 9.19 12.57 9.40 7.12 10.50 24.36 
4 1.54 1.25 8.43 10.64 10.20 6.64 12.48 29.85 
5 1.29 1.02 10.68 13.77 9.77 5.81 12.88 27.24 
6 1.84 1.18 8.54 9.86 8.55 6.17 15.68 21.78 
7 1.80 1.54 28.09 31.75 8.80 5.75 18.66 23.83 
8 1.71 1.40 7.39 8.11 6.57 7.07 19.61 25.87 
9 2.29 , 1.39 , 16.41 , 19.47 1 8.319 6.94 1 19.90 1 25.82, 









PRCG RB RB RB 
Note. BGD = Basic Gradient Descent 
BR = Bayesian Regularization 
BFGS = The Quasi-Ncwton method of Broyden. Fletcher, Goldfarb and Shamo 
PRCG = Polak-Ribiere conjugate gradient algorithm 
RB = Radial Basis fanction 
Table 4.1 shows that it is worth using training methods other than the simple 
backpropagation, since the lowest values of N4RE were achieved by different training 
methods. Radial basis function ANN gave the best predictions in 3 out of the 8 responses. 
The latter result is added to the fact that training with radial basis function is very fast and 
so is worth trying. The last step in opfirnising the best radial basis function ANN was to 
optimise the error goal. This is discussed in section 4.3.1.1. 
Tables 4.2 and 4.3 show the percent relative deviation of the best ANN and regression sets 
respectively. One can see in Table 4.1 that the best NIRE dissolution value is 17.73, this 
value is the mean (of absolute percentage deviation) of 27 cases presented in Table 4.2. 
Summing up the absolute values of the percent relative deviation presented in Table 4.2, 
and dividing by 27 will yield this average value of 17.73. These values are generated by 
computing [(observed-predicted)/observed] x 100. The data presented here (in Tables 4.2 
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& 4.3) are the signed relative errors from the relevant models (the best ones) used as raw 
data for the statistical tests. Trying to model dissolution vAth only one output neuron did not 
result in a smaller MIRE It was decided hence, not to model other responses with only one 
output neuron. This decision also took into account the limited computation time. The 8 
responses each has 27 cases and in Tables 4.2 and 4.3 are presented respectively as: mean 
weight, thickness, hardness, tensile strength, erosion and impact friability, disintegration 
time and dissolution rate. From section 4.3.2 onwards a comprehensive statistical 
comparison of ANN and regression prediction results is discussed. 
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Table 4.2: Percent relative deviation of the best ANN (abbreviated as "A_") for each case 
when excluded from training set. The abbreviations for the responses stand for (from 
second left to right column): mean weight, thickness, hardness, tensile strength, erosion and 
impact friability, disintegration time and dissolution rate respectively. 
Case Aý_Weight A-Thickn A_Hardn Ajensil A-Er_Fd A-lm_Frl A-Disint A Dissol 
1 1.70 0.58 -12.44 -11.35 -0.88 3.86 5.33 25.14 
2 -1.13 0.45 4.87 -1.32 -11.17 -2.16 10.47 15.61 
3 -0.78 0.18 2.30 2.51 6.82 -3.33 -27.21 -4.53 
4 -0.26 0.62 -14.56 -20.05 10.98 5.67 -5.34 -17.46 
5 1.02 1.45 1.26 5.13 -11.34 -10.00 7.89 -18.88 
6 -4.55 -1.97 4.01 15.21 1.52 3.71 19.77 -79.25 
7 0.93 -0.31 7.76 -1.68 0.97 0.47 12.78 1.27 
8 -1.98 -1.91 4.66 7.49 -12.66 -5.12 6.84 -77.20 
9 0.50 0.28 1.85 -2.03 -3.50 4.19 -19.31 -4.22 
10 0.37 0.90 -10.67 -8.15 5.81 6.97 6.31 10.58 
11 1.96 -0.08 -3.91 -3.73 -4.81 -4.64 -18.78 48.39 
12 1.10 -0.21 3.14 0.92 10.75 -19.96 17.56 -8.10 
13 -3.89 1.14 -3.79 -8.91 7.61 -4.64 8.08 -12.46 
14 0.37 -0.63 10.92 12.02 8.80 0.66 20.32 15.92 
15 -1.21 -0.17 -23.48 -23.23 -4.34 -3.97 -3.88 10.52 
16 1.83 2.76 -4.81 -9.80 2.46 3.78 7.11 -1.92 
17 -1.26 -0.43 8.97 11.26 14.74 -3.83 17.07 -31.13 
18 -1.90 -2.59 -0.31 0.63 -0.56 5.81 2.66 -0.47 
19 0.37 0.24 -51.49 -51.80 -1.32 10.37 -7.35 10.40 
20 -2.49 -3.02 2.45 8.34 7.07 12.71 -2.13 29.81 
21 1.51 3.23 -3.04 -4.36 -12.77 -1.28 10.88 9.53 
22 -0.31 0.52 5.08 3.83 -7.80 3.87 -11.62 -3.66 
23 0.34 -0.39 -3.91 -1.97 -0.83 11.90 -2.57 -0.38 
24 -0.15 -0.14 -3.36 -0.88 10.07 2.44 -22.28 6.67 
25 0.11 -1.61 -1.21 -0.74 -6.74 11.45 -0.89 6.94 
26 1.65 0.23 0.92 0.75 0.04 6.28 8.83 -2.36 
27 1.16 1.54 4.34 -0.88 -11.03 2.16 0.36 25.89 
114 
Table 4.3: Percent relative deviation sets of the best regression models (abbreviated as 
"R_") for each case when excluded from training set. Ibe abbreviations for the responses 
stand for (from second left to right column): mean weight, thickness, hardness, tensile 
strength, erosion and impact friability, disintegration time and dissolution rate respectively. 
Case Fý_Weight R_Thickn R_Hardnn Rjensil R_Er_Fri R Im 
- 
Fd R Disint R Dissol 
1 1.05 0.38 -1.81 -9.50 -5.14 0.72 -6.83 34.75 
2 -1.02 -0.82 8.60 0.50 -8.98 -6.58 11.50 -5.10 
3 -0.16 -0.70 11.56 2.83 6.00 -3.02 -12.77 10.01 
4 0.30 1.13 -19.08 -4.54 8.59 6.3 2.21 -19.56 
5 1.46 1.18 6.59 16.37 -2.60 -5.07 8.79 -13.49 
6 -2.23 -1.89 -10.40 -9.79 -5.13 -2.78 2.59 -93.82 
7 1.75 0.16 6.96 2.50 -5.19 -1.92 25.43 15.22 
8 -0.97 -1.23 0.26 -2.69 3.28 -6.73 -12.96 -85.95 
9 0.13 0.18 5.81 0.15 8.31 -2.03 0.40 2.38 
10 -0.31 -0.92 -4.30 -11.38 -11.68 13.49 16.34 -8.87 
11 1.62 1.24 -11.40 -0.02 2.40 -6.7 10.63 34.74 
12 0.71 0.24 0.33 9.18 4.14 -9.35 -9.25 -22.68 
13 -5.43 -0.22 3.27 -1.34 2.55 -0.87 13.28 -22.95 
14 0.02 0.46 8.97 4.41 -27.44 9.35 -5.39 16.61 
15 -1.09 -0.54 6.30 0.64 8.74 -5.14 -3.87 22.28 
16 1.58 2.14 10.96 0.95 14.14 10.13 5.79 5.19 
17 -0.65 0.13 -2.48 11.90 3.32 -6.53 6.34 -22.22 
18 -1.76 -1.09 -2.40 10.31 4.01 -6.97 -1.43 4.53 
19 -0.40 -0.06 -52.33 -47.43 -7.29 -2.58 -3.63 -6.61 
20 -2.90 -2.80 -2.42 -1.97 13.69 11.74 -5.26 -20.16 
21 1.45 1.48 6.55 -0.54 -13.81 -7.47 10.58 16.12 
22 0.56 -0.17 12.74 6.87 -2.14 4.27 -5.23 6.36 
23 0.56 0.15 -1.87 8.05 1.55 9.17 -11.61 -0.71 
24 0.76 -0.31 -2.79 -6.77 7.61 0.82 -27.01 6.96 
25 -0.73 -1.27 -1.65 10.10 -7.18 7.67 -10 - 
09 3.14 





27 3.16 2.29 -1.96 -5.99 -7.63 _ 1.51 4.85 13.88 
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4.3.1.1 Arriving at the best ANN that models the dissolution rate 
response 
The mean squared error (MSE) is the value that the ANN tried to minimise. The 
performance goal parameter (also called error goal) in the ANN is the value of the MSE 
that upon ANN attaining that value the training will stop. Figure 4.1 demonstrates 
optimisation of the performance goal value for better prediction of the dissolution response. 
On the y-axis is the mean relative error value and on the x-axis is the performance goal 
parameter value (MSE). The NM represents the quality of prediction since it is a 
measurment of the predictive ability (since it is calculated on the validation set) whereas the 
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Figure 4.1: The change in NM as a function of changing the error goal (MSE). The N4RE 
is for the dissolution rate response modeled by radial basis funcfion ANN. 
As can be seen in Figure 4.1 when the error goal falls below 0.1333, which was the 
optimised solution with the minimum URE for dissolution response, there is a sharp 
increase in NIRE. As the error goal increases there is a more moderate deterioration in the 
ANN predictive ability. It is hence worth monitoring the radial basis function ANN error 
goal since it can be quite sensitive to this parameter. 
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4.3.2 Testing MRE of ANN versus regression 
4.3.2.1 Data distribution of relative errors differences 
In order to select the appropriate statistical test, for comparison between the two methods, 
it is necessary to examine the data with respect to the type of population distribution it has. 
Specifically if there is a normal distribution it is possible to conduct a paired west. The 
initials "DIP on Figure 4.2 and Table 4.4 represents the difference between ANN and 
regression absolute percent deviations from observed values. They both present the results 
of the following responses, mean weight, thickness, hardness, tensile strength, erosion 
friability, impact friability, disintegration time and dissolution rate respectively (from top 
figure to bottom one and from left to right column of figures). The y-axis on Figure 4.2 
represents the frequency and the x-axis the difference between the absolute percent 
deviations of ANN and regression for each response. Table 4.4 presents Shapiro-Wilk test 
that is quantitative statistical test for normality. The significance values are for the null 
hypothesis that the data are a sample from a normal distribution. 
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Figure 4.2: Bar plots (histograms) for the differences between ANN and regression 
absolute percent deviations from observed values. The bars represent the actual values 
whereas the black line represents normal distribution. 
Note. The figures above relate to the following responses respectively (from top figure to 
bottom one and from left to right column of figures): mean weight, thickness, hardness, 
tensile strength, erosion and impact friability. 
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Figure 4.2 (cont. ): Bar plots (histograms) for the differences between ANN and regression 
absolute percent deviations from observed values. The bars represent the actual values 
whereas the black line represents normal distribution. 
Note. The figures above relate to disintegration time and dissolution rate responses 
respectively (from left to right figure) 
Table 4.4: Shapiro-Wilk normality test for the difference between ANN and regression 
absolute percent deviations from observed values. 
Statistic Signif icance 
DIF_WEIGH . 928 . 072 
DIF THICK . 945 . 232 
DIF HARDN . 941 . 183 
DIF TENS[ . 958 . 405 
DIF_ER_FR . 967 . 545 
DIF IM FIR . 
979 
. 835 




DIF DISS 1 . 
963 , . 
471, 
Note. The abbreviations for the absolute percent deviations differences (left column) stand 
for the following responses respectively: mean weight, thickness, hardness, tensile strength, 
erosion and impact friability, disintegration time and dissolution rate respectively. 
As can be seen from the plots in Figure 4.2 and from Table 4.4, the normality assumption 
could not be rejected for any of the responses (there is no value in Table 4.4 below 0.05 
level). Hence, it is possible to conduct West. 
119 
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Average Percent Deviabons Differerwces 
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4.3.2.2 T-Test 
In the following analysis the MRE of ANN versus regression was compared using a one 
tailed, paired West. The data sets that were compared were taken from Tables 4.2 and 4.3 
using the absolute values. The left-hand column represents the name of the statistical 
measurement or test. The abbreviations in Table 4.5 relate to the following responses: 
hardness ("Hardn"), erosion friability ("Er_Fri") and dissolution rate ("Dissol"). "A_$' and 
"R_" relate to ANN and regression respectively. Table 4.6 shows the responses for which 
regression predictions were better than ANN ones. The responses shown in this table are 
mean weight, thickness, tensile strength, impact friability and disintegration time 
respectively. The t-test statistics is not shown (as in Table 4.5) since it is not possible to 
reject the null hypothesis with responses that have lower MRE of regression relative to 
ANN, since the hypothesis tested is that ANN predicts better than regression. 
Table 4.5: T-Test to inspect whether MRE of ANN is significantly different from that of 
regression for the responses with lower NIRE for ANN. 
A_Hardn R=Hardn A_Er_Fd R_Er_Fd A_Dissol R_Dissol 
MRE 7.39 7.65 6.57 7.25 17.73 19.28 
Vadance 103.54 100.61 20.25 29.89 431.23 498.92 
t Stat -0.23 -0.53 -0.97 
p(T<=t) one-tail 0.41 0.30 1 0.17 1 
t Critical one-tail 1.71, 1.71 1.71 
Note. The abbreviations relate to the following responses: hardness ("Hardn"), erosion 
friability' (Erjri) and dissolution rate ("Dissol"). "A,. 2' and "R_" relate to ANN and 
regression respectively. 
Table 4.6: NM of ANN versus regression in the responses that regression has lower 
MRE. 
I IkWeight I kWeight I kThickn I R_Thickn I kTensil I kTensil I klm Fri I Fý_Iryjjd I kDisint I kDisli]nt 
13 JMRE 1 1.291 1.281 1.021 0.881 8.111 6.991 5.751 5.641 10.501 9.13 
Note. The abbreviations relate to the following responses: mean weight thickness, tensile 
strength, impact friability and disintegration time respectively "A-" and "R-" relate to 
ANN and regression respectively. 
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4.3.3 Bivariate correlation 
To determine which method predicts better, and if there is any coff leation between ANN 
and regression predictions, bivariate correlation was employed. Pearson correlations and 
Spearman's non-parametric correlations between the responses and the predicted responses 
of ANN and regression are shown in Tables 4.7a and 4.7b respectively. Tables 4.7a and 
4.7b relate to the following responses respectively (from top to bottom in each table): mean 
weight, thickness, hardness, tensile strength, erosion and impact friability, disintegration 
time and dissolution rate. The headings "Dissolution", "A_Dissolution" and 
"R_Dissolution" stand for the observed values, the predicted values by ANN and the 
predicted values by regression for the dissolution response respectively. To read the data, 
for example, looking at the first table (Table 4.7a) in the upper left-hand comer, on the 
second row and second column there is a value of 0.939. That means, the Pearson 
correlation coefficient between ANN predictions and the observed values (for the mean 
weight response) is 0.939. 
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Table 4.7a: Pearson correlations between the responses and the predicted responses of 
ANN and regression. 
WEIGHT kWEIGHT R WEIGHT 
WEIGHT 1.000 . 939** 0.379* A_WEIGHT . 939** 1.000 . 625** R WEIGHT . 379* . 625** 1.000 
THICKNESS A THICKN R-THICKN 
THICKNESS 1.060 - . 988** . 947** A-THICKN . 988** 1.000 . 982** R-THICKN . 947** . 982** 1.000 
HARDNESS A HARDN R HARDN 
-WRDNESS 1.000 . 967** . 877** A HARDN . 967** 1.000 . 956** R-HARDN . 877** . 956** 1.000 
TENSILE A TENSIL RJENSIL 
TENSILE 1.000 . 974** . 885** A-TENSIL . 974** 1.000 . 957** RJENSIL . 885** . 957** 1.000 
ER-FRIAB A-ER_FRl R-ER-FRI 
ER-FRIAB 1.000 . 988** . 957** kER, 
_FRI . 
988** 1.000 . 984** R. ER_FRI . 957** . 984** 1.000 mmmmý IM-FRIAB A-IM-FRI R-IM-FRI 
TM--FRIAB 1.000 . 986** . 994** A-IM_FRI . 986** 1.000 . 993** 
Rý_IM_FRI 
ý . 
994** . 993** 1.000 Mý= DISINTEGRATION 
- 
A-DISINT R DISINT 
BISINTEGRATION 1.5 00 . 975** . 897** A-DISINT . 975** 1.000 . 957** R-DISINT . 897** . 957** 1.000 
DISSOLUTION A DISSOL R DISSOL 
-61SSOLUTION 1.000 . 916** . 539** A-DISSOL . 916** 1.000 . 787** R-DISSOL . 539**l . 787**l 1.0001 
Correlation is significant at the . 05 
level (I -tailed). 
Correlation is significant at the .01 level (I -tailed). 
Note. The tables above relate to the following responses respectively: mean weight, 
thickness, hardness, tensile strength, erosion and impact friability, disintegration time and 
dissolution rate, e. g. "Dissolution", "A_Dissolufion" and "R 
- 
Dissolution" stand for the 
observed values, the predicted values by ANN and the predicted values by regression for 
the dissolution response respectively. 
122 
Table 4.7b: Spearman's non-parametric correlations between the responses and the 
predicted responses of ANN and regression. 
WEIGHT A WEIGHT R WEIGHT 
WEIGHT 1.000 . 948** . 447** A WEIGHT . 948** 1.000 . 648** FýWEIGHT . 447** . 648** 1.000 
THICKNESS 
, 
A THICKN R THICKN 
THICKNESS 1.000 - . 984** . 91F A THICKN . 984** 1.000 . 959** R-THICKN . 915** . 959** 1.000 
HARDNESS A HARDN R. HARDN 
HARDNESS 1.0ou . 946** . 857*-* A-HARDN . 946** 1.000 . 960** R HARDN . 857** . 960** 1.000 
TENSILE A TENSIL R TENSIL 
TENSILE 1.000 . 971** . 885 A-TENSIL . 971** 1.000 . 962 RJENSIL . 891** . 962** 1.000 
ER-FRIAB A ER FRI R ER FRI 
ERJRIAB 1.000 . 979** . 925** A ER FRI . 979** 1.000 . 950** R ER FRI . 925** . 950** 1.000 
IM-FRIAB A IM-FRI R-IM-FRI 
IM-FRIAB 1.000 . 962** . 964 A-IM 
- 
FRI . 962** 1.000 . 980 R IM FRI . 964** . 980** 1.000 
DISINTEGRATION A DISINT R DISINT 
DISINTEGRATION 1.000 . 952** . 890-- DISINT A . 952** 1.000 . 961 ** _ R-DISINT . 890** . 961 ** 1.000 
DISSOLUTION A DISSOL R DISSOL 
UISSOLUTION 1.000 . 898** . 447*: A DISSOL . 898** 1.000 . 660** R DISSOL . 447** . 660** 1.000 
**. Conrlation is sipificant at the .01 level (I -tailed). 
Note. The tables above relate to the following responses respectively: mean weight, 
thickness, hardness, tensile strength, erosion and impact friability, disintegration time and 
dissolution rate. e. g. "Dissolufion", "A - 
Dissolution" and "R_Dissolufion" stand for the 
observed values, the predicted values by ANN and the predicted values by regression for 
the dissolution response respectively. 
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General examination of the results in the correlation tests between ANN and regression to 
the actual observed values reveals the superiority of ANN in all the tests, However, both 
ANN and regression produced models that are valid at the 99% confidence level for all 
response variables (one exception is the Pearson correlation of regression predicted values 
to the mean weight observed values that shows only 95% confidence level). The gap 
between the correlation coefficients of ANN and regression is quite big in the responses of 
mean weight and dissolution rate. 
4.3.4 Precision test of ANN versus regression 
To compare the precision of ANN versus regression, F-Tests for variances of percent 
relative errors (signed MRE) between ANN and regression were conducted, and the results 
are presented in Table 4.8. The left-hand column is the name of the statistical 
measurement/test involved. The other columns are the values of these measurements/tests. 
The abbreviations for the responses are (from left to right column and continued below): 
mean weight, thickness, hardness, tensile strength, erosion friability, impact friability, 
disintegration time and dissolution rate respectively. "A_" and "R_" stand for ANN and 
regression percent relative deviation respectively. 
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Table 4.8: F-Test for variances of percent relative errors between ANN and regression. 
A Weight R_Weight A Thickn R Thickn A Hardn R Hardn Ajensil R_Tensil 
Mean -0.19 -0.03 0.03 -0.01 -2.76 -0.86 -3.07 -0.71 
Variance 2.85 3.03 2.03 1.35 152.34 160.57 171.81 135.38 
F 0.94 1.50 0.95 1.27 
A_Er_Fri R_Er_Fd A_lm_Fd R_lm_Fd A_Disint R- Disint A=Dissol R_Dissol 
Mean -0.08 -0.47 1.38 -0.06 1.52 -0.33 
- 
-1.68 -5.04 
Vadance 65.07 84.18 51.79 45.28 166.07 127.92 754.70 858.41 
F 0.77 1.14 1.30 0.88 
Note. The abbreviafions for the responses stands for (from left to right column and from top 
table to bottom one): mean weight, thickness, hardness, tensile strength, erosion and impact 
friability, disintegrafion time and dissolution rate respectively. "A -" and 
"R_" stand for 
initials that relate to ANN and regression percent relative deviation respectively. 
in the precision test data presented in Table 4.8 one can see at the thickness response that 
the variance of regression relative errors is 1.35 whereas the variance of ANN relative 
errors is 2.03 and the calculated F value is 1.50. Hence, the regression model for the 
thickness response is about 5 0% more precise than the ANN one C'abouf' because F-test is 
done on idependent samples and not paired data as in this study, so it is not possible to use 
significance values generated in this test). 
4.3.5 Bias examination 
To examine if the predicted values generated by ANN and regression models are 
significantly below or above the observed values, bias tests were conducted. Bias tests on 
signed residuals (observed minus predicted) of ANN ("A2) and regression ("R,. 2') are 
shown in Table 4.9. The left-hand column gives information on whether the model is ANN 
or regression one and the response modelled. The abbreviations in Table 4.9 from top 
downwards stand for responses of. disintegration time, dissolution rate, erosion friability, 
hardness, impact friability, tensile strength, thickness and mean weight respectively. This 
set of abbreviations is repeated since it relates to ANN as well as regression. 
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Table 4.9: Bias test on signed residuals (observed minus predicted) of ANN ("A_") and 
regression ("R-"). 
one-Sample Test 
Test Value =0 
95% Confidence 
Sig. Mean Interval of the Difference 
t df (2-tailed) Difference Lower Upper 
A_DISINT . 794 26 . 434 1.060E-02 -1.69E-02 3.805E-02 
A_DISSOL . 471 
26 
. 
641 9.595E-03 -3.22E-02 5.144E-02 
kER_FRI . 335 
26 . 740 2.611 E-03 -1.34E-02 1.863E-02 
A_HARDNN -. 993 26 . 330 -1.41 E-02 -4.32E-02 1.507E-02 
kIM_FRI 1.061 26 . 
298 6.72SE-03 -6.30E-03 1.975E-02 
A_TENSIL -1.027 26 . 314 -1.48E-02 -4.44E-02 1.482E-02 
kTHICKN . 160 
26 
. 874 
3.400E-04 -4.03E-03 4.707E-03 
A_WEIGHT -. 508 26 . 616 -1.41 E-03 -7.13E-03 4.304E-03 
R_DISINT . 084 26 . 934 9.02E-04 -2.1 E-02 2.29E-02 
R_DISSOL -210 26 . 835 -4.21E-03 -4.5E-02 3.70E-02 
R_EFý_FRI -. 121 26 . 905 -8.32E-04 -1.5E-02 1.33E-02 
R_HARDNN . 116 
26 . 908 1.54E-03 -2.6E-02 2.89E-02 
Fý_IM_FRI . 056 
26 . 955 3.09E-04 -1.1 E-02 1.1 5E-02 
Fý_TENSIL -. 010 26 . 992 -1.1 5E-04 -2.4E-02 2.34E-02 
R_THICKN -. 008 26 . 994 -1.37E-05 -3.6E-03 3.62E-03 
R WEIGHT 1 -. 014 1 26 1 . 989 1 -3.96E-05 I -6. OE-03 I 5.89E-03 
Note. The abbreviations from top downwards stand for responses of. disintegration time, 
dissolution rate, erosion friability, hardness, impact friability, tensile strength, thickness and 
mean weight respectively. This set of abbreviations is repeated twice since it relates to 
ANN as well as regression. 
Looking in Table 4.9, one can see that there are high significance values for all the tests. It 
can be seen from the bias of ANN and regression models, that there is no one model that 
violates the west (the null hypothesis is that the mean values of signed residuals is not 
differ from zero), so there is no bias in any of the models. One can also examine the 95% 
confidence interval and see that the zero value is widiin the interval for all the models. 
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4.3.6 The predictive ability as a function of the response value 
To examine the influence of the response value on the predictive ability of ANN versus 
regression, two different sets of plots were employed and will be presented in this 
subsecfion. 
Figure 4.3 shows the difference between the absolute residuals (observed-predicted) of 
regression minus those of ANN on the y-axis, as a function of the observed value on the x- 
axis (scaled values). The initials "RD" on the y-axis stands for the residual difference. The 
plots of Figure 4.3 relate to the following responses (from top figure to bottom one and 
from left to right column of figures): mean weight, thickness, hardness, tensile strength, 
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Figure 43: The difference between the absolute residuals (observed-predicted) of 
regression minus those of ANN on the y-axis, as a function of the observed value on the x- 
axis (scaled values). 
Note. The figures above relate to the following responses (from top figure to bottom one 
and from left to right column of figures) respectively: mean weight, thickness, hardness, 
tensile strength, erosion and impact ftiability. The initials "RD" on the y-axis stands for the 
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Figure 4.3 (cont. ): The difference between the absolute residuals (observed -predicted) of 
regression minus those of ANN on the Y-axis, as a function of the observed value on the x- 
axis (scaled values). 
Note. The figures above relate to disintegration time and dissolution rate respectively (from 
left to right figure). The initials "RD" on the y-axis stands for the residual difference. The 
line is the least-square regression line, which demonstrates the trend. 
To explore the issue of whether the ANN is better than regression in certain response 
domains the graphs in Figure 4.3 were plotted. In the first graph, which relates to the mean 
weight response, one can see that the two extreme values, left and right points on the 
graphs have values higher than zero, this means that on these points there are larger errors 
for the regression model. This information may lead to the conclusion that ANN predicts 
better, extreme values of mean weight, that is at very low and very high values of this 
response. In these graphs, the least-squarc regression lines show the data trend. Looking at 
the extreme point of the fastest dissolving tablet (dissolution response), one can see a very 
high positive value suggesting better predictive ability of ANN for this high dissolution 
value. There is positive trend line in the thickness response, suggesting improvement in 
ANN predictions (as the response became bigger) relative to regression ones and in the 
impact friability response (in the latter, the slope is mainly due to two outliers at the upper 
right comer of the graph). The hardness regression trend line suggests ANN performance 
deteriorates relative to regression as hardness increases, but a close look reveals the slope is 
quite small and is mainly due to an outlier with a large negative value which belongs to a 
high hardness value. Observing the tensile strength one can see on the right-hand side of the 
graph 3 points with values that are considerably less than zero. The latter fact would 
suggest that the regression model is better at predicting high values of tensile strength and 
the negative slope of the regression trend line tells the same story. The same trend of 
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improving regression performance relative to ANN in high values of the response variable 
is evident in the graphs of erosion friability and disintegration time (but it seems mainly, 
due to one outlier with big negative value in each one of the graphs). 
The dependency of the percent relative error (MRE), on the y-axis, as a function of the 
response value (scaled values), on the x-axis, is demonstrated in Figure 4.4. The MRE data 
was taken from Tables 4.2 & 4.3, using the absolute values. The red squares are ANN 
relative errors whereas the red line is the least-square regression line that demonstrates the 
trend, similarly green relates to regression data points and trend line. 
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Figure 4.4: Percent relative error (in absolute values) as a function of the response value 
(scaled values). 
Note. The figures above relate to the following responses (from top figure to bottom one 
and from left to right column of figures) respectively: mean weight, thickness, hardness, 
tensile strength, erosion and impact ftiability. In red and green are ANN and regression 






Figure 4.4 (cont. ): Percent relative error (in absolute values) as a function of the response 
value (scaled values). 
Note. The figures above relate to disintegration time and dissolution rate respectively 
(from left to right figure). In red and green are ANN and regression results 
respectively. The regression lines represent the trend. 
Looking at the graphs in Figure 4.4, the greater the slopes of the graphs the more the 
dependency of the error upon the response value. The slopes of the trend lines for 
regression are greater for most of the responses except mean weight and thickness. I lence, 
according to these lines, regression errors are more dependent on the response value of the 
important responses. In fact for the responses of tensile strength and erosion friability ANN 
does not show any error dependency as a function of the response value. However, since 
these lines are only an aid in detecting trends, the latter statements may be tested by looking 
carefully at the positions of the MRE datapoints, ANN & regression show bigger MRE for 
low values of mean weight response. Regarding thickness response, ANN has several 
points on the upper left side of the graph. It is possible to see that the MRE is lower for 
both methods for high values of this response. For hardness and tensile strength responses, 
both methods have one outlier point with the same low response values. Regression has one 
outlier point for low value of erosion friability and ANN has one outlier point for impact 
friability response. There are lower MRE for both ANN & regression for the slower 
disintegrating tablets. The big slope of the dissolution rate trend line, for both ANN and 
regression, could be misleading because it is big due to 2 outliers of the slowest dissolving 
tablets. The 2 outliers not only cause the greater slope for the 2 trend lines but also 
considerably alleviate the average MIZE for both ANN and regression. The extremely large 
MRE of the slowest dissolved tablets demonstrates the inability of the models to predict 








It is worth using various training methods for ANN. Using radial basis function ANN could not only 
give a reduced training time advantage but also could give more accurate predictions. This type of 
ANN however requires close monitoring of the error goal value. 
The fact that trying to model ANN with only one output neuron resulted in a bigger MRE than the 
complex topology of 8 output neurons reveals that complex topology does not mean a disadvantage. 
The advantage of training with 8 output neurons lies not just with computation time (because all are 
computed once) and ease of opfin-ýisafion but is also an aid in the learning process. The reason for 
this is that there is information embedded in the weights regarding correlation between the 
responses, which is lost if one takes a topology of one response for each ANN. It is obvious that 
disintegration time can provide information about dissolution rate, since there is some correlation 
between these two responses. This issue will be tackled later. 
Bivariate correlations between the predicted values of ANN/regression to the observed values show 
better results for ANN in the parametric and non-parametric tests for mean weight response. ANN 
shows lower MRE than regression for the predictions of hardness, erosion friability and dissolution 
rate responses. T-tests that were conducted on the absolute relative percent deviations (MRE) 
showed ANN models don't have lower NIRE (that are statistically significant). Comparing the MRE 
results, ANN also predicts better extreme values of the mean weight and dissolution rate responses. 
Both ANN & regression predict better high values of disintegration time. ANN has more difficulty 
than regression in predicting low values of thickness. 
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0 5. Modelling Properties of Powders using 
Artificial Neural Networks and Regression: 
The Case of Limited Data 
5.1 Introduction 
Artificial neural networks (Hussain et al., 1991) and regression (Schwartz et al., 1973) are 
commonly used for modelling relationships. This chapter exan-dries the ability of both ANN and 
regression to model properties of powders when only a limited amount of data is available. The data 
used here was taken from a published article dealing with hard-gelatin capsule formulations (Hogan 
et al., 1996). This data is very limited (in terms of characterising space with so many dimensions) as 
the study involved only 33 experiments although there were 9 independent variables that were 
manipulated over 4 different levels for each variable. For comparative purposes, a full factorial 
design conducted at 4 levels would mean 262144 (4) experiments and this is clearly not feasible. 
Comprehensive statistical comparison was used in an attempt to answer the following questions; 
which method is more accurate; does the accuracy depend on the response value; which method 
predicts better the extreme response values; which method is more precise; which method is less 
biased. One question that may be asked why repeat the same work on another data set? The answer 
is that it is possible when modelling different data types that the answers to the questions would 
change from the previous study. The type of data in this study is different from the tablet study since 
it also has qualitative variables (disintegrant type and filler type) and not just quantitative variables. 
The use of this type of variable for modelling by ANN and regression has been done (Kesavan & 
Peck, 1995). So these studies and the studies in previous chapters are complementary. It is expected 
that the ability to model the data using both ANN and regression would be poor due to limited data. 
The quesfion of what to do with limited data arises in pharmaceutical companies all the time. Hence, 
they need to make decisions using limited data. Companies face the problem of whether to ignore 
past experiments (that were not well designed) and to conduct better ones that are well designed. It 
135 
is possible that the solution to an optimisation problem lies in the old experimcnts, and that with 
good modelhg and optimisation techniques this solution will be found. If such a scenario occurs, 
the work of analysing data could save the fime and money of lab work. 
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5.2 Methods 
5.2.1 Experimental data 
In the capsule formulation study, (the raw data was taken from Hogan et al., 1996) a total of 33 
formulations of hard gelatin capsules were manufactured. The independent variables that were 
manipulated were (from left to right in Table 5.1): drug particle size (pm), drug solubility (gA), filler 
type (the values are ranked data according to the relative solubility of the fillers), filler level 
disintegrant type (characterised by their relative swelling volume in percent), disintegrant level 
lubricant level (%), glidant level (9/6), and drug concentration C/o). The drugs used were phenytoin, 
theophylline, paracetamol, propranolol and arninophylline. The fillers used were (filler type' relates 
to the choice of filler) calcium phosphate, microcrystalline cellulose, maize starch, starch 1500, 
lactose monohydrate. The disintegrants used were ('disintegrant type' relates to the choice of 
disintegrant) Explotab, AcDiSol, Amberlite, Polyplasdone XL and maize starch. The lubricant and 
glidant used were magnesium stearate and Aerosil respectively. The response variables were 
minimum bulk density (gCrrf3), maximum bulk density (gCnf3 ), Hausner's ratio, Carr's 
compressibility index (%), coefficient of fill weight variation (%), area under the dissolution curve 
(%Min), mean dissolution time (min), variance of the dissolution time and disintegration time. 
overall, 9 independent variables and 9 response variables were examined. The data comprising the 
independent variables and the responses are given in Tables 5.1 and 5.2. 
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Table 5.1: Independent variables that were manipulated. 
Case D (ps) D (sol. ) ft fi dt dl 11 gi dc 
T- 26.00 15.00 2 44.00 1680 5.00 1.00 0.00 50.00 
2 26.00 15.00 2 43.50 1680 5.00 1.00 0.50 50.00 
3 26.00 15.00 2 42.50 1680 5.00 1.00 1.50 50.00 
4 26.00 15.00 2 42.00 1680 5.00 1.00 2.00 50.00 
5 26.00 15.00 2 44.00 1680 5.00 0.00 1.00 50.00 
6 26.00 15.00 2 43.50 1680 5.00 0.50 1.00 50.00 
7 26.00 15.00 2 42.50 1680 5.00 1.50 1.00 50.00 
8 26.00 15.00 2 42.00 1680 5.00 2.00 1.00 50.00 
9 26.00 15.00 2 48.00 1680 0.00 1.00 1.00 50.00 
10 26.00 15.00 2 45.50 1680 2.50 1.00 1.00 50.00 
11 26.00 15.00 2 40.50 1680 7.50 1.00 1.00 50.00 
12 26.00 15.00 2 38.00 1680 10.00 1.00 1.00 50.00 
13 65.00 0.20 2 43.00 1680 5.00 1.00 1.00 50.00 
14 57.00 8.00 2 43.00 1680 5.00 1.00 1.00 50.00 
15 26.00 15.00 2 43.00 1680 5.00 1.00 1.00 50.00 
16 122.00 50.00 2 43.00 1680 5.00 1.00 1.00 50.00 
17 26.00 200.00 2 43.00 1680 5.00 1.00 1.00 50.00 
18 26.00 15.00 2 73.00 1680 5.00 1.00 1.00 20.00 
19 26.00 15.00 2 58.00 1680 5.00 1.00 1.00 35.00 
20 26.00 15.00 2 28.00 1680 5.00 1.00 1.00 65.00 
21 26.00 15.00 2 13.00 1680 5.00 1.00 1.00 80.00 
22 26.00 15.00 1 43.00 1680 5.00 1.00 1.00 50.00 
23 26.00 15.00 3 43.00 1680 5.00 1.00 1.00 50.00 
24 26.00 15.00 4 43.00 1680 5.00 1.00 1.00 50.00 
25 26.00 15.00 5 43.00 1680 5.00 1.00 1.00 50.00 
26 26.00 15.00 2 43.00 600 5.00 1.00 1.00 50.00 
27 26.00 15.00 2 43.00 190 5.00 1.00 1.00 50.00 
28 26.00 15.00 2 43.00 150 5.00 1.00 1.00 50.00 
29 26.00 15.00 2 43.00 110 5.00 1.00 1.00 50.00 
30 26.00 15.00 1 48.00 1680 0.00 1.00 1.00 50.00 
31 26.00 15.00 1 38.00 1680 10.00 1.00 1.00 50.00 
32 26.00 15-00 5 48.00 1680 0.00 1.00 1.00 50.00 
33 1 26.00 
1 15.00 15 1 38.00 1 1680ý 10.00 
1 
1.00 1 1.00 
1 
50.00 
Note. The independent variables that were manipulated are: drug particle size (D (ps)), 
drug solubility (D (sol. )), filler type (ft), filler level (fl), disintegrant type (dt), disintegrant 
level (di), lubricant level (11), glidant level (gl), and drug concentration (dc). 
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0.50 0.82 1.63 38.79 15.09 2480.0 28.6 107.6 10.5 
2 0.50 0.79 1.58 36.71 1.19 1268.0 15.1 23.1 8.6 
3 0.46 0.72 1.58 36.81 2.40 957.0 12.5 14.0 8.2 
4 0.43 0.68 1.58 36.76 1.28 1907.0 19.0 42.4 7.5 
5 0.50 0.76 1.52 34.21 2.51 1994.0 18.0 54.9 6.9 
6 0.50 0.72 1.44 30.56 1.86 1733.0 17.4 33.0 7.2 
7 0.48 0.71 1.48 32.39 1.36 1869.0 18.8 49.5 8.4 
8 0.47 0.70 1.49 32.86 1.18 1775.0 17.3 45.5 10.4 
9 0.49 0.72 1.47 31.94 0.95 1069.0 11.0 16.3 9.0 
10 0.50 0.74 1.49 33.11 0.79 2087.0 20.8 72.4 8.2 
11 0.50 0.71 1.43 30.28 1.44 2719.0 25.5 111.4 7.7 
12 0.48 0.74 1.54 34.90 4.06 1834.0 19.7 55.9 7.9 
13 0.54 0.78 1.44 30.57 1.40 200000.0 2000.0 200000.0 6.6 
14 0.56 0.80 1.43 30.19 0.72 1980.0 19.1 70.6 8.2 
15 0.49 0.74 1.51 33.78 0.75 706.0 9.0 7.8 9.9 
16 0.62 0.83 1.33 24.70 1.90 2993.0 28.3 128.4 7.6 
17 0.53 0.80 1.51 33.75 0.90 1571.0 22.2 41.3 11.5 
18 0.55 0.78 1.42 29.49 0.80 1361.0 16.4 31.2 7.5 
19 0.52 0.76 1.47 31.79 0.98 1593.0 16.9 45.6 7.7 
20 0.44 0.67 1.51 33.58 2.38 2486.0 22.6 98.7 7.4 
21 0.40 0.62 1.53 34.68 3.57 2032.0 18.8 74.8 11.4 
22 0.54 0.80 1.48 32.50 0.85 2044.0 19.0 68.1 10.8 
23 0.46 0.72 1.59 37.24 1.25 3081.0 28.1 147.8 7.4 
24 0.40 0.58 1.46 31.30 1.64 1261.0 12.7 27.3 7.0 
25 0.38 0.64 1.66 39.84 18.52 2012.0 19.9 56.6 7.6 
26 0.44 0.73 1.64 39.04 0.84 1546.0 16.3 39.6 7.7 
27 0.46 0.72 1.57 36.11 1.12 3356.0 29.1 172.8 9.3 
28 0.44 0.68 1.57 36.50 1.10 3683.0 29.6 229.3 9.8 
29 0.46 0.73 1.59 36.99 0.96 1336.0 14.5 29.4 7.6 
30 0.54 0.83 1.52 34.34 2.42 7121.0 70.4 840.5 12.1 
31 0.53 0.80 1.52 34.16 1.32 2798.0 25.0 117 *1 8.9 32 0.40 0.61 1.54 35.25 20.67 82319.0 760.1 
1 
117068 5 ' 10.0 33 0.42 0.651 1.57, 36.15, 5.94, 2467.0 25.1 86 31 7.31 
Note. The response variables measured (presented from left to right) were: minimum bulk 
density (Vmin), maximum bulk density (Vmax), Hausner's ratio (H), Carr's 
compressibility index (Carr), coefficient of fill weight variation (CFV), area under the 
dissolution curve (AUC), mean dissolution time (NMT), variance of the dissolution time 
(VDT), and disintegration time (DT) respectively. 
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5.2.2 Development of ANN and regression models 
The ANN models were developed by examining different topologies and different leaming 
methods including backpropagation and radial basis function ANN. There were 9 input 
units and 9 output neurons in all the topologies. Ile effect of number of epochs (iterations) 
was also explored. The regression equations were derived only from a simple linear model 
of the form ai*xi + a2*X2 + ... + ag*xg = y. Hence the maximum coefficients in the model 
could only be 9. Four different methods of variable selection were employed: no selection 
(simple linear model), stepArise regression, backward elimination and forward selection. 
In ANN the input and output data was scaled according to zscore and values between 0.1 - 
0.9. A detailed explanation of this scaling method (method 4) is described in Chapter 3 
(section 3.2). There was no scaling in the quantitative variables of regression. With regard 
to the two qualitative variables that relate to the choice of filler and disintegrant dummy 
variables were used (Mendenhall & Sincich, 1996). They are called dummy variables since 
the numbers assigned to the various levels are arbitrarily selected. One coding scheme that 
was tested was to assign one variable to each disintegrant/lubricant. When the 
disintegrant/lubricant is part of the formulation the related variable gets a value of I and if 
not, a value of 0. Hence, in this study, it means the choice of disintegrant and filler are 
represented by 10 variables (5 possibilities for each choice of disintegrant/lubricant). This 
method is advantageous for the interpretation of the regression equation over the method of 
putting the values as they are in only two dummy variables, a method that was also 
examined in this study. Obviously, when one tries to predict with regression or ANN he 
should aware that the input values entered could not include, in this case, other 
disintegrant/filler than the ones that were used to build the models. 
The generalisation ability of both the ANN and regression models was determined using 
the leave-one-out method (Hussain et al., 1994). In this method all the data is used for 
training and for validation. A total of 33 data points (cases) are used with 32 of the cases 
used for building the model and one for validation. By subsequently excluding another case 
from the model and building the model according to the other 32 cases and performing this 
procedure for all 33 cases a validation set consisting of 33 cases is generated. The same 
methodology of comparison between ANN and regression was applied as in the study in 
the previous chapter, except that Wilcoxon signed-rank test (Norusis, 1997) that is a non- 
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parametric test was used instead of Mest. The Wilcoxon signed-rank test takes into account 
the size of the differences between the two related pairs of MRE and gives each one a rank. 
17he smallest difference get rank of value 1, the one afterwards get the value 2 and so on, 
e. g. 10,5, -4,0, get ranks of 3,2,1, and the 0 value is ignored. Ilic positive ranks (3 +2= 
5) and the negative ranks (= 1) are then summed up separately for the comparison. '111is 
non-parametric test tests the same null hypothesis as the Mest that was used in Chapter 4. 
Hence, a one tailed test was conducted to see if ANN predicts significantly better than 
regression. 
An example of one ANN topology used in this study is presented in Figure 5.1.17he first 
layer on the left is the input layer. The middle layer is called the hidden layer since it is not 
visible to the outside. The first layer on the right is called output layer since the output of 
the ANN is going out through this layer. The latter two layers are composed of perceptrons 
since the first layer on the left is just composed of input units that do not apply any 
operation on their data. This type of ANN is called feedforward, multilayer perceptron 
(MLP). 
Particle size Minimurn bulk density 
Solubility - OZ\\ Maximum bulk density 
Z/', / Filler eype -TvIIL 
--I 
I-rl lausner's ratio 
Filler level Ca ompressibl index Y-rCaff's oompressiblity index ff's c 
fill 
ty 
gt C fficient of fill weight iation Disintýýra: MpWe -oefficient of Wei h vaniation 
Disinte7grant level Area under the dissolution c7 
irwl Lubricant level issolution ti Meanud ionsimet] 
el Glidant lev Variance of the dissolution time 
Dnig cmoncentration Disintegration tune 
Figure 5.1: Example of one ANN topology used in the study. The input units, which 
receive data from the independent variables, are on the first layer on the left. The output 
layer, which outputs the response variables, is the first one to the right. In this case there are 
only two perceptrons, in the hidden layer, but the number of perceptrons in the hidden layer 
was varied. 
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5.3 Results & discussion 
'Ibis study tried to develop ANN and regression models that will succeed to predict all 9 
responses of the capsule data using the leave-one-out validation method. Both methods 
succeeded in predicting just 5 out of the 9 response variables. The responses that were 
modelled successfully were minimum bulk density, maximum bulk density, Hausner's 
rafio, Carr's compressibility index and disintegration time. The best learning method for the 
ANN was backpropagation with momentum and adaptive learning rate. 
5.3.1 MRE results 
All the numbers tabulated in Tables 5.3-5.5 represent the MRE. The results of the leave- 
one-out for validation are presented in Tables 5.3 & 5.4. ANN that were trained on all 33 
cases and tested on these cases (termed 'screening experiments' in previous chapter) are 
presented in Table 5.5. The results of the best topologies of the ANN are shown in Tables 
5.4 & 5.5. For improving the predictions of the disintegration time, ANN with only one 
output neuron were tested. The best ANN used backpropagation with momentum and 
adaptive learning rate, with 10,000 epochs. As neurons were added to the hidden layer of 
the latter ANN, the predictive ability deteriorated. The NUIE results for 1-6 hidden neurons 
were 10.488,14.821,17.469,20.047,22.721 and 23.815 respectively. The topology of the 
best ANN models (designated in bold in Table 5.4) for predicting the minimum bulk 
density, maximum bulk density, Hausner's ratio, Carr's compressibility index and 
disintegration time were 4,4,1,3,4 hidden neurons respectively. The relative errors in 
percent of each response that could be modelled for ANN ("A,. 2') and regression ("R,. 21) are 
presented in Table 5.6. 
Table 5.3: The MRE of regression. In bold are the lowest MRE. 
Model Vmin Vmax H Carr DT Average 
Simple Linear 4.165 4.761 3.413 6.205 13.535 6.416 
Stepwise Regression 4.238 4.158 2.908 5.548 13.037 5.978 
Backward elimination 4.238 4.833 2.857 5.488 13.037 6.091 
Forward selection 4.238 1 4.158 1 2.908 1 5.548 1 13.037 1 5.9781 
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Table 5.4: The MRE of backpropagation with momentum and adaptive learning rate ANN 
using the leave-one-out method for validation. In bold are the lowest MRE. 
Epochs VmIn Vmax H Carr DT 
_Average 10 11.064 8.369 5.001 9.043 18.997 10.495 
20 8.853 7.743 3.992 7.450 15.619 8.731 
40 8.798 7.249 3.951 8.197 14.042 8.447 
80 7.662 6.432 3.674 6.863 14.465 7.819 
160 5.789 5.701 3.250 6.371 13.984 7.019 
320 4.580 4.172 3.431 6.853 14.360 6.679 
640 4.542 4.037 3.153 5.960 12.144 5.967 
1000 3.944 4.548 3.021 5.860 13.007 6.076 
1280 3.971 3.649 2.861 5.960 14.238 6.136 
2000- 3.784 3.548 3.155 6.235 14.368 6.218 
2560 3.688 3.680 , 3.220 , -- 
6.367 14.225 6.236 
1 00a0lop 4.307 3.724 1 3.206 1 6.339 1 12.297 1 5.975 
---- 20000 
[- 
3.958 3.863 1 3.359 1 6.468 1 15.522 1 6.634 
Table 5-5: The MRE of backpropagation with momentum and adaptive learning rate ANN 
using all the data. In bold are the lowest NRE. 
Epochs Vmin Vmax H Carr DT Average 
10 8.995 6.850 3.699 7.546 14.102 8.239 
20 8.146 6.678 3.840 7.838 13.543 8.009 
40 8.118 3.924 4.034 6.668 11.952 6.939 
80 4.369 3.979 2.689 5.080 12.8301 5.790 
160 3.566 3.967 2.782 5.826 9.114 5.051 
320 2.451 3.249 2.464 4.842 11.017 4.805 
640 2.245 2.910 2.478 4.951 9.165 4.350 
11-280 1 2.538 1 3.015 , 2.481 , 4.874 , 7.213 4024 
12560 1 Z. 4t$, Z l 2.966 1 2.607 1 5.1 1_2 1 7.512 14 
it is shown in Tables 5.4 & 5.5 that there is no ability to predict the validation results by 
training ANN of each topology tested on all the data. This conclusion stems from the fact 
that there is no correlation between the results in Table 5.4 and the corresponding results in 
Table 5.5 (i. e. the best ANN models of Table 5.4 and Table 5.5 are different). Hence, it is 
not possible to choose the number of epochs according to this method. In this study as 
opposed to the previous one, reducing complexity of the network, by not including the other 
responses, contributed to the network performance. The difference between the two studies 
is probably due to the relationships between the responses modelled. It is probable that 
disintegration time is less related to the other responses in the capsule data whereas the 
relationship between dissolution rate (which was modelled separately) and the other 
responses of the tablet study is stronger. 
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It is obvious there was a lack of data hence the ability to predict only 5 out 9 response 
variables. This lack of data is due to big 'holes' in the hypersurface. A second reason is 
related to the connection between the type of response to the independent variables. As an 
example, it might be that variance of dissolution time cannot be predicted by this set of 
independent variables regardless of the amount of data used for modelling. It might be that 
variables that are important for modelling responses, like variance of dissolution time as an 
example, are not included since they are uncontrolled or unnoticed. It is not surprising that 
it was possible to predict minimum bulk density, maximum bulk density as well as Carr's 
compressibility index and Hausner's ratio, since the latter two are calculated from the 
former ones (see Background chapter). 
Hogan et al., (1996) succeeded to model the data using nonparametric canonical correlation 
analysis not only for the responses that the present study succeeded to model but also to the 
responses of coefficient of fill weight variation and variance of dissolution time. Hogan 
used a technique that is primarily descriptive although it may be used for predictive 
purposes. The multiple coefficient of determination in regression (le) is equivalent to 
interranging communalities (d) (Douglas & Love, 1968). They both measure the amount 
of variance in the dependent variable explained by the model. But it cannot be said like in 
regression that if d2 = 1, then 100% of the variance in the dependent variable set is available 
to be explained by the independent variable set. This is since unlike in multiple regression it 
does not deal with a single dependent variable. Hence, it is not possible to compare the Rý 
values (see Appendix B) of this study with the 
& values of Hogan et al. (1996). 
Appropriate comparison could be made by comparing the predictive ability of the two 
methods using the same validation method, as was used in the comparison of ANN versus 
regression in this StudY. 
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Table 5.6: The prediction's relative errors (in percent) of regression and ANN. Each value 
was predicted by excluding it from the model using the leave-one-out method. 
Case Aý_Vrnin A-Vmax A-H A-Carr A-DT R_Vmin R. Vmax R-H R-Carr R-D 
I -6.5Z 4.87 6.71 16.57 -4.69 -8.47 3.10 7.45 13.22 871 
2 0.21 5.41 4.89 8.19 1.97 -1.31 2.83 4.38 8.06 -10.26 
3 -2.79 0.33 4.06 6.40 5.77 -2.44 3.11 4.38 8.33 1.66 
4 -10.97 -3.60 5.78 12.55 -3.32 -9.02 3.73 4.38 8.20 1.37 
5 -1.55 2.04 1.22 4.34 -12.95 -1.30 3.32 0.44 1.03 -4.68 
6 2.67 -3.29 -5.58 -9-89 -8.07 1.02 -2.26 -5.33 -11.30 -11.29 
7 -2.95 -3.89 -2.14 -5.08 -0.84 0.09 -3.75 -2.36 -4.77 -15.74 
8 0.01 -3.94 -1.32 -7.21 1.31 -0.62 -5.28 -1.65 -3.21 0.65 
9 1.33 -2.25 -3.44 -7.46 -27.08 0.60 -2.26 -3.09 -6.30 -11.49 
10 4.21 1.33 -1.70 -0.30 1.62 2.69 0.61 -1.65 -2.40 -14.23 
11 1.50 -3.43 -6.02 -13.12 -0.92 2.69 -3.75 -6.09 -12.36 -6.52 
12 -3.42 -1.15 1.48 0.61 2.14 -1.98 0.61 1.79 3.08 4.58 
13 -3.10 -0.82 -0.32 2.33 -18.58 0.15 0.26 0.27 1.69 -19.12 
14 -1.44 1.08 -2.30 -0.89 6.04 6.03 4.20 -1.73 -2.58 3.30 
15 1.28 1.33 -0.54 -1.03 22.04 0.50 0.61 -0.25 -0.28 12.35 
16 13.01 4.75 -2.10 -3.87 -1.87 -8.14 -6.12 2.13 0.92 23.27 
17 -3.98 2.57 -0.52 1.19 -7.34 22.91 8.34 -0.25 -0.37 -48.41 
18 3.11 0.75 -1.88 -6.86 -3.23 -4.44 -8.55 -6.87 -11.81 6.57 
19 0.79 -2.13 -1.07 -2.58 -2.97 -1.26 -2.54 -3.09 -3.16 -4.09 
20 -4.55 -4.01 -1.64 -5.93 -25.44 -2.55 -4.26 -0.25 -5.23 -32.42 
21 -2.22 -5.00 0.99 -7.40 29.64 -5.21 -9.62 1.12 -8.38 18.33 
22 4.91 4.62 -0.58 -2.93 27.68 4.06 3.05 -1.06 -1.96 16.94 
23 2.15 4.43 2.67 6.17 -4.82 1.12 3.85 3.78 7.29 -13.02 
24 -3.04 -13.77 -8.43 -16.12 -9.63 -6.44 -14.07 -7.22 -15.15 -14.83 
25 -4.64 3.97 5.35 12.37 -2.00 -3.56 6.41 7.18 12.18 1.69 
26 -4.48 2.89 6.79 10.09 -8.96 -5.34 -0.80 5.00 8.44 -13.77 
27 2.16 0.89 1.38 0.98 8.55 3.09 -2.26 -1.85 -3.82 6.45 
28 -1.95 -1.81 1.76 2.01 15.16 -2.74 -8.49 -2.08 -2.69 11.41 
29 2.38 6.13 2.60 0.11 -25.02 3.86 -0.80 -0.49 -1.16 -15.32 
30 6.57 7.61 2.05 0.60 19.12 4.89 6.88 1.87 4.05 20.18 
31 1.34 0.51 2.39 4.89 -6.13 2.47 3.05 1.87 3.49 13.12 
32 2.57 -2.98 1.62 -4.30 24.93 4.25 0.09 -2.78 -3.82 23-50 
33 13.88 
1 9.53 1 -3.07 
1 
-9.04 , -6.32 
1 12.16 , 8.39 , -0.14 
1 
-0.36 
1 21. iýj 
Note. The abbreviations for the responses stand for (from second left to right column): 
minimum bulk density, maximum bulk density, Hausner's ratio, Carr's compressibility 
index and disintegration time respectively. This set is repeated twice for ANN and 
regression ("112') respectively. 
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The following table summarises the NIRE results. The abbreviations in Table 5.7 relate to 
the following responses respectively (form second left column to right one): minimum bulk 
density (Vniin), maximum bulk density (Vmax), Hausner's ratio (11), Carr's 
compressibility index (Carr) and disintegration time (DT). 
Table 5.7: Average percentage deviation between predicted and observed values for the 
best models of regression analysis and ANN. 
Model Vmin 
_ 













Note. The abbreviations in the table above relate to the following responses: minimum bulk 
density (Vmin), maximum bulk density (Vmax), Hausner's ratio (H), Carr's 
compressibility index (Carr) and disintegration time (DT). 
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5.3.1.1 Optimising the number of epochs and hidden neurons 
In order to optimise ANN performance the number of epochs was varied as well as the 
number of hidden neurons to get the best ANN model, as was mentioned before in section 
5.2. ne ANN MIZE results presented previously on Table 5.4 summarise the results of the 
backpropagation with momentum and adaptive learning rate training method. It does not 
however present all on that particular training method since it does not present the results 
for each topology but only the best ones. All the results, except the ones that relate to 20000 
iterations, for the response of disintegration time are presented in Figure 5.2. 




Figure 5.2: The change in MRE as a function of number of hidden neurons and epochs for 
the disintegration time response. 
Looking at Figure 5.2, the coloured circles are the actual values whereas the surfaces were 
generated using interpolation between these circles. On the bottom right comer one can see 
the minimum point with ANN set-up of 4 hidden neurons and 640 epochs to achieve MRE 
of 12.144. As mentioned before the best ANN for this response employed just one output 
neuron (the plot above considered just the disintegration predictions from ANN of several 
output neurons) with MRE of 10.488. 
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Number of Epochs 01 Number of Hidden Neurons 
Each point in Figure 5.2 represents an average of percent deviations from predictions 
generated by running the ANN 33 times and excluding one each time. When ANN was 
trained for 20,000 epochs it generated reasonable results for topology 2,3,4 with MRE of 
15.522,21.584 and 15.615 respectively. The MRE of the topology with only one hidden 
neuron was 2.3 1X10114 . This 
high number was due to only one trained ANN out of all the 
33, so that when one case was excluded, trying to predict its value generated percent 
relative error of that high order. This one specific ANN modelled several responses 
simultaneously but was given just one hidden neuron so it did not have enough weights to 
model the problem. In addition for this small number of weights the ANN performs many 
iterations so the weights became unproportional to their desired magnitude and hence the 
inability of this ANN to predict reasonably. In this particular topology the optimised ANN 
was trained with 40 epochs to attain MRE of 14.6. Ibis demonstrates that overfitting not 
only happens with too many weights because of too many hidden neurons but also when an 
ANN is trained with too many epochs (an examination of the results in Table 5.4 also leads 
to the same conclusion). This reveals one of the differences between ANN and regression. 
As ANN, regression can also overfit with too many parameters resulting from very long 
regression equation relative to the number of data points, but there is no parallel term to 
overfitting due to too many epochs. 
5.3.2 Testing MRE of ANN versus regression 
5.3.2.1 Data distribution of relative errors differences 
The differences (the initials "DIP stand for differences) between the absolute percent 
deviation of ANN and regression are presented on Figure 5.3 in a form of histograms. 
There is normal distribution he on these graphs in order to inspect how the data 
distribution resembles normal distribution. The following responses are presented 
respectively, minimum & maximum bulk density, Hausner's ratio, Carr's compressiblity 
index and disintegration time. For more robust exan-dnation of data distribution, Shapiro- 
Wilk test that is a quantitative statistical test for normality is presented in Table 5.8. 
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Figure 5.3: Histograms for the differences between regression and ANN absolute percent 
deviations from observed values. The bars represent the actual values whereas the black 
line displays the normal distribution. 
Note. The plots are for the following responses respectively (fi-om top figure to bottom one 
and from left to right column of figures): minimum & maximum bulk density, Hausner's 
ratio, Carr's compressiblity index and disintegration time. 
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Table 5.8: Shapiro-Wilk normality test for the difference between ANN and regression 
-absolute percent deviations from observed values. N 
Stafistic Signi icance 
DIF VMIN 0.671 0.010* 
DIFý_VMAX 0.941 0.097 
DIF H 0.901 0.010* 
DIF_CARR 0.954 0.278 
IDIFý_DT 1 0.910 
1 1 
0.014* 
*Normality is rejected at the 0.05 level. 
From Figure 5.3 and Table 5.8 it could be seen that the distribution of the differences 
between the absolute relative deviations of ANN and regression is far from a normal 
distribution for 3 out of 5 responses (the other two also don't show typical normal 
distribution). Hence, it was necessary to conduct the nonparametric tests instead of t-tests 
that stand on the normality assumption. 
5.3.2.2 Nonparametric tests 
To test whether ANN predicts better than regression, Wilcoxon signed ranks tests were 
performed on absolute percent deviation (MRE) of ANN versus regression, and are 
presented in Table 5.9. 
Table 5.9: Nonparametric tests, of Wilcoxon signed ranks test to test whether ANN 
predicts better than regression. "Dif 'stand for the difference between ANN and regression 
(ANN minus regression). 
Response Mean-Dif Median-Dif Significance 
V-MIN -0.476 0.250 0.52T 
V MAX -0.610 -0.130 0.235 
H 2.860 2.100 0.643 





0 .1 36J 
According to the results presented in Table 5.9 the nonpararnetric tests did not show ANN 
predicts better than regression. The most significant advantage ANN has is in its predictive 
ability of disintegration time response (but still, it is not statistically significant). 
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5.3.3 Bivariate correlation 
To determine which method predicts better, and if there is any corrleation between ANN 
and regression predictions, bivariate correlation was employed. Pearson correlations and 
Spearman's non-parametric correlations between the observed responses and the predicted 
responses of ANN and regression are shown in Tables S. I Oa & 5.1 Ob respectively. Tables 
5.1 Oa & 5.1 Ob relate to the following responses respectively (from top to bottom in each 
table): minimum bulk density, maximum bulk density, Hausner's ratio, Carr's 
compressibility index and disintegration time. "DT", "A_DT" and "R_DT" stand for the 
observed values, the ANN predicted values and the regression-predicted values of the 
disintegration time response respectively. To read the data, for example, looking at the first 
table (for minimum bulk density response) on the second row and column gives a value of 
o. 889. 'Mat means, the Pearson correlation coefficient between ANN predictions to the 
observed values is 0.889. 
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Table 5.10a: Pearson correlations between the responses and the predicted responses of 
ANN and regression. 
V-MIN A-V-MIN RV MIN 
\ý_MIN 1.000 . 889** . 885** 
A_V-MIN . 889** 1,000 . 767** 
R-V-MIN . 885** . 767** 1.000 
V-MAX kV-MAX R-V-MAX 
V-MAX 1.000 . 877** . 915** 
A-V-MAX . 877** 1.000 . 690** 
R-V-MAX . 915** . 690* 1.000 
H Aý-H R-H 
H 1.000 . 635** . 935** 
A_H . 635** 1.000 . 393* 
RH * 935** 0.393* 1.000 
CARR A-CARR R-CARR 
CARR 1.000 . 590** 0.933** 
A_CARR . 590** 1.000 0.296 
R CARR . 933** 0.296 1.000 
DT kDT R-DT 
DT 1.000 . 518** 0.779** 
A_DT . 518** 1.000 0.046 
R DT 1 . 779** l 0.046 1 
1.000 
Correlation is significant at the . 05 level (I -tailed). 
Correlation is significant at the . 01 level (I -tailed). 
Note. The tables above relate to the following responses respectively: minimum bulk 
density, maximum bulk density, Hausner's ratio, Carr's compressibility index and 
disintegration time respectively, e. g. "DT", "A - 
DT" and "R 
- 
DT" stand for the observed 
values, the predicted values by ANN and the predicted values by regression regarding the 
disintegration time response respectively. 
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Table 5.10b: Spearman's non-parametric correlations between the responses and the 
predicted responses of ANN and regression. 
V-MIN A-V-MIN R= V=MIN 
\ý. MIN 1.000 . 931** . 934** 
A_V-MIN . 931** 1.000 . 807** 
R_V-MIN . 934** . 807** 1.000 
V MAX A V-MAX R-V-MAX 
\ý_MAX 1.000 . 881** . 917** 
AV MAX . 881** 1.000 . 738** 
FýýMAX . 917** . 738** 1.000 
H A-H R-H 
H 1.000 . 510** . 964** 
H AH 
- . 
510** 1.000 . 384* 
H Rý 
r 
. 964** . 384* 1.000 
CARR A CARR R-CARR 
CARR 1.000 . 452** . 962** 
A_CARR . 452** 1.000 . 275 
R-CARR . 962** . 275 1.000 
DT A-DT R-DT 
DT 1.000 . 410** . 696** 
A_DT . 410** 1.000 . 046 
R DT . 696** -. 046 1.000 
Correlation is significant at the . 05 level (I -tailed). 
**. Correlation is significant at the .01 level (I -tailed). 
Note. The tables above relate to the following responses respectively: minimum bulk 
density, maximum bulk density, Hausner's ratio, Carr's compressibility index and 
disintegration time respectively, e. g. "DT", "A - 
DT" and "R 
- 
DT" stand for the observed 
values, the predicted values by ANN and the predicted values by regression regarding the 
disintegration time response respectively. 
A quick view of all the results in Table 5.10 (parametric and non-parametric) reveals higher 
correlation coefficients for regression relative to ANN. However, both ANN & regression 
models were significant in all the tests of correlation coefficients at the 99% confidence 
level. The correlation coefficients (both parametric and non-parametric) for the relation 
between ANN and regression have confidence level of more than 99% for the responses of 
minimum and maximum bulk density, 95% for Hausner's ratio and less than 95% for 
Carr's index (weak correlation). For the disintegration firne, the correlation coefficients 
show values that demonstrate there is no correlation between ANN and regression 
predictions. 
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5.3.4 Precision test of ANN versus regression 
To compare the precision of ANN versus regression, F-Tests for variances of percent 
relative errors (signed NIRE) between ANN and regression were conducted, and the results 
are presented in Table 5.11. In the left column is the name of the statistical 
measurement/test involved. The other columns present the values of these 
measurements/tests. The abbreviations for the responses stand for (from left to right 
column and continued below): minimum bulk density, maximum bulk density, Hausner's 
ratio, Carr's compressibility index and disintegration time respectively. "A_" and "R_" 
stand for initials that relate to ANN and regression percent relative deviation respectively. 
Table 5.11: F-Test for variances of percent relative errors between ANN and regression. 
A_V_min R_V_min A_V_max R_V_max A-H R-H 
Mean 0.20 0.23 0.39 -0-37 0.28 -0.07 
Vadance 24.80 37.25 20.61 28.07 12.95 13.60 
F 0.67 0.73 0.95 
A_Carr R_Carr A_DT R_DT 
Mean -0.44 -0.64 -0.43 -1.22 
Vadance 56.68 48.83 202.18 270.21 
F 1.16 - 0.75 
Note. The abbreviations for the responses stand for (from left to right column and from top 
table to bottom one): minimum bulk density, maximum bulk density, Hausner's ratio, 
Carr's compressibility index and disintegration time respectively. "A,. 2' and "R " stand for 
initials that relate to ANN and regression percent relative deviation respectively- 
Looking at the precision test results on Table 5.11, it can be seen there are no major 
differences between the precision of the two methods. The biggest difference is in the 
response of minimum bulk density. In this response, the variance of ANN percentage 
relative errors is 24.80, the variance of regression percentage relative errors is 37.25 and 
the F-value is 0.67. Hence, ANN is more precise than regression by about one third 
C-abouf' because F-test is done on independent samples and not paired data as in this 
study, so it is not possible to use significance values generated in this test). 
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5.3.5 Bias examination 
To examine if the predicted values generated by ANN and regression models are 
significantly below or above the observed values, bias tests were conducted. Bias tests on 
signed residuals (observed minus predicted) of ANN ("A_") and regression ("1ý2') are 
shown in Table 5.12. The left-hand column gives information on whether it is ANN or 
regression modelling type and the response modelled. Tle abbreviations for the responses 
stand for (from the top): Carr's compressibility index, disintegration rate, Hausner's ratio, 
maximum and minimum bulk density respectively. This set of abbreviations is repeated 
since it relates to ANN as well as regression. 
Table 5.12: Bias test on signed residuals (observed n-dnus predicted) of ANN ("A,.! ') and 
regression ("R, _! 
'). 
One-Sample Test 
Test Value =0 
95% Confidence 
Sig. Mean Interval of the Difference 
t df (2-tailed) Difference Lower Upper 
CARR 1009 
32 992 4,364E-03 -, 9323 9411 
A_DT 397 32 . 694 9,315E-02 -. 3854 5717 
A_H 638 32 . 
528 6.136E-03 -1,35E-02 2,574E-02 
k\ý_MAX 821 32 418 4,456E-03 -6.60E-03 1,551 E-02 
A_), ý_M IN 439 32 664 1,885E-03 -6.86E-03 1,063E-02 
R_CARR -, 188 32 . 
852 -7,92E-02 -. 936947 . 77852518 
R_DT -, 136 32 . 892 -3,73E-02 -. 595663 . 
52096649 
R_H 072 32 . 
943 
. 00070838 -. 019368 . 02078484 
R_VýMAX -, 229 32 820 -1,47E-03 -1,5E-02 1,16E-02 
R_)ý_M IN 308 1 32 1 760 1 1,64E-03 I -9,2E-03 I 1,25E-02 
Note. The abbreviations from top downwards stand for responses of. Carr's compressibility 
index, disintegration time, Hausner's ratio, maximum and minimum bulk density 
respectively. This set of abbreviations is repeated twice since it relates to ANN as well as 
regression. 
The bias results presented on Table 5.12 reveals there is no model with a significance value 
which is so low that the null hypothesis (according to the null hypothesis there is no bias) 
could be rejected. Hence, there is no bias in any of the models. One could also examine the 
95% confidence interval and see that the 0 value lies vAthin the interval of all the models. 
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5.3.6 The predictive ability as a function of the response value 
As was mentioned in the previous chapter, sometimes one model is better on a certain 
response domain than the other. What follows is a presentation of two sets of graphs to 
detect the relationship between ANN and regression errors in predictions to the response 
values. 
Figure 5.4 shows the difference between the absolute residuals (observed-predicted) of 
regression minus those of ANN on the y-axis, as a function of the observed value on the x- 
axis. The initials "RD" on the y-axis stands for the residual difference. The plots of Figure 
5.4 relate to the following responses, from top to bottom, respectively: minimum bulk 
density, maximum bulk density, Hausner's ratio, Carr's compressibility index and 
disintegration time. Figure 5.5 is the same plot as the one that relates to disintegration time 
in Figure 5.4 with one exception - one outlier data point is omitted. Figure 5.6 demonstrates 
the dependency of the percent relative error QVIRE) on the y-axis upon the response value 
on the x-axis. The N4RE data was taken from Table 5.6, on-&ting the sign to get the 
absolute values. The red squares are ANN relative errors whereas the red he is the least- 
square regression line which demonstrates trend, similarly green relate to regression data 
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Figure 5.4: I'lie difference between the absolute residuals (observed-predicted) of 
regression minus those of ANN on the y-axis, as a function of the observed value on the x- 
axis. 
Note. The figures above relate to the following responses respectively (from top figure to 
bottom one and from left to right column of figures): minimum bulk density, maximum 
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Figure 5.5: The difference between the absolute residuals (observcd-predictcd) of 
regression minus those of ANN on the y-axis, as a function of the observed value on the x- 
axis. The response is disintegration time. One outlier data point was omitted. 
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As can be seen from the first 4 graphs on Figure 5.4, there is no one method that is better 
for a certain domain of these response variables. There is one slight trend at the 
disintegration time graph: it can be seen that ANN predicts better on the low values 
whereas regression predicts better for capsules that disintegrate slower (high values). The 
trend lines does not show this due to a very big residual difference (due to much better 
predictive ability of ANN versus regression on this point) which has a value of 4.72. 
omitting this value and calculating the regression line will yield the graph in Figure 5.5. 
The regression line on Figure 5.5 shows that as the capsule's disintegration time increases 
regression predicts better than ANN. This is the same trend that was mentioned before. 
Hausner's ratio and Carr's index show negative slope mainly due to 2 extreme big residual 
differences in each response with the values of -0.05,0.07 and -3.1,1.5 respectively, so 
there is less information to be gathered from these slopes. As can be seen from the last 
three examples, sometimes outliers can shift the regression trend line in a way that prevents 
us from seeing the overall picture. Hence, there is no replacement for looking carefully at 
the data points on the gr4phs for detecting trends. 'Me disintegration time graph is an 
example that once two clusters were detected, a regression line can be only used as a tool to 
clarify the trend between the two clusters. 
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Figure 5.6: Percent relative error (in absolute values) as a function of the response value. 
In red and green are ANN and regression results respectively. The regression lines 
represent the trend. 
Note. The figures above relate to the following responses respectively (from top figure to 
bottom one and from left to right column of figures): minimum bulk density, maximum 
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Examination of the graphs in Figure 5.6 show almost the same slope for ANN and 
regression, for minimum and maximum bulk density variables. ANN trend lines for 
Hausner's ratio, Carr's index and disintegration time graphs show a bigger slope compared 
to regression, suggesting that ANN has a bigger dependency on error as a function of the 
response value. Looking at the graph of maximum bulk density there are two points with 
big MRE one for regression and one for ANN. The extreme MRE for the lowest value of 
maximum bulk density demonstrates inability of the models to predict well values of low 
response values of maximum bulk density. It is noticeable by the trend line in this graph 
that MRE decreases as bulk density gets bigger. Hausner's ratio, Carr's index and 
disintegration time show positive slopes that suggest the predictive ability of the models 
deteriorates as the corresponding response values increase. 
Looking at the actual datapoints, one can see that there are no real trends that could be 
detected by visual inspection except for the disintegration time response. In this response 
there is deterioration in the predictive ability as disintegration time increases. This is more 
obvious for ANN than for regression. 
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5.4 Conclusions 
There is no possibility of saving time by predicting MRE results through running ANN on 
all data points as can be seen from looking at Tables 5.4 and 5.5. In the response of 
minimum bulk density ANN is about one third more precise than regression. On the 
response of disintegration time a topology of one output neuron gave better results than a 
topology of several output neurons. By using just one output neuron the complexity of the 
ANN declined since there were fewer weights and they did not have to take into account all 
responses, in this respect it is like the regression model. Probably there is not a strong 
correlation between disintegration time to the other responses, since if there were such 
relationship the information from the other responses would aid in learning and better 
predictions resulting in lower NM of the more complex topology. Hence, not taking into 
account all ANN responses can cause ANN to learn better depending on the type of data 
involved. 
The responses, which show better MRE results of ANN relative to regression, are 
minimum and maximum bulk density as well as disintegration time. Since the differences 
between ANN and regression absolute percent deviations from observed values did not 
resemble a normal distribution, it was not possible to conduct a paired t-test. Hence, 
Wilcoxon non-parametric tests were conducted. These tests showed ANN predictions are 
no better than regression ones. On examinations of correlation coefficients of ANN and 
regression to predicted values, it was shown both methods correlate in 99% confidence 
level for all 5 responses. An interesting point to note is that there is no significant 
correlation between ANN and regression values in the responses of disintegration time and 
Carr's compressiblity index. That means, that regarding the latter responses using an ANN 
will produce quite different predictions than using regression. 
Regarding the relation between the response values and the errors in predictions for both 
ANN and regression two phenomena were detected. Regarding disintegration time 
response, ANN and regression relate to this response in such a way that ANN predicts 
better for faster disintegrating capsules whereas regression predicts better for the slower 
disintegrating ones. ANN is more susceptible to this response value than regression since it 
shows greater deterioration in the predictive ability as the response value increases. 
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ibe regression models tested here were very limited since they did not include interaction 
and squared terms as in the tablet study. So there may not have been enough flexibility to 
model the system. This may explain the difference in the predictive ability of ANN versus 
regression for the disintegration time response, although this was not found to be 
statistically significant. To verify this conclusion, a more complicated regression model was 
constructed. Its starting equation included all squared terms and also interaction terms 
between filler type and filler level, disintegrant type and disintegrant level, lubricant level 
and glidant level, and all possible interactions concerning drug properties. Backward- 
elimination that was done on this equation yielded an equation that could generalise better 
than the best ANN model, since using the leave-one-out for validation on this equation 
yielded NM value of 8.66! 
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6. Multiobjective Optimisation of Tablet 
Formulations and Processes 
6.1 introduction 
Achieving the desired properties for a tablet is important for a number of reasons. This is an 
imperative primarily for regulatory approval since in order to get approval for the product it 
must have adequate properties, e. g. disintegrate fast enough. Another reason may be that 
the regulatory requirements are made more stringent and the product needs improvement. 
The advantage of tablet properties that exceed the requirements of the regulatory authorities 
lies in increasing the chance that more time elapses before there is a need for improvement, 
if any improvement is required at all. Doing optimisation and achieving goals that are 
beyond what is needed, alleviate the quality of the product and it is good both for the 
consumer and for the company, e. g. increase in dissolution rate could cause the user to have 
a relief from pain (in case of pain-killers) faster. Another issue is that optimisation of tablet 
properties saves time and money by decreasing the number of experiments. There is also 
another advantage of being able to develop the formulation faster and maybe to be first on 
the market. This is an important marketing principle that could yield money for a 
pharmaceutical company- 
From the nature of pharmaceutical formulation it is clear that problems need to be 
addressed in a manner that takes into account all the relevant responses. For example it is 
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no use optimising formulation and process parameters to improve dissolution rate response 
without taking into account tablet hardness. Increasing the compaction force will usually 
cause the tablet to be harder and dissolve slowly and vice versa. The essence of the 
pharmaceutical formulation and process problem is hence the optimisation of conflicting 
variables, and to resolve this multiobjective optimisation is required. 
There are number of multiobjective optimisation techniques used for optimisation of 
pharmaceutical formulations. Graphical techniques were commonly used for optimisation 
in the pharmaceutical field (Schwartz et al., 1973). These have evolved to numerical 
methods like the Monte Carlo approach, which uses random number techniques to reach 
the optimum solufion (Takayama & Nagai, 1989). Building a regression equation and 
optimising using graphical methods and/or simplex algorithm (Turkoglu et al, 1992; see 
Edwin & Stanislaw, 1996 for a description of the simplex algorithm and other optimisation 
algorithms) is one common approach that symbolises the more general approach of 
building a model and optimisation. There is also a method that does not use any model, this 
is dynamýic multiobjective optimisation (Shek et al, 1980). The dynamic optin-: iisation is an 
iterative process of feeding the computer the latest experiment and it suggests a new 
experiment that is supposedly closer to the optimum solution point. With the emergence of 
the use of ANN in pharmaceutical formulation development these ANN too were 
incorporated into the process of optimisation. There is the direct approach of inversion of a 
trained ANN (Turkoglu et al., 1995; Achanta et al., 1995) but the more popular methods 
involve a combination of ANN and optimisation methods e. g. a combination of ANN and a 
genetic algorithm (Dowell et al., 1997/1999). The latter approach was implemented in 
Cad/Chem software for formulation optimisation (Colbourn & Rowe, 1996). Another 
approach is model building using regression/ANN and multiobjective optirriisation by a 
generalised distance function method. This was done in several studies relating to solid 
dosage forms (Takahara et al., 1997a) as well as the formulation of gels (Takahara et al., 
1997b). The last two articles by Takahara and co-workers used an ANN and an 
optimisation algorithm whereas a combination of regression with multiobjective 
optimisaflon was the methodology in earlier papers (Levison et al., 1994, used this 
approach to optimise formulation of gels). There is also another variation of the 
multiobjective optimisation method that enables one to give preferences for the different 
responses to be optimised (Takayama & Nagai, 1991). This study will present a novel 
method for multiobjective optimisation that incorporates ANN for building the model and 
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the Goal Attainment method of Gembicki (1974) for optimisation. The Goal Attainment 
method can also take into account the priorities of the responses to be optimised, Tlle next 
sections explain this method. 
The aim of this study was to minimise disintegration time and impact friability 
simultaneously by creating and using a novel computer program that implements a new 
optimisation algorithm. The combination of ANN with the Goal Attainment method 
(Gembicki, 1974) for optimisation was the new algorithm implemented. The responses 
were arbitrarily chosen with the guideline being that their optimisation goals are conflicting. 
only two responses were chosen to simplify this study and to avoid too much detail, but all 
8 responses could be optimised simultaneously in the same manner. An example of this 
multiobjective optimisation is set out below. 
In this example the object is to minimise F(x). X Consists Of X19 X2 and X3 representing the 
independent parameters of lubricant (0/o), disintegrant level (%) and compaction force (W) 
respectively. The feasible region is defined as LI. x belongs to the three dimensional 
%3, So r, XC 913 parameter space -, briefly denoted as x r= 913). 
The constraints on x were: 
0.1 :5 xi :! ý 100 
1.0 :5 X2 !ý 100 
3.0 < X3 :5 100 
The corresponding feasible region is generated using the trained ANN. Tbe trained ANN is 
the function F which generates the appropriate solution according to x. For each x value 
there is an appropriate y= F(x) value in Figure 6.1 which defines the feasible region for the 
objective function, this space is denoted by A. Since there are two responses to be 
optimised the objective function is in two dimensional parameter space. It can be 
summarized as: 
A=(yE 912) where y= F(x) subject to x r= fl. 
Note that Figure 6.1 does not represent the true F(x) values for the optimisation problem 
presented in this work, rather it is a depiction of an arbitrary objective function region. 
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impact Friability 
Figure 6-1: Objective function (F(x)) region (A) for disintegration time and impact 
friability. In the region, closed by the line (not the white area), are the allowed values 
generated from simulating ANN on independent variables -x (not true values, just for 
illustration purposes). 
Since F(x) is a vector, the components of which (the two responses) are competing, there is 
no unique solution to the problem. The concept of non-inferiority (Zadeh, 1963), that is also 
called Pareto optimality (Censor, 1977), is used to characterise the objective function. A 
non-inferior solution is one in which improvement in one objective requires a deterioration 
of other one. In this case improvement of impact friability (lowering % friability) will cause 
deterioration in disintegration time (increasing disintegration time) and vice versa. From 
Figure 6.2, on the curve between points C and D there are two non-inferior points A and B. 
if one moves from point A to B there is a lowering of impact friability as BIm < Alm but 
also an increase in disintegration time since Bdi > ADi. Multiobjective optimisation is 
concerned with the selection of non-inferior solution points. 
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Disintegration time (min. ) 
Figure 6.2: Selection of noninferior solution points. Moving from A to B causes 
improvement in impact friability response (reduction) but deterioration in disintegration 
time response (elongation). The region that is closed by the line (not the white area) is the 
objecive function space (A). 
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6.2 Methods 
The data for this study was taken from Patel (1996) using data for only 2 responses out of 
the 8. The ANN that was used had 3 input neurons and 2 output neurons. ANN was trained 
on all the data using backpropagation of a Levenberg-Marquardt algorithm (Scales, 1985; 
see Hagan et al., 1996 for explanation of how this algorithm is implemented in ANN) for 
100 epochs. The data was scaled between values of -1 to 1. The goals that were set for the 
multiobjective optimisation were to achieve 0.1% impact friability and disintegration time 
of 0.1 second. The goals were set arbitrarily with the guideline that the two responses 
should achieve the lowest value possible. It is obvious there are also constraints to tablets 
formulation and process variables, values of 0 kN or the other extreme of 100 kN for 
compaction force are obviously not acceptable. The lowest levels of lubricant, disintegrant 
and compaction force were 0.1%, 1% and 3 kN respectively. The upper levels were set to 
100% for lubricant and disintegrant and 100 kN for compaction force. The starting values 
for the optimisation routine were 0.25%, 2%, 14 kN for lubricant, disintegrant and 
compaction force (case 9 in Table 3.1). Theses starting values were chosen since the input 
parameters yielded good response values of 0.91% and 21.67 seconds for impact friability 
and disintegration time respectively. Another starting guess was chosen by taking the input 
parameters of the first data point (see case I in Table 3.1). 
The search for the best input parameters used the Goal Attainment method of Gembicki 
(1974). In applying this method to this study F, (x) is the ANN output with respect to 
impact friability and F2 W is the ANN output with respect to disintegration time. The aim 
is to minimise y (variable) subject to: 
XE0; F, (x) - wi *y _-ý goal 1; 
F2 (X) . W2 * y: 5 goal 2; 
where w, and w2are the weights. These weighting vectors express a measure of the relative 
trade-off between the objectives. The first condition is obvious since it is not desirable that 
the optimisation routine searches for impossible values of x like concentrations not in the 
range 0 to 100%. The goal values define target responses that in this case were set to 0.1% 
impact friability for goal I and 0.1 second for disintegration time of goal 2. Obviously, 
these values are imaginary since in this system they are far too strict to be of any practical 
relevance. Hence, there will be under-attainment as opposed to over-attainment of the 
goals. Nevertheless, the goals set up the overall target and the place where the search 
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begins. The weighting factors of w, and w2 set up the direction of the search from the goal 
point. By changing their values one can control the preferences between the goals, e. g. 
setting W2 to 0 Will impose that the disintegration time will be less than the target goal 2, 
since F2 (x) -0*y :5 goal 2 equal to: F2 (x) :5 goal 2. In this case disintegration time has 
been given priority over impact friability. The concept of searching a region composed of a 
rigid barrier in one of the responses is very relevant to pharmaceutical formulation 
problems, since the regulatory authorities impose strict limits on the range of values for 
some responses. For this reason the current method of multiobjective optimisation seems 
suitable to our domain more than other multiobjective optimisation algorithms that do not 
offer this possibility. For example, the goal could be set to be disintegration time :9 600 
seconds as a strict barrier. In this study the two weights were given the same values of 0.1 
so the two responses were given the same importance. It is obvious just from looking at the 
equations why minimisation of y will cause also minimisation of the responses; if the 
disintegration time equation is rearranged and the values used in this study are entered into 
the equation it takes the form: 
FAX) - 0-1 :5 
0*1 *y which is (F2 W-0.1) / 0- 1 !! ý Y 
From the equation above, minimising y imposes a more stringent condition on 
disintegration time, so the disintegration time has to be smaller. On the other hand 
increasing the weight will allow disintegration time to be bigger, so there will be more 
freedom to the condition and the goal will be less rigidly met. Figure 6.3 displays the actual 





Figure 6.3: The parameter's settings used in this study for multiobjective optimisation 
using the Goal Attairunent method. 
The feasible function space A which is composed of F, (x) component on the x-axis and 
F2(x) component on the y-axis, no longer depends only on the independent variables 
constraints, but also depends on y. Decreasing y vAll cause a decrease in A, so the size of 
the feasible space is constantly changing during optimisation. 
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goal I=0.1 F, (x) = impact friability 
6.3 Results and discussion 
After running the multiobjective optimisation program with the data of Patcl (1996), the 
optimised solution was 0.1%, 3.12%, 16.9 kN for lubricant, disintegrant and compaction 
force respectively. The solution yielded the following responses values: 0.69% for impact 
friability and 8 seconds for disintegration time. Exactly the same solution was generated 
with the two different starting guesses, but the starting data point which was further away 
converges to the solution after 28 optimisation iterations as opposed to 33 iterations with 
the starting guess which was closer to the solution. This solution is better than any results 
generated in the experiments. Looking separately, at Table 3.2, for the best impact friability 
response one can see in case 17 a value of 0.65% (and 59 seconds for disintegration time) 
and for the best disintegration time the value in case 9 is 22 seconds (and 0.91% for impact 
friability). These response results are for two different input vectors of parameters as 
opposed to one input vector of the optimised solution. With respect to the disintegration 
time one can see the solution generated extrapolated beyond the response value, since the 
lowest disintegration time is 22 seconds 
it is possible to set the goal of the optimisation routine to values that will not cause ANN to 
extrapolate beyond the response values. Setting the goal values to 0.65% and 21.67 
seconds for the best impact friability and disintegration time response respectively yielded 
the corresponding results of 0.85% and 28.22 seconds for the impact friability and 
disintegration time respectively. The optimýised input parameters for this result are: 0.1% 
1.71%, 15.6 kN for lubricant, disintegrant and compaction force parameters respectively. 
However, the leave-one-out experiments that were described in previous chapters showed 
ANN can sometimes extrapolate to the response values quite reasonably. Thus, it may be 
unwise not to try a potentially good solution and to compromise on the second solution that 
is inferior because it uses more limited goals. Still, there is extrapolation problem with 
respect to both optimisation solutions, of the different goal settings, since they both 
suggested lubricant concentration of 0.1% and the lowest lubricant concentration used by 
patel (1996) was 0.25%. To avoid this problem it is possible to set in advance the 
constraint of lubricant concentration to be not lower than 0.25%. 
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The optimisation path for the less stringent constraints (imposed by unreal goals) with 
relation to the response values is demonstrated in Figure 6.4. The first row of figures relates 
to the starting guess that is closer to the solution and second row is for the arbitrary starting 
guess. Looking at the graphs one could see that the optimisation routine has big fluctuations 
in the beginning and then the fluctuations became smaller and smaller as it approaches its 
solution. Looking at the top right plot one can see that at one stage of the optimisation the 
optimisation routine generated inferior disintegration time response than that of the starting 
guess due to very big fluctuations. The disintegration time after 5 iterations was 97.78 
seconds, which is about five times greater than the starting guess. The point here. that one 













Figure 6.4: The simultaneous lowering of impact friability and disintegration time as a 
function of number of optimisation iterations, by using a novel computer program that 
incorporates ANN with the Goal Attainment method. The value of the response is on the y- 
axis. The number of iterations is on the x-axis. The first row of figures relates to the starting 
guess of the independent variables chosen to be close to the optimum solution (this starting 
guess was found by inspecting the experimental data). The second row relates to the 
arbitrary starting guess. 
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Multiobjective optimisation procedure forces one to have knowledge of the system to be 
optimised. The knowledge is important for telling the optimisation algorithm what are the 
optimisation goals and the relative trade-offs between the goals, but also to give it the 
constraints. For example, if from literature it is known that the amount of magnesium 
stearate should be 0.25 - 5% as lubricant, it must be dcrined as constraints to the 
optimisation algorithm. It is important to note that recommended concentration can change 
for the same excipient depending on its role in the formulation. If the constraints are not 
properly defined the optimum solution that is arrived at could have unrealistic values of 
independent variables. Hence, it is important that the expert system that incorporates the 
opfin-fisafion routine gives the user the knowledge necessary for optimisation, as in this case 




This study suggests there is no need to search for the data point with the best responses as 
the starting guess for multiobjective optimisation. In this study a random selection of data 
point out of the 27 tablet experiments arrived at the same optimum point but faster (with 
less optimisation iterations) than the data point with good response values that was 
especially selected. Another point is that one should not use too few optimisation iterations 
since there are big fluctuations in the beginning of the optimisation process, these became 
more moderate as the number of iterations increases. 
This study investigated the use of multiobjective optimisation of a new method. It was 
feasible to do this method. It should be now more generally applied. Other people should 
experiment with this method in solving various practical multiobjective optimisation 
problems. 
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7. Expha Expert System 
7.1 Introduction 
A pharmaceutical formulator, refiring or leaving can cause a gap that impairs the ability of a 
pharmaceutical company to improve or create formulations for existing/new products. If the 
experiments that the formulator performed were not documented properly the problem is 
even greater. A new formulator would find it difficult to take the place of an experienced 
formulator and this problem is worse if he/she has no prior experience. Ile novice 
formulator does not know where to start and hence is likely to conduct more experiments 
than the experienced formulator, wasting the company's time and money. Another issue is 
that the formulation generated by a novice formulator will probably have inferior properties 
to one that the expert formulator would make, although both might pass the pharmacopoeia 
limits. The experienced formulator is more likely to arrive at the better formulation. Often, 
the problem is that experienced formulators fail to document fully their development 
process. This is partly due to the type of person pharmaceutical formulators sometimes are. 
Sometimes experienced formulators possess immense creativity at the expense of a less 
developed habit for documentation. In contrast, for example, one may say that quite the 
opposite is true for the quality assurance personnal. These statements are of course only 
generalisations that are not always true 
(based on my limited experience as a worker in a 
pharmaceutical company). As was mentioned 
before, poor documentation can impair the 
performance of a new formulator 
in a new position- In addition, the documentation of all 
available parameters is important 
for the success of optimisation process. A formulator 
conducting trial and error experiments can 
do many of these without arriving at an optimum 
formulation with adequate properties. Trial and error is necessary in many cases but the 
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data generated should be analysed rigorously, and sometimes, systematic studies may need 
to be done and only than one may arrive at optimum and robust formulation. 
Not many pharmaceutical expert systems exist in the field of solid dosage form 
development. Cad/Chem (Colbourn & Rowe, 1996) is a system used for formulation 
optimisation not just in pharmacy. In the pharmaceutical solid dosage forms area it was 
used (Kesavan & Peck, 1995) to optimise tablet formulation. It uses ANN for building 
models and genetic algorithms for optimisation. It was mentioned first since it differs from 
the other expert systems that will be discussed. It has no knowledge of the problem and it is 
just a modelling and optimisation tool as opposed to the expert systems that will be 
discussed later that have knowledge of the pharmaceutical problem. There is an expert 
system for capsule filling and related problems in powder technology (Lai et al., 1996). 
This system consists of a database of excipients and a database of many formulations. It has 
very valuable knowledge of facts and rules generated from inquiring 10 experts in the field 
of capsule formulation development. There is an expert system for solving tablet's coating 
defects (Rowe & Upjohn 1993a). It was developed with the aid of a special tool for 
developing expert systems called Expert System Shell. Zeneca Expert System (Rowe & 
Upjohn 1993b) is used for solving tablet formulation problems. First it suggests a 
formulation, then it predicts the tablet properties of the suggested formulation. The user 
tries the formulation and 'feeds' the computer the observed values of the new tablet 
properties. Accordingly, the computer corrects itself and suggests another formulation. This 
iterative process continues fill the user is satisfied from the tablet properties. The Cadilla, 
expert system for tablet formulation (Ramani et al., 1992) suggests a formulation to the 
user, if the user rejects the system's advice 
it suggests another formulation. Ibis latter 
system lacks an optimisation stage. An expert system for tablet formulation was developed 
using a mulfivariate statistical method called canonical analysis (Podczeck, 1992). It 
analyzed the behavior of different mixtures of excipients with 15 drug substances. The 
statistical analysis was translated into facts and rules. 
Currently, there is no explicit write-up in the scientific literature of a tablet formulation 
expert system despite such software are available. 
Proprietary systems are very expensive 
so it was not possible to 
have access to them within the remit of this project. Nevertheless, 
there are general programs for formulation 
like Cad/Chem that could be used only for the 
formulafion opfimisafion stage. 
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Ile purpose in creating Expha is to develop an expert system designed to aid die derinition 
and optimization of a solid dosage formulation and manufacturing process, Ilis will reduce 
the number of experiments. Hence, it shortens development time and saves money. The 
quality of formulation will improve since it will have better response properties. Another 
specification is to use the expert system to educate undergraduate, postgraduate and new 
scientists in the field of tablet formulation and to expose them to expert systems. 
Typically (using Expha) one would collect the data, model this data as a function of the 
variables investigated using either regression or ANN and then carry out optimisation. 
There are models that are not likely to vary from one problem to another, these models 
could be incorporated within the decision making within Expha. Details of building models 
and opfirnýisation are given in Chapter 2. 
7.2 Specirications & features 
Expha is an expert system designed only for tablet formulation. It should have a database of 
excipients and tools to allow expansion of this database by the user. It should also have a 
database of formulations and processes that will be created from scratch by the user. All 
this data acquisition will be done by a friendly user interface that will help to make the 
process of acquiring data an easy one and aid in preventing mistakes. Data retrieval from 
the databases should be an easy task that uses a friendly user interface. The requested data 
should be presented on the screen or in the form of reports. It should possess basic 
pharmaceutical knowledge in the form of rules. The rules are not meant to be 
comprehensive. Expha should have modelling and optimisation, components. The modelling 
part will enable the user to choose between ANN and regression. In each one of the 
modelling methodologies the user should be able to build various models which may than 
be incorporated within Expha and used in decision making. The next section delves into 
specific issues concerning Expha. 
Explia should give advice on the manufacturing process, formulation and miscellaneous 
issues like a recommendation to micronise a drug substance. Another goal is information 
collection, for the appropriate documentation of all the experiments with all the relevant 
parameters. For example, the precise 
documentation of process parameters and formulation 
ingredients is very important. The next issue is fightly connected to the previous one. It is 
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the use of the information gathered for developing regression/ANN models. The regression 
models could give insight into the pharmaceutical system; e. g. it can be seen in many 
pharmaceutical systems that as more lubricant is added dissolution rate deteriorates. The 
exact quantitative relation between lubricant level and dissolution rate could be seen from 
the regression equation. In a similar manner, in another system of a drug with different 
excipients other phenomena may be detected. The ability to look into the pharmaceutical 
system is an educating tool by itself that enhances the understanding of formulation and 
process issues. The novice formulator can see that a trend like the one described previously 
is repeated in many formulations and acquires more knowledge of formulation 
development, so taking into account the amount of lubricant for example. Another goal is 
the development and use of models for optimisation. After the experimental data is 
collected and models are created the software can be queried as to which parameters give a 
solution that will best satisfy the different responses. 
For example, if lubricant or disintegrant levels were manipulated, what values of these 
parameters would give the golden path yielding good hardness and adequate dissolution 
rate. The ability to perform optimisation is cardinal since it reduces the number of 
experiments conducted, in turn reducing money spent on formulation development. The 
software generating optimal values by utilising efficiently every piece of information 
derived from experiments also improves the product quality. The next section will discuss 
the backbone of this expert system-its structure that will help it achieve its goals. 
Expha expert system should be divided into three main partsý database, modelling and 
optimisation. There should 
be dependency between the parts since without data from the 
database models cannot be built and without models optimisation cannot be done. Expha's 
structure is presented in Figure 7.1. 
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Structure of Expha Expert System 
Figure 7.1: The structure of Expha. The yellow boxes represent the main parts ofExpha. 
The yellow boxes in Figure 7.1 represent the main parts of the Expha. The database part 
should be divided into two parts, data acquisition for decision-making and data acquisition 
for modelling. Decision-making means to decide on the process, warns the user when he 
selects an excipient quantity that is not within the recommended concentration range, give 
formulation and process tips to the user etc. In all these acts the software responds 
according to the data in the database. The program designer influences the software's 
method of data acquisition from the user. The embedded pharmaceutical knowledge of the 
database developer influences the collection of data also for modelling, e. g. inputting fields 
which seem to be relevant for describing the drug entity and selecting process variables 
which seems to be relevant, and this can influence the modelling. This is the developer's 
subjective concept that is derived from his pharmaceutical knowledge. Pharmaceutical 
knowledge is also influential in deciding on the rules applied to the data. Not all the data 
that will be acquired is used for decision making or for modelling. The reason for putting 
the extra data will be explained by examples; the "Drug properties" form should include 
properties that seem important for designing formulation. Part of these fields will be used 
only for data storage and for viewing. Why is it necessary to store data in fields if no 
operation is performed on them? There are two reasons, sometimes seeing relevant data can 
influence decisions (regarding formulation or process) and it might be that in the future 
some rules would be applied to these 
fields. Once one has the data on numerous drugs in 
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the system one can input rules that influence formulation of all the drugs in the expert 
system, having already collected the information. The justification for this is quite obvious 
in modelling, since one can decide later to model parameters thought earlier to be of less 
importance. 
The rules applied to the data generate decisions as is illustrated on the right side of the chart 
presented in Figure 7.1. Parallel to this, on the left side of the chart is the description of the 
process of building up models that will set the basis for the optimisation routine to decide 
on the opfirnised values of independent variables parameters. 
7.3 Expha development 
The first stage in developing this expert system was to define the types of operations that 
would be performed. Two major activities were defined, one is numerical in nature and the 
second is linked to acquisition and manipulation of data. Another aspect that is technical in 
its nature and less of a programming challenge is the user interface. Although it is probably 
the easiest part to develop this may be the most important part. It was necessary to find a 
computer language that is strong in this field. From analysing these activities it was decided 
to use a computer language with powerful calculation ability on a platform based on a 
database. Hence, the base for the core of the system was the MATLAB" programming 
language for the numerical calculations and Microsoft Accese for dealing with data, 
Visual Basie for Applications was chosen for the user interface language since it is very 
fast and efficient for this purpose. 
The next step was to build a program with MATLAB10 that would perform all the 
necessary operations of model 
building and optimisation. It was followed by the step of 
analysing the types of 
data that would be used. After all data types were characterised it 
was necessary to determine 
how the data tables relate to each other. Otherwise data will 
float in the database without the ability to be retrieved in the form of a report or any other 
relevant manner. After the overview of the 
data layout is clearly determined it is necessary 
to delve into the details of each data table. For example, it is imperative to define all drug 
properties that are of 
interest for formulation development. Someone who knows a lot about 
tablet formulation development or at least has extensive background knowledge about this 
subject does this. After the 
database was constructed the data manipulation algorithms 
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were developed. That means calculations on the data or data queries etc. These algorithms 
were implemented with Visual Basic" for Applications. After the database and numerical 
calculation parts were developed, the mechanism of communication and data exchange 
between the programs was developed. The last stage in development was planning the 
collection of data from the user. This influences the types of forms and what they will look 
like. Building a graphical user interface (GLTI) is a methodology on its own that helps to 
achieve the goal of building a user interface that is truly user friendly. 
7.4 Expha expert system 
The aim of this section is giving the user ability to use the Expha software with a better 
understanding of how it functions. The explanation is aided by viewing the relevant forms. 
The emphasis is on a small number of forms found within the software and expWning the 
logic behind them. Some of the forms presented will be the main ones and others represent 
the group of forms they are derived from. 
First will be given a general overview of this expert system. Afterward comes the use of the 
software. The guide through using the software 
follows the natural flow of the program 
with the collection of data and 
building formulations. Then model building and optimisation 
is discussed, as it is the natural continuation of using the data that has been collected. The 
section ends with the on-going process of maintaining the excipients 
database. 
7.4.1 General overview 
in this section a general overview of Expha will be undertaken by examining the menus. 
Looking at Figure 7.2, there are general Windowsý menus; File, Edit on the left side and 
Window, Help on the right side. The five menus in between were created especially for 
Expha and will be discussed. From the left, "Excipients Expert" menu is composed of 
forms that enable maintenance of an excipients database. "Tablet Expert" menu is 
composed of forms that make up the 
backbone of the program. The data collected on these 
forms can be used for building models and for optin-dsation. This menu includes the 
database engine that executes the algorithm, which decides on the process and also 
functions that give tips to the user regarding process and formulation. "Raw Data! ' menu 
includes the tables of data which were collected with the forms that belong to the "Tablet 
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Expert" menu. These tables, of raw data menus, are used by copying the relevant data 
within them into Microsoft Excelo sheets embedded in a form ("Data Input") under the 
"Optimisation" menu, because this form includes the facilities to input the data for building 
models and optimisation. The rest of the forms under "Optimisation" menu" del-Inc the type 
of regression or ANN models and is used to set optimisation parameters ft)r 
regression/ANN. The fact that the "Optimisation" menu includes programs that are 
computationally intensive means the speed of running these programs is dependent u[X)n 
parameters like speed of the processor and amount of RAM memory. "Example 
Formulation" menu includes forms that give formulations examples according to the 
In the example in Figure 7.2, the user has chosen from "Example Formulation" menu the 
"Wet Granulation" sub-menu and from this a planetary mixer was chosen. The end product 
is a form called "Wet Granulation - Planetary Mixer Formulations" with 3 hyperlinks that 
will each open the relevant 
formulation according to the name of the hyperlink when 
selected. Later in this chapter, only the parts that relate to the other four menus "Excipients 
Expert", "Tablet Expert", "Raw Data" and "Optimisation" will be discussed. 
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Figure 7.2: One form out of example formulation part. 
7.4.2 Flowing with the program - "Tablet Expert" menu 
forms 
In this subsection Expha flow is explained using the "Tablet Expert" menu fbrms. "Fablet 




"Process Variables" (with several subforms) 
"Granule Properties" 
"Compression Press Variables" 
"Tablet Properties" 
When the user opens Expha the first fonn which opens is "Drug properties- that 
belong to "Tablet Expert" menu. This form is shown in Figure 7.3 below. 
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Figure 7.3: "Drug Properties" form of Expha expert system. 
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"Drug Properties" form is composed of different fields, describing the drug. Drug 
properties that were considered important and were put in the form arc compactability. 
hydrophobicity, flow properties, stability and solubility. According to the values entered by 
the user, Expha recommends a process, computes values online and gives formulation tips. 
The button "Formulate" transfers the user to the next form, which actually recommends the 
process. 
Understanding how to fill data in this form is a very important step in understanding Expha. 
Beginning with the first field on the upper left the user gives drug identity number ("Drug 
ID"), then the name of the drug, in this case called "Example Drug". Afterwards. the drug 
dose, tablet weight and batch size is filled in. These fields are important not just to this form 
but also to the form used to select the formulation. The other fields describing drug 
properties are discussed below. 
Compactability value is calculated by dividing the hardness with compaction force to get 
the slope of the following graph: 
a 
02468 10 12 
Compaction Force (W) 
Figure 7.4a: Hardness as a function of compaction force. 
The graph in Figure 7.4a follows equation y=a*x+b. As can be seen in Figure 7.4a the 
line passes through the origin, so b=0 and y=a*x. 
The slope is a=y/x, and the calculated graph slope is a=8/ 12 = 0.667. This graph is a 
gross approximation of the behaviour of materials, this limitation is quite clear since the 
pattern of this graph will change with different materials. Also, for the same material the 
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graph may not be bear over all the range of compaction force. Compactability value of less 
then 0.5 was set as the value under which the drug cannot be directly compressed, but 
instead a granulation process should be used. Figure 7.4b taken from the book 
"Pharmaceufical Dosage Forms Tablets" (Lieberman et al., 1989) shows real examples of 
how various materials behave under increasing compaction force. It represents the variation 
of crushing strength with applied force. 











Figure 7.4b: Crushing strength versus applied force for compacts of various materials. The 
figure is reproduced from the book "Pharmaceutical Dosage Forms Tablets" (Lieberman et 
al., 1989). 
It is obvious that the linear assumption is an over simplified one as could be seen in the line 
plotted regarding Dextrose monohydrate. In this material, the linear behaviour is valid only 
for the low compaction force. 
The next group relates to drug hydrophobicity. The user can fill literal values, or to choose 
"Defined" from the combo box (combo box is a type of field that enables the selection of 
certain values out of a predefined 
list) thus enabling the user to enter a contact angle value. 
-, -he hydrophobicity value is worth considering when developing the formulation since it 
influences dissolution rate and success in tablet coating. To simplify, the less hydrophobic a 
drug is the more chance it will dissolve faster. The angle which the liquid makes with the 
Lactose anhydrous ' 
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solid surface at the point of contact is the contact angle (Gennaro, 1990). When wetting is 
complete the contact angle is zero and when there is no wetting the contact angle is 180". In 
the latter instance the drop touches the surface at only one point. It is wise to measure 
contact angle with water since the industry is moving toward aqueous tablet coating to 
prevent environmental damage and explosion hazards of organic liquids. The lower the 
contact angle of water with drug is, the more chance there is that coating the drug with 
aqueous solution would yield better adherence to the surface of drug (in that case the tablet 
surface). Contact angle is also important in granulation in assessing whether the binder 
solution will stick to the granules. 
There are various fields to fill for the Flow Properties. Selection of a literal value from 
"Drug Flo%V' combo box is important for the decision on the process and the formulation, 
Currently the field's numerical values are not incorporated into the decision making of the 
process. Nevertheless, they can be used by setting numerical values as cut off zones which 
define what is poor flow for each field, e. g. user enters some value x for angle of repose 
(refer to section 2.2 for description of angle of repose), if x is bigger then y, which is the cut 
off value, then the flow is poor. Limitation to this is that studies showed that angle of repose 
by itself is not a good predictor of flow (Amidon & Houghton). 
Tbe stability group (refer to section 2.2 for discussion on stability), in contrast, already 
incorporates into the decision making the literal or numerical values since the cut off zone is 
set to a numerical value. In Figure 7.3 it can be seen in the solid stability combo box that 
the user choosing the value "defined" enables k and Temp. fields (k for a given 
temperature-these values can be found in books of drug profiles, e. g. "Analytical Profiles 
of Drug Substances" by Florey, 1982) and allows the use of the appropriate values entered. 
just as in the compactability group, the result is calculated automatically by the software. 
The value calculated is the percent of drug remaining after 5 hours at 50"C (These values 
were set as an approximation to conditions in the granulation process). Expha calculates 
this value by taking into account two assumptions, explained with a numerical example 
below. The first assumption is that by rule of thumb, every 10*C increase in temperature 
causes k, which is the rate constant of 
decomposition, to double (Lachman et al., 1986). 
-Ibe value is I oooC in the temperature field (Figure 7.3) so k will be consecutively halved 5 
times because I oo - 50 = 50. In other words, for k.. w (the k for 50"C) k will be divided by 
187 
5011C) k will be divided by ten to get a value of 5* 1 O's hF1. The second assumption is that 
the drug decomposes according to first-order kinetics as if it were in aqueous solution. 
Hence, the following equation (Martin et al., 1983) becomes applicable: 
Log (Cin / Cuj) =t* kn,, / 2.3 03 
Whereas Ci, is the initial drug concentration entering the granulation process, C. Ais the 
fulal drug concentration going out from the granulation process, in this case after t=5 
hours. Putting the user values: 
Log (Ci,, / Cut) =5*I O's / 2.3 03 
Cin / Cout = 10 
1.0855E4 
And the percent remaining is Cin / Cwt * 100 = 99.975% which is the result in Figure 7.3. 
Regarding stability in solution (water) property (Figure 7.3), the user chooses a literal value 
of "Stable". Alternatively, the user can selects numerical values for k and Temp. variables. 
The cut-off zone for allowing wet granulation is 95%, so below that value of percentage 
drug remaining Expha will not recommend wet granulation. The assumption here is that all 
the granulation process is done when the drug is dissolved in water, in reality the drug is in 
a semi-solid state. This is why allowing a high value of 5 percent decomposition 
compensates for the too rigid assumption. It can be seen in Figure 7.3 that since a literal 
value was chosen for stability in water, the k and Temp. fields became disabled. 
-1be final group that characterises drug contains fields that relate to drug solubility. The 
solubility values of the drug are very 
important for the decision on the formulation. One of 
the important responses they influence is the dissolution of tablet. If drug solubility in water 
value is low, operations 
like adding surfactant or micronisation of drug should be 
considered. If the solubility value 
is high and the drug is high dose, it is possible that a 
disintegrant may not be needed. 
After the drug properties form is filled the user can use the formulate button which runs the 
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Figure 7.5: Expha algorithm for process decision. 
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What is missing in this flowchart is where the boundaries (cut-ofl' zones) lie for each 
decision. some of these values were mentioned earlier. Generally it was decided to use 
reasonable values, e. g. ý! 80% of active drug was defined as high dose. The execution result 
of the flowchart is seen in the "Identify Process" form (Figure 7.6). which 1`61lows the 
"Drug Properties" form. Expha automatically chooses the process by selecting the 
appropriate button on the "Identify Process" form. 'Mere is also an explanation of the 
selection. However, the user can reject Expha recommendation and select another process. 
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Figure 7.6: "Identify Process" form 
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In this specific example the recommendation was arrived using the straight-line path in the 
algorithm (q. v. Figure 7.5). It responds to the relevant fields in the "Drug Properties" form, 
shown on Figure 7.3. In this example, after Expha decided the process would be 
granulation, it took into account the solid stability field, which represents susceptibility to 
heat. and stability in solution (water) field as a measure of susceptibility to moisture. From 
Expha recommendation in Figure 7.6 it can be seen that the latter two fields on the "Drug 
properties" form were taken into account to arrive at wet granulation as the recommended 
granulation process. 
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Looking at "Select Excipients" form in Figure 7.7, all the fields in colour are data taken 
from the "Drug Properties" form and the user cannot change thern through "Select 
Excipients" form, but has to revert to the "Drug Properties" fiorm. The Process field was 
taken from the Identifý Process" form and can be changed Just by returning to this fbi-ni. 
All the user does in this form is to give a unique number to "Formulation 11)" and to cli(x)sc 
the formulation ingredients. "Formulation ID" is a number, which is connected to 
formulation ingredients and also to all data relevant to the l'ormulation, like the process 
variables involved in producing the formulation. 
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Figure 7.7: "Select Excipients" form. 
To use this form first a value is given to "Formulation ID" field, in this case 56. Expha will 
not allow the user to first select the excipients thus avoiding situations where the user has 
built up a formulation and forgotten to link it to a "Formulation ID". Otherwise the 
formulation data would sit uselessly in the database with no possibility of use. Upon 
entering "Formulation ID", if there is already a formulation with this ID number it will be 
shown immediately on the screen. 
So this screen enables the user to enter new formulations 
as well as updating and looking at old ones. After entering Ton-nulation ID" the user 
selects excipients; by moving to the 
"Select Functional Category" combo box. He chooses 
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selects exciplents by moving to the "Select Functional Category" combo box. lie chooses 
the relevant group, in this case it is diluent. Afterwards a subform (child of "Select 
excipients" form) opens and on activating the combo box with the ID No. (of the excipient) 
the user can see all the excipients that belong to the relevant group and select the 
appropriate excipient, microcrystalme cellulose in this case. Important information on areas 
such as interactions is presented in the big text box below the excipient name The 
minimum and maximum recommended values (from literature) for the excipient are 
presented to the right of the excipient name. The user selecting 13% invokes an Expha 
waming that this concentration is not recommended but allows the user to use this 
concentration by pressing OK on the subform. By pressing on the OK button the exciplent 
is entered into the formulation in the main form. The field "ExQuantity" is the amount taken 
in percent. From this value the fields of "MgPerTab" (the amount in miligram per tablet) 
and "TotalQuantityGr" (the total amount for the batch in gram) are calculated online. 
on the right side of the screen there are various buttons that give information to the user 
and enables him to pass on to other stages. The two buttons at the top allow the user to 
jump directly to the model building and optimisation stage using regression and ANN. The 
"Set Process Variables" button moves the user to a form that allows the relevant parameters 
of the process to be input. The parameters that the computer asks the user to fill are 
changed according to the process, e. g. 
for wet granulation the computer Will ask different 
parameters than for direct compression. "Advice" button gives advice regarding building 
the formulation and the process. The next two buttons produce reports that can be printed. 
Drug report shows each active ingredient and the "Formulation ID" it belongs to. 
Formulation report shows for each "Formulation fD" the composition of the formula. The 
,, Nlanufacturing instructions" button gives manufacturing instructions that are changed 
according to the process. 
Going back to our example, after selecting microcrystalline cellulose as diluent at 13% the 
value is entered into the 
formulation which now adds up to 100% of all formulation 
constituents. When the user pushes the 
"Advice" button, the screen looks as in Figure 7,8: 
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Figure 7.8: "Select Excipients" form with invoked advice remark. 
The remark was generated in response to values entered into the database relevant to the 
virtual drug named "Examp 
ie Drug". "Set Process Variables" button opens the form in 
Figure 7.9, which asks the user for information about the process. To add a new record the 
user selects the "Add 
Record" and "Formulation ID" value is copied from select excipient 
screen as the default value. 
Hence, after filling this form there are two sets of data. which 
relate to the same 
formulation (see "Formulation ID" field in Figure 7.8) that is 56 in this 
case. One set is the 
formulation ingredients and the other one is process variables. In this 
manner data about the same 
formulation ID is collected using the subsequent forms, 
pressing "Continue" to move 
from one form to another according to Expha flow. The final 
form is the "Tablet Properties" form, which includes the different responses like 
disintegration time, dissolution rate etc. At the end of the collection data process there are 
several sets of data, each one stored 
in a different table. This type of database structure is 
relational and not 
flat since it consists of several tables that are related to each other. This 
relational database structure enables all 
the data relevant to the same formulation ID to be 
retrieved. Figure 
7.9 shows the wet granulation process variables form, and the "Raw Data" 
menu from within the relevant sets of 
data (generated by filling the forms) can be put into 
"Data Input" form as data for building models and optimisation. 
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Figure 7.9: Wet granulation process variables form. 
"Raw Data" menu includes the following tables: 
"Active Ingredients in Formulations" 
"Formulations" 
"Dry Granulation Variables" 
iranulation Variables" -Wet C 
"Direct Compression Variables" 
. jranule 
Properties" "Ci 
,, Compression Press Variables" 
'Tablet Properties" 
A hypothetical example of how Patel's data (Patel, 1996) which was used in the tablets 
study. of Chapters 3 and 4, could 
be used by Expha will be explained in this section. From 
the "Raw Data" menu, choosing "Formulations" and "Compression Press Variables" will 
yield the two relevant sets of 
data for the independent variables. Specifically, from 
"Formulations" data set the two fields percentage of disintegrant and lubricant will be set, 
from -Compression Press Variables" data set the field of compaction force is set. "Tablet 
properties" will supply data for the 8 responses like disintegration time etc. 
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I 
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Figure 7.10: Expha flow. 'I fie boxes that are without text in bold (green boxes) relate to 
one form, whereas the one in bold (blue box) relates to multiple forms. 
in Figure 7.10, each box represents one form except "Process Variables" box which 
represents several forms since the process variables change according to the process. and 
for each process there is one form. All these forms can be accessed through "Tablet Expert" 
menu. The flow is from top to bottom but the user can jump from one form to another not 
through the forms themselves but through the menu. This capability enables the user skip 
non-relevant forms, e. g. if granule properties were not measured the user can jump directly 
to , Compression Press Variables" form. After data have been collected it is now possible to 
build models for optimisation. 
7.4.3 Data modelling and optimisation 
After the data is collected it is possible to move to the stage of building models and 
optimisation. From the menu of 
"Optimisation" one can go to "Data Input" form. this yields 
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the top form in Figure 7.11. 
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Figure 7.11: "Data Input" and "Regression Parameters" forms. 
The user needs to copy data from the relevant fields in the "Raw Data" menu tables into the 
"Input" and "Output" embedded excel sheets. By opening the "Input" data file the user 
copies the independent variables 
data to this sheet. In the same manner the response data is 
copied to the "Output" 
data file. One can also put data of independent variables in "Data for 
prediction" data file to get the program's predictions. From the "Optimisation" menu the 
user can choose "Regression 
Parameters" and the form that opens is at the bottom of Figure 
7.1 L On the left side of this form, the user fills in the parameters that build up the model. 
number of input variables and type of regression model. On the right side is the user's 
starting guess to the optimisation process. 
The number of input variables must correspond 
to the number of fields filled 
in for the starting guess, e. g. if the user enters just two input 
variables (in the relevant 
field, "Number of input variables") the optimisation starting guess 
must comply with this to 
have only two values. 
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Figure 7.12 shows the "ANN Parameters" flon-n. which is invoked firom "optimisation" 
menu. 
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Figure 7.12: "ANN Parameters" form. 
In the "ANN Parameters" form the user can choose from a variety of training methods. 
There is no one algorithm that is best suited for all purposes (Demuth & Beale, 1998). In 
terms of speed Levenberg-Marquardt is considered the fastest training algorithm for ANN 
of moderate size (up to a 
few hundreds weights). However. this statement is very general 
since the speed of convergence 
depends on a variety of factors, e. 9- complexity of the 
problem, the number of 
data points in the training set, the number of weights and the 
performance goal (MSE goal). 
For example, if the performance goal is small, accurate 
training is required, so there is more chance the Levenberg-Marquardt algorithm will 
converge faster than other algorithms. 
The BFGS quasi-Newton is next in terms of 
convergence speed. 
This algorithm is generally faster than the conjugated gradient 
algorithms. Within this group of conjugate gradient algorithms the powell-Beale algorithm 
is usually the fastest one (see Demuth & Beale, 1998 for comparison between the speed of 
learning algorithms). It is not always better to have fast convergence, it may be that ANN 
trained with a fast algorithm will not give as low a validation set error as the ones reached 
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by slow algorithms like simple backpropagation or simple variations of this algorithms. 
ibis study gives a good example to support this point; looking at Table 4.1, one can sce 
that out of the 5 backpropagation-learning algorithms (they had the best prcdictive ability 
for 5 specific responses) there is not a single ANN that used Lcvcnbcrg-Marquardt 
algorithm as its training method. In addition, simple backpropagation predicted best the 
mean weight response. For more elaborate discussion on ANN training methods one can 
consult the book by Hagan et al. (1996) which uses MATLAB.. as a learning aid and gives 
exercises in this language. 
On the right side of the form the user must enter the two fields "No. of input neurons" and 
"No. of output neurons" although these are already set by the type of the problem. Here, 3 
input neurons were entered as the number of independent variables and just one output 
neuron because the aim was to model 
just the disintegration time response from Patel's 
data (Patel, 1996). To complete defining ANN topology the number of hidden neurons 
must be set. The number of hidden neurons 
is set by the user and influences factors like 
generalisation ability and training time. 
Training time can be set directly by adjusting the 
"Time (seconds)" field. Training time can also be set in non-direct manner by fields of "No. 
of epochs" or "Performance goal" 
(mean square error target). It is enough that just one of 
the latter three conditions is met to 
halt training. The next field, learning rate, is very 
important in training method of basic gradient descent backpropagation, but has no 
importance in backpropagation using adaptive learning rate. The reason for this is that in 
the latter method the learning rate 
is changing all the time through the lean-drig process. The 
field labeled as "Epochs between showing progress" influences the amount of output that 
shows the progress of training 
in terms of the parameters-time in seconds, NISE and 
gradient. Like the 
form for "Regression Parameters" the user has to fill the starting guess 
for optimisation, located on the lower right side of the form. The "Update ANN 
parameters" button causes optimisation results form to open. Figure 7.13 shows this form 
, with a sub-fOrm showing prediction and optimisation results generated after 
ANN training. 
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Figure 7.13: Optimisation results form along with a sub-lorm showing the results after 
running ANN and optimisation routines. 
The "Run ANN" button runs the ANN training and Optimisation routines. The two 
programs run sequentially. 
First training, then OPtimisation. 11 X-1p,, is output firom the 
optimisation routine and the rest of the output 
is from the training phase. In a similar 
manner "Run Regression" causes the regression equation to be generated and afterwards 
the optimisation routine is invoked. The ANN in this example was trained with the ANN 
parameters set 
in the previous form. As mentioned before, the response data. which is 
disintegration time, were taken from the tablet study experiments, but the last 5 cases left 
out of the training and were used 
for prediction. The predictions by the ANN is shown in 
the sub-form ("Predicted =") along with 
"x_op" which show the optimised independent 
variables values. 
The optimised independent variables are 1% lubricant. 5% disintegrant 
and compaction 
force of 3 kN (Figure 7.13). The permitted range of values (constraints) for 
the independent variables 
in this optimisation routine were: 0.25-2%, 1-5%, 3-20 kN for 
lubricant, disintegrant and compaction force respectively. Pressing "OK" on the subform 
does not mean that this important data is lost since below the "Run ANN" button there are 
two hyperlinks connected to 
files which store the predicted and optimised values. After 
pressing "Run ANN" there 
is also a graph (Figure 7.14) that shows the progress of training 
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on-line. On the x-axis is the number ofepochs and on the y-axis is a logarithmic scale of the 
MSE. 
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Figure 7.14: MSE (mean square error) as a function of number of epochs plot. The 
honzontal line in black is the target MSE and in blue is the training progress. 
The plot in Figure 7.14 was generated using ANN trained with the Levenberg-Marquardt 
ajgorlthrn, with parameters as 
defined in "ANN Parameters" form presented in Figure 7.12. 
The plot corresponds to the optimisation results sub-form that was shown in Figure 7.13. 
As can be seen, the training stopped after 12 epochs since it achieved the performance goal. 
I' After the training phase of ANN it can he saved to be used in decision-making in 
e. g. the user can train 
ANN to predict the stability of a drug in a granulation process and 
t1his ANN could be used 
in a later stage. 
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7.4.4 Database maintenance using "Excipients Expert" menu 
This section explains how to maintain the excipients database. 
Th, e following form (Figure 7.15) is used to add a new excipient or to edit one. 
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Figure 7.15: "New/Edit Excipients" form. 
This form can be viewed by choosing "Excipients Expert" menu then selecting "Ncw/Fdit 
Excipients". By using the blue combo box on the top right of the form microcrystalline 
cellulose was selected. 
The left side is used for filling data. "Excipient 11)" (field) is a 
unique number, which connects 
the excipient identity number to other tables. Hence. the 
e, xcipients 
database is a relational one. "Reference" field is the source for data used in the 
subfOrm(s) (the s 
in parhentesis since some excipients belong just to one functional 
category or one subform). 
Figure 7.15 shows an example of how to use the functional 
category buttons; the 
"Disintegrant" button was selected in order to open the "Disintegrant 
Concentration" subform and fill in the minimum and maximum disintegrant concentration. 
The data for these concentrations was taken from Handbook of Pharmaceutical I-xcipients 
(JJPE) (Wade & Weller, 1994). 
Hence the relevant field has the value "HPE2" (2 standing 
for second edition). There 
is also a second field of reference that relates to the source of 
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interactions and essential Information. In this case it is from Pharmaceutical I)osage Forms 
Tablets (PDFT) (Lieberman et al., 1989), It is important that the user fills in details in the 
sarne manner. In this case, the user must provide adequate reference to allow for efficient 
data searching and updating. For example, a user could request all the exciplents that used 
HPE2 as a source, to update upon receiving a new edition of IlPE This leads to the point 
that the database is not static and has to be updated and reviewed all the time, 
In the middle of the form there are buttons that lead to the subforms and to the right of 
these buttons there is information if the excipient belongs to the relevant functional group 
Figure 7.15 shows that m1crocrystallIne cellulose could function both as diluent and 
disintegrant. Consider an example of using the Binder button, to open the relevant subform 
and filling in details on the sub-form. 
After saving the sub-form it closes, and on the right 
side of Binder will be the excipient 
ID and excipient name to show that now the excipient 
ID relates to 3 data tables, disintegrants, diluents and the new one-binders. It is important 
that the user can see which functional category the excipient belongs to when updating the 
new excipient. For example, it is easy to review quickly and efficiently the exciplents to see 
that they relate to the correct functional group. The user can see all the relevant information 
of the group by selecting 
from "Excipient Expert" menu the relevant groups as can be seen 
in Figure 7.16. 
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lFigure 7.16: "Disintegrants" infiormation form. 
"Disintegrants" information form is only for viewing. The combo box on the top left side 
allows the user to see a 
list of all disintegrants. The minimum and maximum concentration 
as well as 
interactions and important information relevant for the specilic excipient are 
displayed in the big text box. There 
is also an embedded MSWord" document, which gives 
general information on 
the relevant functional category. 
The "Excipient Expert" menu 
is a revealing demonstration of the power of a properly 
designed relational database. If the user tries to 
delete unintentionally the wrong excipients 
from the primary table using the menu 
"Edit/Delete excipients from primary table" Fxpha 
does not allow this deletion 
because it relates to other tables as well. So the user first has to 
delete the connection of the excipient to other tables using the menu "Edit/Delete excipients 
from functional category group". 
After breaking links it is then possible to delete the 
,, xcipient 
from the primary table. This behaviour of Expha prevents chunks of data that are 
not connected to any excipient, 
from being left in the database. If a user changes an 
excipient 
ID by mistake, the data which relates to this excipient is not lost because all the 
tables which the excipient 
is connected to also update their reference according to the 
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excipient's new ID number. Ibis is also saves a lot of work if the user wants intentionally 
to change excipient ID, since it is necessary only to do it once in the main excipients form 
and all the sub-forms connected to this excipient are automatically updated VAth die 
excipients new ID. In short, this relational structure saves time, effors and is easy to 
maintain. 
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7.5 Testing and field trial 
'I"here is a well-known phrase that a person in a good health is one whose condition is yet to 
be correctly diagnosed. Using the same principle, software without bugs/problcms is one 
that has not been adequately tested. There is surely more truth in this last postulate than the 
phrase about human health. In the pharmaceutical industry, each factory has a quality 
assurance (QA) department that verifies the pharmaceutical product is of acceptable 
quality. Part of its role is to inspect the manufacturing process and to identify sensitive 
areas that are prone to cause problems in the product's quality. The QA department also 
contains quality control (QC) that is responsible for all the analytical tests of the finished 
product like dissolution as well as analytical tests of in-process material like granule 
properties. In the same manner that QA of the pharmaceutical world is a very broad subject 
that is also true for QA in the software industry. Although it might seem that QA in 
pharmaceutical world is of more importance it is not always the case since computers also 
control real-time equipment that if it is not functioning properly would cause the loss of 
human life, e. g. hospitals real-time systems. There was no attempt to perform professional 
QA work on Expha expert system since there is no in-house expertise and the tools a 
software engineer specialised in this field would have were not available. Nevertheless. 
there was an attempt to employ part of the QA philosophy of the pharmaceutical industry to 
trace critical points through the manufacturing process (of the software in this case). In 
order not to end up with a product that 
has so many bugs it is not convenient to work with. 
In general, everything that was programmed to 
do some sort of operation was tested. For 
example, the advice 
button on the "Select Excipients" form was checked to ensure it gave 
the advice it was supposed to give and not advice that 
is not updated in accord with a 
change in data. 
Another example is that the algorithm for manufacturing process was 
tested. For the latter purpose 
different drug properties settings were used to give assurance 
that Expha could guide the user 
for all manufacturing process possibilities. 
-fbere was extensive testing of Expha calculations, each calculation result being tested by 
Comparing the Expha calculations with manual ones. 
Parts of the calculations are in critical 
areas; checking that the calculations of 
Drug Properties form are done properly, e. g. 
stability calculations are 
important part of Expha. After entering K and temperature values 
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the computer calculates the percent of drug remaining after 5 hours at 5011 Celsius. r-rC)M 
Figure 7.3 for k of 5x I Oat a temperature of 100* Expha calculated that 99.975% remains 
in those conditions. The manual calculation explained earlier yields the same result as the 
c<)mputer. 
J-his section will present tests that were conducted to verify appropriate functioning of 
model building and optimisation. Appropriate functioning means trying to trace 
inappropriate interactions between the underlying computer program modules vrithin 
F-xpha. The emphasis here is on the correct functioning of the various modules on selection 
of appropriate options in the dialog boxes and not on the numerical 1-alucs that maybe 
producedfor our test problem. 
A description of the experiment settings follows. The airn of the regression/ANN modelling 
part was to learn the equation y= x2 -I For that purpose Expha was given X values ftOm 
zero, to twenty as input data and output 
data was the corresponding y values generated ftom 
the latter equation. To test the success of leaming, x values of 1,2,3,4,5 were put as the 
set for prediction. The starting guess 
for the optimisation process was 100.11je 
nlinimum/maximum point 
is the goal for the optimisation process. It is calculated from the 
derivative of the equation (= 2x) and the second derivative (= 2) indicates if it is a minimum 
or maximum point. Regarding the equation 
discussed, the optimised x value yields a 
minimum (since 2 
is bigger than 0) point of 0. The chosen regression model was second 
order with interaction terms. 
The topology for ANN was one input neuron and one output 
neuron (it stems 
from the nature of the problem constraints) with 5 neurons in the hidden 
layer. The number of neurons was chosen as five to enable enough flexibility but to a%nid 
overfitting due to too many weights. 
All twelve training methods available on Expha were 
tested. 'Ibe number of epochs was set to 1000 and the second criteria to stop training was 
NISF, (mean squared error) of 0.002. 
FI ure 7.17 presents Expha output after the regression module was run. "a-coefficients" g 
are the regression coefficients of 
the regression equation, which is presented under the 
header "Equation =", starting with a(O) and in ascending order. "Predicted" are the 
predicted responses 
for independent variable x values. "x-op" are the optimised values of 
the input variables which minimise the 
dependent variable. The latter two terms "Predicted" 
and --)ý_opl' are also relevant 
to final output of ANN results screens presented in figures 
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7.19,7.21,7.23,7.25,7.26,7.27. The latter screens relate to the following training 
algorithms respectively: gradient descent with a maximum of 100 epochs (all other ANN 
training algorithms used 1000 epochs), gradient descent with a maximum of 1000 cpoclis, 
Levenberg-Marquardt algorithm and Bayesian regularization (Figures 7.25 - 7,27). The 
difference in the latter three figures is that the values for prediction in Figure 7.25 are like 
. 111 other ANN that were trained. 
Whereas in Figure 7.26 the values for prediction are 
between 0.5 to 19.5 in increments of 1 (0.5,1.5, ... 19.5) and in Figure 7,27 the set for 
prediction is 60,70,80,90,100. Figures 
7.18,7.20 and 7.22 show learning curve plots for 
gradient descent with a maximum of 
100 epochs, gradient descent with a maximum of 
1000 epochs and Levenberg-Marquardt algorithm respectively. On these plots die y-axis is 
the mean squared error (MSE) and the x-axis 
is the number of epochs. Ile black line is die 
target performance representing MSE of 0.002. Figure 7.24 shows learning curve of 
l3ayesian regularization training method. As in the other plots the x-axis represents the 
number of epochs (in all the three plots of this 
figure). The y-axis of the three plots from the 
upper to the bottom one stand 
for sum squared error (SSE), sum squared weights (SSNV) 
and effective number of parameters. 
Table 7.1 summarises the results that were presented 
Carlier in this section. 
Table 7.2 shows the predictions of additional ANN training methods. 
in both tables on the left column are the independent x values and on the second column are 
the target values according to the equation y= xý - 
3. The last row in the tables represents 




Figure 7.17: Pushing "Run Regression" button yields this output when regression module 
in Expha was trained on data for the equation y=x2-3. The coefficients of the regression 
equation ("a_coefficients") and the predicted responses 
("Predicted") arc shown together 
, With the optimal value of the 
input variable (N-ol)"). 
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lFigure 7.18: Part of Expha output after pushing "Run ANN" button when ANN module in 
Expha was trained on data from the equation y=x2-3. The training algorithm is ANN 
trained with backpropagation using gradient descent with a maximum of 100 epochs. On 
the y-axis is the mean squared error and on the x-axis is the number of epochs. The black 
line is the target performance representing MSE of 0.002. 
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]Figure 7.19: Final part of Expha output after pushing "Run ANN" button when ANN 
nnodule in Expha was trained on 
data from the equation y= x2 - 3.17he training algorithm is 
ANN trained with backpropagation using gradient descent with a maximum of 100 epochs. 
-predicted" are the predicted responses for independent variable x values of 1.2.3.4.5. 
"y 11 is the optimised value of the input variable which minimises the dependent variable. OP 
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]F-igure 7.20: Part of Expha output after pushing "Run ANN" button when ANN module in 
Expha was trained on data from the equation y= x2 - 3. The training algorithm is ANN 
trained with backpropagation using gradient 
descent with a maximum of 1000 epochs. On 
the y-axis is the mean squared error and on the x-axis is the number of epochs. The black 
line is the target performance representing MSE of 0.002. 
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Performance is 0.00199959, Goal is 0.002 
lFigure 7.21: Final part of Expha output after pushing "Run ANN" button when ANN 
module in Expha was trained on data from the equation y= x2 - 3.17he training algorithm is 
ANN trained with backpropagation using gradient descent with a maximum of I 00o 
epochs. "Predicted" are the predicted responses for independent variable x values of 1,2.3. 
4,5. , x_op" is the optimised value of the input variable which minimise the dependent 
variable. 
212 
Ldt ExdpmftExpert TablotbpW RawData Opowntion 
Ed* ý&dow Help 
101 








]Figure 7.22: Part of Expha output after pushing "Run ANN" button when ANN modulc in 
Expha was trained on data from the equation y= x-' - 3. The training algorithm is ANN 
trained with Levenberg-Marquardt algorithm with a maximum of 1000 erx-schs. On the v. 
axis is the mean squared error and on the x-axis 
is the number of ep(xh%.. The black linc is 
the target performance representing MSE of 0.002. 
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lFigure 7.23: Final part of Expha output after pushing "Run ANN" button %hen ANN 
module in Expha was trained on data from the equation y= x-' - 3. The training alg(-m6thm is 
ANN trained with Levenberg-Marquardt algorithm with a maximum of looo epochs. 
"Predicted" are the predicted responses for independent variable x values Of 1.2.3.4.5. 
r, x_opII is the optimised value of the input variable which minimise the dependent %artable. 
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Figure 7.24: Part of Expha output after pushing "Run ANN" button when ANN modulc in 
Expha was trained on data from the equation yýx3. Ilic training algorithm is ANN 
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Figure 7.25: Final part of Expha output after pushing "Run ANN" bution when ANN 
module in Expha was trained on data from the equation y= x2 - 3. The training algorithm i% 
ANN trained with Bayesian regularization with a maximum of 1000 crKxhs. "Predicted- 
are the predicted responses 
for independent variable x values of 1.2.3.4.5. "x 
_ 
op- is the 
optimised value of the 
input variable which minimise the dependent variable. 
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IFigure 7.26: Final part of Expha output after pushing "Run ANN" button %%hen ANN 
module in Expha was trained on 
data from the equation y= x2 -I flie training algorithm is 
ANN trained with Bayesian regularization with a maximum of 1000 epochs. "Prcdictcd" 
are the predicted responses 
for independent variable x values between 0.5 to 1,9-5 in 
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Figure 7.27: Final part of Expha output after pushing "Run ANN" button when ANN 
module in Expha was trained on data from the equation y= x2 - 3. The training algorithm is 
ANN trained with Bayesian regularization with a maximum of 1000 epochs. "Predicted" 
are the predicted responses for independent variable x values of 60,70,80.90,1 Oo. Ix_op,, 
is the optimised value of the input variable which minimise the dependent variable. 
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Table 7.1: 71be predicted "y" values of regression and ANN. On the left column are the 
independent "x" values. The second column is the target values according to the cquation 
Y=X 2-3. The third column presents the predicted values of regression model. Columns 4. 
7 are the predicted values of various ANN. The last row represents the number of cpochs 
of each ANN setting. 
x y=XZ -3 Reg LM BGD 100 BGD 1000 BR 
-2.00 -2-00 0.32 22.65 -1.78 -2.00 
2 1.00 1.00 1.85 27.50 -0.22 1.00 
3 6.00 6.00 4.27 31.02 2.48 6.00 
4 13. 
1 22.00 zz uu zz*uu 22.00 21-19 53.57 27.11 22.00 rE 
-poi 7ch sd - 13 100 859 11000 
Note. Reg = Regression, LM = ANN trained with Levenberg-Nlarquardt algorithm, BGD 
100 = ANN trained vvith backpropagation using gradient descent Vvith a maximum of 100 
, epochs and BGD 
1000 is the same except that the maximum number of epochs is 1000. 
13R = ANN trained with Bayesian regularization. 
Table 7.2: The predicted "y" values of ANN. On the left column are the independent "x" 
values. The second column 
is the target values according to the equation y= x2 - 3. 
Columns 3-11 are the predicted values of various ANN. The last row represents the 
number of epochs of each 
ANN setting. 
x 
7--7- -1 GDM GDX OSS BFG CGF RP CGP CGB SCG 
-2 00 -1.99 -3.65 2.52 -1.51 0.67 -6.16 -1-85 -0.13 -1.08 1 . 1 00 -0.44 -2.41 3.61 -0.36 1.89 0.41 -0.7 0.95 0.02 2 . 
6 00 2.37 0.4 6 2.34 4.59 13.05 1.96 3.67 2.59 3 . 13 00 4 . 2200 uu uu 27.6 26.47 27.742 26.94 29.08 25.64 26.23 28.69 26.35 . ' ýE 
p'o)-c7h7sd 
= 803 187 8 6 18 
' 
56 18 5 6 
Note. The abbreviations stand for ANN training method. GDM = gradient descent with 
momentum. GDX = gradient 
descent with adaptive learning rate. OSS = one step secant 
method. BFG = 
BFGS quasi-Newton method. CGF Fletcher-Reeves conjugate gradient 
, jgorithm. 
RP = resilient backpropagafion. CGP Polak-Ribiere conjugate gradient 
, jgorithrn. CGB = 
Powell-Beale conjugate gradient algorithm. SCG = scaled conjugate 
gradient algorithm. 
Optimisation using the regression model yielded a suggested x value of 0 
for the minimum 
point whereas opfimisation of 
all 3 ANN models, that were best optimised (the 3 ANN 
training methods of columns 
4-6 in Table 7.1), yielded a minimum x value of 9. 
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7.6 Discussion 
An expert system has been created that has the capacity to help formulators at all levels of 
experience achieve their goals. The Expha expert system possesses basic formulation rules, 
11as facilities for data acquisition with tools for data modelling and OPtimisation. 
An expert system was created that is very practical for data collection and for building 
models and opfin-dsation. It is unique in the sense that it combines ANN as well as 
regression. The latter gives an advantage since regression may model less complicated data 
better than ANN may. A unique combination is also created between ANN and type of 
C)ptirnisation technique-two areas that are traditionally not connected. Usually, 
()ptimisation with ANN is used with the newer models like genetic algorithm. The system 
incorporated knowledge in pharmacy. The set of rules could have been much better if more 
experts in tablet formulation development were involved in its development stage. With 
even more rules it would still have 
kept the same basic structure of an expert system. The 
latter limitation prevents the system from becoming the sole solution provider for tablet 
formulation problems. In a pharmaceutical company with a number of experts for tablet 
forrnulation it is not likely that Expha's advice will be needed. Formulation experts could 
use Expha for processing data, doing modelling and opfin-dsafion. The latter part is a strong 
aspect of Expha since it has extensive modelling techniques and the user can change many 
parameters in that area. Expha could 
be beneficial if used by pharmacist or other scientists 
that need educational guidance in the field of tablet formulation. Such people can be found 
in the schools of pharmacy and in the pharmaceutical companies. The section to be 
followed will discuss testing and field trial of Expha. 
]Figure 7.17 shows the regression equation Expha calculated. The equation that Expha tried 
to find the appropriate parameters is: 
*2 
y- a(0) + a(l) *X+ a(2) x. 
After the training process Expha yielded to following values for the coefficients a(, ), a(2) and 
'a(3) respectively: -3,0,1. 
Hence, the linear term of the equation became redundant to yield 
the equation: 
Y == -3 + xý- 
It is obvious that the regression model has learned the data successfully since it generated 
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the appropriate equation. In accord vAth that, Expha predicted the appropriate y values 
relevant to the x values of the prediction set. The optimised x value was calculated as 
3.3 X 10,17 which is very close to the desired x minimum point value (theorctically, die 
n1inimurn point should be zero). 
The overall structure of the code was the same as was used in previous chapters. Tbc 
underlying ANN structure was the same, no attempt was to optimise the topology since 
examples of doing so were already demonstrated in chapters 3,4 and 5. "Mis expUns %vhy 
one that selects different algorithm gets different answers. Obviously, the topology selected 
is inappropriate for the problem selected. A more appropriate topology with fewer hidden 
neurons should give similar predictions using the different leaming methods but not 
identical because of the possibility of each method converging to a different local minima. 
]Figure 7.18 shows ANN trained with backpropagation using gradient descent with a 
Inaximum of 100 epochs. This ANN succeeded in learning the data and to lower the MSE 
as the number of epochs increased. The prediction results of Figure 7.19 show that the 
predicted values are quite far from the desired ones. Hence, it was decided to increase the 
number of epochs to 1000. Figure 7.20 shows it was right to continue training since the 
MSE kept lowering till it arrived at the target value of 0.002 after 859 epochs. Figure 7.21 
presents much better predictions 
(see Tables Tim for the desired y values) than the ones 
arrived at with 100 epochs of training 
(Figure 7.19), this is in accordance with the 
differences in the MSE shown in graphs 7.18 and 7.20. Till now the learning patterns of the 
graphs and the improvement 
in the predictive ability as the number of epochs increases are 
standard and typical to simple 
backpropagation, so there is no need to suspect there is a 
flaw in the program regarding this lean-dng method. Since 1000 epochs was more than 
enough for simple backpropagation to arrive at the 
desired NISE it was decided it would 
also be enough for other training methods that 
learn faster, with less iterations. Figure 7.22 
shows a typical fast algorithm that arrives at the solution 
in only three epochs. in this case, 
this is the Levenberg-Marquardt algorithm and 
its predictions are presented in Figure 7.23. 
Table 7.1 summarizes training results for the models presented earlier. Table 7.2 shows 
other ANN models and typical 
learning behaviour of ANN can be seen, the more simple 
. arning methods, 
like simple backpropagation or simple variations of this training method le 
like momentum, need more epochs to arrive at the target MSE value relative to the more 
sophisticated ones. 
Ibis behaviour is typical and was shown in studies presented in earlier 
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chapters and suggests the ANN training algorithms work correctly. Looking more closely at 
the speed of the algorithms, by inspection of the training results in Table 7.1 and 7.2, one 
can see that the fastest ANN was the one trained with the Levenberg-Marquardt algorithm. 
lle conjugate gradient algorithms (Hagan et al., 1996) and the quasi-Newton (Dennis & 
schnabel, 1983) learned the data in about the same number of iterations, they both needed 
less than 10 iterations. This order of leaming algorithm speeds is in accordance with die 
literature (Demuth & Beale, 1998) as discussed earlier in section 7.4. Ile one step secant 
method (Battiti, 1992) also learned the data in less than 10 iterations. The quasi-Ncwton 
algorithm requires more storage and computation time than the conjugate gradient 
algorithm. The one step secant method 
is an attempt to bridge the gap between these two 
methods. This method is considered as a compromise between full quasi-Newton algorithm 
and the conjugate gradient algorithm. As such 
it is not surprising it has the same levels of 
speed as the latter two training methods. Looking 
in Tables 7.1 & 7.2 one can see that the 
fastest algorithms are not the best ones in terms of predictive ability. The leaming algorithm 
with the best predictive ability was the Bayesian regualization ANN (MacKay, 1992). In 
this ANN the weights and biases are assumed to be random variables with specified 
distributions. The regularization parameters are related to unknown variances associated 
, with these distributions. These parameters are estimated using statistical techniques. 
This 
algorithm for training ANN provides a measure of 
how many ANN parameters (weights 
and biases) are being effectively used. 
Looking in Figure 7.24 on the bottom plot (number 
of parameters is on the y-axis and number of epochs 
is on the x-axis) one can see the ANN 
uses approximately II parameters. 
This type of ANN eliminates the guesswork required in 
detemlining the number of neurons in the hidden layer, since no matter how large is the 
number of parameters 
in the ANN, the effective number of parameters should be the same. 
Bence, Bayesian regualization ANN avoids the problem of overfitting by too many 
parameters in the 
ANN. 
in the optimisation process there is a feedback mechanism between the model, whether it is 
ANN or regression one, and the optimisation algorithm. In this case an arbitrary value of 
100 was the starting point from which the optimisation algorithm queried the model as to 
the predicted response (y) and according to 
input from the model the optimisation algorithm 
decided on the next guess and so on. Figure 7.25 shows that the Bayesian regularisation 
model succeeded 
in predicting the five y values accurately but failed in the optimisation 
process since the 
final guess was the optimisation starting guess. It was suspected that 
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there might be flaw in the optimisation routine. Another possibility was that the ANN 
model did not succeed in generalising the data and just memorised the data, To check the 
generalisation ability the model was queried with values it was not trained on. From Figure 
7.26, the model predicted accurately the responses for the independent variable x values 
between 0.5 to 19.5 in increments of 1 (0.5,1.5, ... 19.5). Once the possibility for lack of 
generalisation ability was eliminated it was decided to check the extrapolation ability. The 
model was queried about the y values of the following independent variable x values: 60, 
70,80,90,100 and the responses it generated are given in Figure 7.27, they are 1333.9, 
1336.2,1336.6,1336.7,1336.7 respectively. Hence, the lack of optimisation ability is 
because the model could not extrapolate and not because of a bug in the optimisation 
algorithm. 
in order to help in the selection of the appropriate training algorithms, basic descriptions 
and highlights of Expha ANN training algorithms are given in this section and will also be 
incorporated with Expha. 
i3asic gradient descent - the simplest backpropagation training algorithm. It updates the 
weights in the direction of the negative of the gradient All the calculations of the 
derivatives (e. g. for calculation of the gradient) in all the training methods described in this 
section are with respect to the weights and biases. Detailed example of a calculation of 
feedforward and backward pass with this training method was given in the Background. It 
is slow training method. 
Gradient descent with momentum - this is the same method as previous one with added 
rnorrientum term. The momentum allows the ANN to respond not only to local trends in the 
error surface but also to recent trends in the error surface. Ille momentum can help in 
avoiding local n-dnima. This method 
is often faster than basic gradient descent and it too is 
explained in the Background. 
Adaptive learning rate - the performance of the algorithm is highly sensitive to the adequate 
setting of the learning rate. If the 
learning rate is too high the algorithm became unstable. If 
it is too low it will take long time for the algorithm to converge. The solution is in the form 
of variable learning rate that adapts 
its size according to the error surface. This training 
Inethod is faster than 
basic gradient descent and it is also explained in the Background. 
p, esilient Backpropagation (Riedmiller & Braun, 1993) - ANN usually use sigmoid transfer 
functions as activation functions. In this thesis two types of these functions were used (in 
the neurons of the hidden layer), one outputs value in the range of 0-1 and the other -1-1. 
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nese functions are 'squashing' functions since they compress an infinite input range to a 
finite output range. Hence, the gradient could have a small value so it will cause only minor 
changes in the weights and biases although much bigger changes are needed. ne aim of 
this training method is to eliminate this destructive learning effect caused by the size of the 
partial derivatives. It does so by taking into account only the sign of the derivative to 
determine the direction of the weight update. The magnitude of the weight change is 
determined by a separate parameter. If the derivative is zero there is no change in this 
parameter. Whenever the weights are oscillating the weight change will be reduced. If the 
weight is changed for several iterations in the same direction than the weight change will be 
increased. This algorithm is considered a fast one. 
The following algorithms are based on conjugate gradient algorithms (Hagan & Demuth, 
1996). The backpropagation algorithms adjust the weights in the steepest descent direction 
that is the negative of the gradient. This can cause the most rapid decrease in the error 
function but it does not necessarily produce the fastest convergence to a predefined NISE. 
In conjugate gradient algorithms a search is performed along conjugate directions. The 
learning rate determines the size of the weight update also termed as the step size. Usually, 
in a conjugate gradient algorithm the step size is adjusted in each iteration. The search for 
the optimal step size is done in the conjugate gradient 
direction (step size that will minimize 
the error function). In the first iteration there 
is a calculation of the negative of the gradient. 
po = -90 
Where go is the gradient in the first iteration. 
-fben there is a line search to determine the optimal distance to move along the current 
search direction. 
Xk+1 ` Xk+ akpK 
Where xkis a vector of current weights and biases and akis the leaniing rate. 
Then the next search direction is conjugate to previous search directions. The new steepest 
descent direction is combined with the previous search direction. 
Pk --"ý -9k 
+ PkPk-I 
Where 8kis a constant. The manner in which this constant is calculated differentiates the 
different conjugate gradient algorithms. 
The conjugate gradient algorithms are usually much faster than gradient descent with 
variable learning rate and sometimes 
faster than resilient backpropagafiorL 
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in the Fletcher Reeves conjugate gradient algorithm (Hagan & Demuth, 1996) the 
.8k 
constant value is the ratio of the norm squared of the current gradient to the norm squared 
of the previous gradient. 
in the Polak-Ribiere conjugate gradient algorithm (Hagan & Demuth, 1996) the fik constant 
value is the inner product of the previous change in the gradient with the current gradicnt 
divided by the norm squared of the previous gradient. It is impossible to say which one of 
these two conjugate gradient algorithms is better and their performance is considered 
sirnilar. 
powell-Beale conjugate gradient algorithm (Powell, 1977) differs from other conjugate 
algorithms in the reset point of the search direction. The conjugate gradient algorithms reset 
the search direction to the negative of the gradient (see in the first iteration described 
earlier) when the number of iterations is equal to the number of weights and biases. 7be 
criteria of resetting the search direction according to Powell-Beale conjugate gradient 
algorithm is 
I gTk., gk 
IZ0.2 11 gk 112 
Where gk is the current gradient. This expression checks if there is orthogonality left 
between the current gradient and the previous one. There are problems in which this 
algorithm is preferable on the Polak-Ribiere conjugate gradient algorithm. But it is difficult 
to predict a-priori on which problems it is better. 
Scaled conjugate gradient algorithm differs in that it is not performing a line search 
procedure that requires extensive computations. Each one of the conjugate gradient 
algorithms performs line search. A 
line search procedure evaluates the error goal for a 
given number of points, e. g. starting at certain 
distance and doubling it in each step along 
V,, ith the search direction. When the error goal 
increases between two successive points 
than the miniinum lies in the area between these two points. The size of the interval is then 
reduced and two new points are 
located between this minimum interval. The values of 
these points determine a section of the interval that can be discarded and a new point is 
placed within the new 
interval. This procedure is repeated till certain interval value is 
reached. This line search algorithm 
is called Golden Section Search (Hagan & Demuth, 
1996) but there are many other line search procedures. The line search requires the ANN to 
, Ompute 
the responses to all training inputs several times for each search. Moller (Moller, r 
1993) developed this Scaled conjugate gradient algorithm, that doesn't use the line search, 
in order to save computation time. This training algorithm may requires more iterations 
than the other conjugate gradient algorithms 
but the number of computations in each 
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iteration is much lower (less time to compute each iteration). 
The following two algorithms that will be described are Quasi-Newton algorithms. 
Newton's method is an alternative to the group of conjugate gradient algorithms. It is based 
on the following equation 
Xk+ I-A- 
Ak"I 9k 
Where xk is a vector of current weights and biases, gkis the current gradient and Akis a 
rnatrix of the second derivatives of the error function. Ibis matrix is called Hessian matrix. 
In comparison to the conjugate gradient group this method often show better results but it is 
rnuch more time consuming because of the need to compute the Hessian matrix. As an 
attempt to bypass this problem of computation a group of algorithms called Quasi-Newton 
Algorithms was developed that approximate the Hessian matrix by the use of the gradient. 
j3FGS algorithm (Dennis & Schnabel, 1983) - this quasi-Newton algorithm is considered 
the most successful one. BFGS are abbreviations for Broyden, Fletcher, Goldfarb and 
Shanno. This algorithm will usually converge faster than the conjugate gradient algorithm 
but it requires much more computation time at each iteration. As the number of weights 
and biases became larger it became much more time consuming to calculate the 
approximation of the Hessian matrix. Hence, this method is recommended for small ANN. 
]For the larger ANN (with more weights and biases) it is recommended to use resilient 
backpropagation or one of the conjugate gradient algorithms. 
one step secant algorithm (Battiti, 1992) - this algorithm is considered a compromise 
between the full quasi-Newton (also called secant) algorithm and the conjugate gradient 
a, lgorithm. It assumes that at each 
iteration the previous Hessian was the identity matrix. In 
addition to memory saving 
by doing so it also eliminates the need to compute a matrix 
inverse for the new search direction. The computation time is less than needed for the 
13FGS algorithm but more than the conjugate gradient algorithms. 
l, evenberg-Marquardt algorithm 
(Hagan & Demuth, 1996) - this method also tries to 
approximate the 
Hessian matrix. If the error function that is to be minimised is the SSE 
error function as all the 




,, Vhere IF is the Jacobian matrix which contains the first derivatives of the ANN errors, it 
is much simpler to compute the Jacobian matrix then to compute the Hessian matrix. The 
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gradient can be calculated as 
g =J'c 
where V is a vector of the ANN errors. The basis for the Levenberg-Niarquardt algorithm 
is the following equation: 
Xk+ I -'ý Xk - 
pT j+ýIj] -1 jT e 
Where xk is a vector of current weights and biases. Newton's method described earlier is 
best used near the error minimum. In big y values the training method became gradient 
descent with small step size. When u equals zero the training method became Newton's 
method with approximation of the Hessian matrix. Since the aim is to move towards 
Newton's method - if the SSE decrease there will be reduction in the u value and if the 
SSE increase there will be increase in theu value. As was mentioned before, in ANN of up 
to several hundreds weights and biases (moderate size ANN) this training method is 
considered the fastest one. 
i3ayesian regularization - this training method tries to minimise both the SSE and the 
number of weights (and biases) to generate an ANN topology (small as possible) that has 
good generalisation ability. The update of the weights and biases was done in Explia with 
the Levenberg-Marquardt algorithm (Bayesian regularization with Levenberg-Marquardt 
algorithm is discussed in Foresee & Hagan, 1997). The advantage of this ANN was 
demonstrated earlier (Table 7.1 demonstrates that it was the only ANN training method that 
could predict accurately the simple function) in that it eliminates the problem of 
inappropriate topology selection by the user. 
As was mentioned in section 7.4.3 (below Figure 7.12) there is not one definite ANN 
training method that is the best and should 
be used in all cases. It was also mentioned that 
the speed comparison of the algorithms 
is important, a subject that was also addressed 
previously in this section since the speed of the algorithm to converge to a desired MSE is 
very important property of the algorithm and one of the 
factors that should be considered 
vvhen selecting one. 
Speed is even more critical in view of the fact that in small number of 
experiments 
(that is usually the case) the most robust way to validate the model is the 
leave-one-out, which is very time consuming. Hence, it is recommended (in my view) to 
begin with the fastest algorithm that is the Levenberg-Niarquardt algorithm. If the 
validation results are not satisfactory then go 
to the Bayesian regularization method %%hich 
saves the time of 
finding adequate methodology. If either of the methods is not giving 
satisfactory validation results 
then try the other training algorithms. In any case it might be 
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useful to the user to read the short descriptions of each training method presented earlier (it 
will later be incorporated into the help menu of Expha), since they not only relate to training 
speed but also to other parameters like size of ANN and complexity of calculations. To 
avoid overfitting it is important to note that it might be useful to follow Kolmogorov's 
theorem (in all ANN training algorithms described earlier except Bayesian regularization) 
which states that twice the number of independent variables plus one is enough hidden 
neurons to model any function. Tables 7.1 and 7.2 show the usefulness of this guideline 
since it demonstrated inability of ANN that 
did not follow this guideline (the ANN used 
should have maximum of 2xI+I=3 
hidden neurons so 5 hidden neurons that were used 
lead to too complex ANN) to properly learn a simple equation. 
Since the expert system does not currently give details as to how one goes about developing 
an optimised formulation, the general approach to 
developing an optimum formulation is 
given below and will 
be at some stage be incorporated into the help menu of Expha. First, it 
is suggested looking in the "Example formulation" menu that 
has formulation examples 
from "Pharmaceutical Dosage Forms Tablets" (Lieberman, 1989) and "Physicians Dcsk 
Reference" (published by Medical Economics Company, Inc., 1997) which also has data on 
formulations but without the quantities of the excipients used or the process involved. One 
can also look in the 
"Select Excipients" form to see formulations that were already made in 
the past by the organization where the 
Expha was being used. There are other facilities that 
can give the user 
basic idea regarding the formulation like the "Advice" button or from the 
recommended excipient concentrations. 
The user then decides on which parameter he will 
focus and then implement an experimental design e. g. full factorial as Patel (Patel, 1996). 
Alternatively, he can enter into Expha 
formulations that were done in the past (%%ilich may 
of may not 
have followed an experimental design) with the aim to get optimised 
formulation on the basis of this limited data. 
Expha enables all the experimental variables to be stored for all the experiments as well as 
the measured properties. 
This data can then be used to develop a model in Expha using 
either regression or 
ANN and then to predict the optimum formulation. There are t, %%, o 
approaches to optimization: static and 
dynamic or sequential. With the static approach one 
defines number of experiments at the beginning. Typically this would employ a full 
factorial design as in Patel's data (Patel, 1996) and then one fits in regression a polynomial 
, quation. 
In ANN one would train the net as was done in earlier chapters in this thesis. 
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nen one should validate the model and optimise to get the optimum formulation. Ilic 
second approach is sequential and is based on the simplex method. Here you carry out a 
starting set of experiments and then the simplex identifies the next experiment and you 
carry on in this way sequentially. This approach is not yet implemented in Expha. 
-rbe process of building models and optimisation is the most sensitive (prone to 
programming errors) since it involves transferring data to the MATLAB" software, which 
acts as a calculation server to Expha, and receiving the calculated values from NIATLAB". 
14ence, correct communication between the programs is essential for success in the 
calculations. The algorithms for modelling and optimisation work correctly, in this case 
c, onimunication being essential between the two programs-the MATLAB" programs of 
ANN/regression models and the optimisation routine. The success of the modelling and 
C)ptimisation algorithm was verified 
by looking at the patterns of learning and optimisation 
and checking that they were reasonable. 
In this section comparison between Expha and other expert systems VAII be made. As 
opposed to Lai et al. (1996) capsule 
formulation expert system that contains many rules, 
F, "ha contains only few rules. As in Expha expert system, Lai and her co-workers (Lai, et 
al., 1996) utilised a database of excipients. Formulations are deduced automatically, 
whereas Expha only aids in 
formulating. In Expha one can see all the knowledge and in the 
capsule expert system there 
is no access to the database since sometimes, proprietary 
julowledge has been used. The programming language that Lai et al. (1996) used is C. Ibe 
programming language used to program 
Expha is Visual Basie for Applications and 
,, ýATLABI. Visual Basic" for Applications" was used to program everything connected to 
the database programming such as rules applied to the data and also for programming the 
user interface. MATLAB' was used 
for the computations involved in building models and 
Optinjisation routines. The user 
interface in Expha is more user friendly because a more 
suitable programming 
language was used for that purpose. Lai et al. (1996) stated that the 
eVert system 
is never completed since the user enters new knowledge all the time. The 
Sarne is true for 
Expha since the user in Expha can enter more excipients into the database 
or enter new information about current excipients. 
]gxpha was not built on an expert system shell (as was done by Rowe & Upjohn, 1993a) 
but was built with programming languages allowing the developer more flexibility. Expha 
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also used ANN but used optimisation techniques different ftorn genetic algorithm. ANN 
and genetic algorithms are incorporated into Cad/Chem, which is software used to build 
models and optimise formulations (Colbourn & Rowe, 1996). Expha also contains 
powerful model building and optimisation facilities. However, it also contains inherent 
database and expert knowledge as opposed to Cad/Chem. This unique combination is not 
used in any expert system. 
In the future Expha will also integrate a tablet coating phase, as opposed to the tabict 
coating expert system (Rowe & Upjohn, 1993a) that is a stand-alone expert system for 
solving tablet coating problems. The reason these two domains of tablet formulation and 
tablet coating were integrated into Expha stems from the concept that tablet coating is 
influenced by factors related to the formulation (i. e. to the core tablet). As an example of 
the latter issue, formulating with a lubricant with a melting point of 50*C and using 600C in 
the tablet coating process will mean pits in the tablet surface due to lubricant evaporation 
from the tablet surface. 
As in Expha, in Zeneca expert system (Rowe & Upjohn 1993b) for tablet formulation drug 
properties are entered into the 
database. It selects the excipients that are characterised by 
their functional category groups, as in Expha. The difference is that Expha does not select 
the exciPients automatically. Expha gives advice regarding the formulation excipients such 
as the inclusion or exclusion of certain 
functional category groups, for example sometimes 
it vAll state there is no need to select disintegrant. The advice is also in the form of 
inforrnation regarding excipients, e. g. the recommended concentratfon of the excipient, a 
factor that is influenced by the role of the excipient in the formulation (the same excipient 
could have several recommended concentrations 
depending on its role in the formulation). 
All the functional category groups that are included in Zeneca expert-system are present in 
F, 7Wha but Expha also contains an antihadherent group which has the role of preventing 
, ticking to the punch and the 
die wall (Lieberman et al., 1989). Both expert systems include 
a database on excipients. 
In Zeneca expert system as in Expha the user enters the measured 
tablet property results like 
disintegration time etc. In Zeneca expert system (Rowe & 
I. jpjohn 1993b) there is an iterative process of suggesting the formulation, comparing it 
V. rith the result and suggesting a new 
formulation (an on-line process). The parallel stage in 
F, xpha is collecting the 
input variables that could dictate, for example, several excipient 
concentrations 
in the formulation. Followed by collecting the measured properties of these 
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tablets with the different formulations. Then there is a model building process and 
according to the user constraints and goals, the computer suggests the optimised tablet 
formulation parameters. 
Regarding other expert system; in the Cadila expert system for tablet formulation (Ramani 
et al., 1992) the user enters drug properties as in Expha. As opposed to Expha there is no 
process of formulation optimýisation. 
The difference between Expha and other systems is that Expha is an open system that will 
be published. Expha is not a proprietary product. It will be useful for other academics to 
use it as a basis and to extend this work in Al and expert systems further. Ille next section 
will discuss the future prospects of Expha. 
NmTLAB' is an object-oriented language (Breiner, 1999) that was chosen carefully to be 
the environment for the intensive computations for ANN, optimisation and also for simple, 
fast regression calculations. The reason for this choice is explained with an emphasis on the 
future benefits. 
NlATLAB"' is much easier to program than other object-oriented languages like C++. C++ 
forces one to delve into programming and deal with messy issues like pointers, a subject 
that relates to the storage of data in computer memory. In MAT'LAD40 the programmer just 
thinks about the algorithm. After knowing logically how to solve a problem it is very easy 
to implement it in MATLAB* language. So any further developer of Expha will easily 
understand the code and 
develop new algorithms without any problem. There is also the 
benefit of a language that is easy to maintain. 
NiATLAB" Programs have been run on a cluster of PC's (Boskovitz et al., 1999). That 
17jearls, it is possible to run an 
ANN simulation on several PCs to reduce training time. 
This time saving is especially important if one wants to use the leave-one-out method as the 
validation method. MATLAB10 
has capabilities of data acquisition. It can communicate with 
a variety of off-the shelf 
PC-compatible data acquisition hardware (St. John-01cayto, 
1999). it means MATLAB" can read in data from machines like a tablet coating machine 
, and pass parameters 
like inlet air temperature directly to the database in Expha. 
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Iniplementation of the tablet coating process has begun. The conccpt behind this is that 
tablet coating is influenced directly by the formulation and by tablet properties. Tbe level of 
lubricant like magnesium stearate has an influence on the tablet contact angle, so it VAII 
irifluence the strength of adhesion of the coating layer to the tablet surface. Lubricant 
properties like melting point should be taken into account, the following example 
(mentioned earlier) demonstrates this. Stearic acid has a melting point of 5411C, when 
Czating with inlet temperature of 60T one can see holes in the tablet coating since the 
lubricant evaporates from the tablet coating layer. Another tablet coating problem is that 
vAth a hydrophilic drug tablet one has to choose a hydrophilic coating to allow hydrogen 
bonds with the tablet surface to be created. Otherwise, tablet surface and coating layer will 
repel each other. If a tablet property like friability is high it will cause coating problems. 
This is because in the coating process debris of powders will be created which sticks to the 
tablets, thus causing uneven 'orange peel' like coating. Another reason is that the coating 
rnaterial has difficulties to stick to the tablet 
because of abbrasion. The key to solving these 
types of problems is selecting the appropriate fields and to invoke according to values 
assigned to these fields appropriate routines, 
like a message box that advises the user 
regarding a specific situation. 
So the first step is to have the appropriate fields in the 
database. "Tablet Properties" form has to have friability (from the tablet coating point of 
view it is the most 
important tablet property since it influence the adhesion of coating layer 
to the tablet surface), excipients 
have to include fields for their melting point, and if they are 
by drophilic or hydrophobic. Tablet coating process parameters, like inlet air temperature, 
have to be included. After putting in the appropriate fields, an algorithm for invoking the 
appropriate action needs to 
be created. It could be a simple one showing only a photograph 
of the result of 
lubricant going out of the tablet coating (i. e. show impaired tablet coating) if 
, 
lubricant melting temperature is lower than inlet air temperature. Hence, it is Obvious the 
there is an advantage utilising the current 
database to implement a tablet coating stage. 
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7.7 Conclusions 
J-he expert system developed is a basic tool that can be a starting point for people new in 
the area of tablet formulation. A number of pharmaceutical rules where implemented, they 
help in process selection or in giving advice related to other areas. lie data itself is also 
useful for formulation, e. g. when an excipient is being chosen, Explia will present minimal 
and maximal concentrations that can 
be used as a guideline for the user. The parts of model 
building and optimisation could be practical also for experienced formulators. In that 
, respect, there was emphasis on the 
implementation of many training methods for the ANN 
and not just using simple backpropagation 
(it gives an advantage since different training 
algorithms could have different learning ability for the same data, as demonstrated in 
Chapter 4). In addition, there are various other parameters of the ANN that can be changed 
like ANN topology or criteria to stop training. All parts of the expert system were validated. 
In that respect special emphasis was given for the modelling and optimisation parts. In 
addition, the parts of 
data input and output like adding more excipients and retrieval of 
C. Xcipients' data or entering/retrieval of 
formulations were extensively tested and proven to 
work correctly. 
-rbe system incorporates new elements that are not available in other expert systems. Me 
system is built 
in a way that enables extension easily in two main paths. One path is the 
possibility to add more modules 
like module for tablet coating with its relevant rules. The 
second area that could 
be expanded is the addition of more rules, in that respect the 
problem is not a programming one 
but the data mining from the experts that could be used 
ill the form of rules and implemented in the expert system. 
, ro Summarise, Expha, a suitable tool for novice formulators was created. Expha can also 
be very useful for experienced formulators. 7be variety of features, the possibility to use it 
for data collection throughout the formulation development process, gives it a good chance 
of being useful 
for many formulators. Hopefully, it will broaden the knowledge of 
formulation development for many formulators and develop their creativity and ability to 
find adequate solutions for difficult formulation problems. 
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8. General Discussion & Closing 
Remarks 
-rhis concluding chapter looks again at the debate about superiority of ANN over traditional 
rnodelling methods. 
Some conclusions arrived at as a result of this work are presented. 
-1bere is a discussion of the issue of the ratio of the number of data points to number of 
unknown parameters 
(composed of bias and weights) in ANN. It also shows how the 
, regression modelling 
in this thesis is different from previous studies and how the 
comparison 
between ANN and regression differs from other studies. Issues such as 
topology selection and various other aspects 
from Chapters three, four and five will be 
discussed, tackling problems like whether it is preferable choosing ANN with output 
netirons representing all responses or 
just one output neuron representing only one response 
at a time. 
The optimisation routine employed on the tablet data (Chapter 6) will be 
discussed briefly. Expha expert system (Chapter 7) will be presented very briefly Vith 
, espect to several summarising 
issues. These include answers to questions; like - how 
V, xpha is different from other expert systems and what 
it is good for. Then difficulties in the 
, reat on 
of Expha follows and its future aspects are discussed. C 
The debate-which method is better to model data, regression or ANN, is a subject that 
, researchers 
in many fields are interested in. Veng-Pedersen & MOdi (1992) wrote an article 
VAth the provocative title: 
"Neural Networks in Pharmacodynamic Modelling. Is current 
r, 4odelling Practice of Complex Kinetic Systems at a Dead End? " One of the concluding 
P11rases of this article was 
ANN offer a challenging empirical based alternatim to any 
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cojýjplex multivariate kinetic system modelling aimed at predictions... This article brought 
criticism by Siegel (1992) who stated that ANN do not give insight to the science, they can 
c)nly be used as a tool to predict various phenomena. If scientists had this tool a long time 
ar '0 
it might be that since they could predict "ith ANN they would not bother to develop 
theories that would lead to building equations (used for predictions) describing the system 
under investigation and make progress in science. Hence, ANN can impair scientific 
progress if used instead of old methods. Siegel also had technical comments regarding the 
study presented in the article. Siegel noticed that ANN extrapolated in an incorrect manner. 
that there is a bias in ANN predictions since most of the ANN predicted values were above 
the observed values. Veng-Pedersen (1992) replied to Siegel's criticism and stated that 
ANN will not replace the current modelling techniques but when traditional modelling 
rnethods do not succeed ANN would 
be in use. It seems Veng-Pedersen was withdrawing 
his statements. 
In accordance with Siegel's opinion (1992) that statistical methods of inspecting model 
predictions should be used, this thesis used statistical techniques in Chapters four and five 
to analyse ANN and regression performance. In spite of the fact that we do not fully 
understand ANN 
it is not true that they are complete black boxes and that they do not give 
insight to the system. There are techniques that help us understand what happens inside 
ANN-4ike Hinton diagrams (Demuth & Beale, 1994) which illustrates the size of the 
weights between neurons 
(the strength of neuron's connections). Other techniques that give 
insight into ANN will probably be developed in future. ANN may predict phenomena we 
, do not 
fully understand but as ANN are better understood the phenomena that ANN can 
rnodel would 
be better understood. 
With many of the studies reviewed in the Introduction, sometimes the models chosen after 
validation phase are models with more weights than 
data-points. Probably the studies also 
, used bias terms 
(not always mentioned if bias terms were used or not) that can be 
, orisidered 
as weights with a constant input connected to them. There is a ntradiction C co 
between these results and the statement made in the Introduction (Hagan et al., 1996) that 
,, %ben there are more weights 
than data-points it should cause overfItting. Another point that 
could be seen 
in different studies and also in this thesis is that overtraining can cause 
Overfitting. It can be avoided 
by carefully monitoring the number of iterations as was done 
jr, this research in the tablets and capsules study (clearly demonstrated in the capsule 
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study). These questions with ANN suggest similar questions for regression such as, what is 
the parallel in regression to overtraining and is it possible in regression to build a model for 
which the number of unknown parameters is greater than the number of data points? These 
questions not being valid suggests that regression and ANN are two different methods in 
essence even to the mathematics behind them. In a personal communication with Prof 
Chris Bishop at the ANN summer school at Cambridge in 1997, he expressed the opinion 
that one could not say as a rule that overfitting would occur if ANN had more weights than 
datapoints. Only a validation step will assure the model is adequate. There are examples of 
ANN with much more weights than the number of data points and yet these ANN have 
gcýod generalisation ability. Fewer weights than number of data points seems to be more a 
, uideline 
than a rule. y 
-Ibis thesis reviewed studies like the one of Hussain et al. (1991) that not only did not 
Optimise the regression model using methods 
like stepwise regression but also did not try 
: Several models 
(like second order etc. ). Add to this the selection of the longest equation 
possible with the same number of parameters as the number of data points. Iley compare 
this regression model with ANN and stated that for their data ANN is the superior 
rnodelling method. 
As opposed to the latter type of studies it was shown in this study that 
, egression prediction performance could 
be improved by trying different models and 
, Mploying 
methods to optimise the regression equation. e 
The comparison between methods 
aimed to be as comprehensive as possible and to survey several aspects and not just to 
,, xarnine 
if ANN has lower NM than regression like Murtonie i et al. (1994a & 1994b). M e 
Additionally, as opposed to other studies, the MRE comparison was done by taking into 
account all the predictions of 
the validation sets (in the tablet's data it was composed of 27 
predictions 
for each response) of ANN and regression to test whether ANN was 
, tatistically 
better than regression. Looking only at the r 
MRE can be misleading. From the 
Clata of 
Ebube et al., (1997) the URE of the eleven ANN predictions (of percent drug 
dissolved after one hour) calculated, using the leave-one-out for validation, resulted in a big 
1, ý may lead to the conclusion that there 
is no predictive ability. The reason for this is the 
very big percent relative error 
in trying to predict the first data point relating to the slowest 
dissolved tablet: (ll. 7-0)/1l. 7xlOO=ll70*/* relative error. In this data point, polymer 2 
fraction was in its lowest value and polymer I fraction was in its highest value (they are the 
independent variables). This reveals a common problem of ANN, that is, the inability to 
arapolate. Hence, for both studies of tablets and ca sules, all percent relative error results ex p 
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frorn the best ANN and regression models were presented (to see if a few data points had a 
major influence on the MRE) and appropriate tests were conducted on these sets. 
In the introduction of this thesis (section 1.7.1.1) it was shown by examining Nlurtoniemi et 
al. (1994a) MRE data that even when MRE seems to be small it still does not show 
whether a successful predictive model was built. As a predictor to the Nlurtonicmi ct al. 
validation set, the average values of the granule size response were taken. Computing tile 
NjRE values of the validation set with this predictor gave better results than Nlurtoniemi et 
al. ANN/regression models. The suggestion of a predictive capability came from the fact 
that the data did not have much variability so the MRE would be low even if only die 
average value is taken as predictor. This study admitted it did not succeed in modelling all 
the responses in the capsule study. 
Ijussain et al. (1994) trained ANN on all the data as a method of selecting the best 
topology. In both studies of the tablets and capsules it was not possible to predict the 
()pfimised ANN (giving the best validation results) topology by training ANN on all the 
data. it was concluded that it is not possible to save computer time by omitting the phase of 
validation experiments on all topologies to choose the 
best one. 
-Ibe selection of ANN with one output neuron to present only one response (at a time) of 
the problem, instead of several outputs 
(to present all responses simultaneously) should be 
considered depending on the relation 
between the responses. In the capsule study 
, disintegration 
time was modelled alone and gave better predictions than ANN trained with 
a, ll responses. 
The tablets study showed the opposite. ANN trained with only the dissolution 
rate as a response showed 
inferior prediction ability to ANN trained with all eight 
, responses. 
This suggests that although training with only one output gives an advantage of 
reducing system complexity 
it is also a disadvantage of loss of information. That loss of 
information stems from the relationship 
between responses. Dissolution rate response is 
Iriore related 
to the other responses in the tablet study than the relation between 
disintegration time response and the other responses in the capsule study. 
In the tablets study ANN Predictions showed 
better correlation (than regression) to the 
observed values 
in the response of mean weight. Examination of NfRE results show ANN 
predicts 
better the extreme values of mean weight and dissolution rate responses. ANN 
237 
showed lower NM for the predictions of hardness, erosion friability and dissolution rate 
responses. However, this difference is not statistically significant. 
In the capsules study the responses that show lower MRE of ANN predictions relative to 
regression predictions (using simple linear models) are the minimum and maximum bulk 
density and disintegration time. For disintegration time response, regression predicted 
values show higher correlation to the observed values than ANN predicted values. As 
opposed to the tablet study, which shows high correlation between ANN and regression 
predictions in all responses, in the capsule study there is no correlation between ANN and 
regression predictions in disintegration time response. The ANN offers a completely 
different predictive alternative in the modelling of disintegration time response. However. 
one complicated regression model that was 
built showed (by its lower MRE relative to 
AW that the ANN had lower MRE in predicting disintegration time response due to lack 
of flexibility of the regression model. 
This regression model that was built arbitrarily just to 
verify one of the conclusions of the study 
(after the study was completed) also took into 
account square and 
interaction terms that gave it more flexibility relative to the simple 
lirlear regression equation. 
, Ibe improvement in ANN predictions, from using only simple backpropagation in Chapter 
3 to Chapter 4 where different learning algorithms were employed, showed it is worthwhile 
, ot just examining 
different topologies and number of epochs but also trying different 
, arning algorithms 
f le or ANN. The ANN did not show better predictions for limited data as 
opposed to 
Bourquin et al. (1998a), who showed ANN is much less sensitive than 
, gression 
to the organisational level of a trial design. Nevertheless, the tablets and capsules I-C 
, tudy show that 
it is worth using ANN because in different respects of these studies it can 
, 
ive better predictions. p 
14ad. this study used just one regression model, as some studies did, the conclusions of this 
, search would 
be that ANN is much better than regression for the prediction of so id Ire 
I 
, dosage 
form properties from well designed experiments as well as not so organised 
, Xperiments. 
However, this study gave a fair chance to regression and using various e 
'tatistical 
techniques showed regression also has its benefits and its worth using this r 
nic , thodology. 
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In regression, after programming the computer tries several models of regression equations 
and checking their validity by the leave-one-out method, each time the program runs a 
model and validates it, this process takes less than one minute. In ANN this process of 
testing numerous models and testing them by the leave-one-out method is a time. 
r, c)nsuming process. In fact, running different ANN models on the tablets and capsules data 
tcK)k several months for each one of the studies. In real life often there are time constraints, 
tiie formulator does not have too much time to build models (i. e. to train them). In this 
respect regression models are superior to ANN ones. Only RBF ANN, that proved to be 
the best models in part of the tablet's properties responses, are not much inferior than 
regression in the area of computation time. Testing RBF ANN with the leave-one-out 
rriethod took only several minutes. 
Another similarity between regression and RBF ANN is 
t1hat both of them, as opposed to ANN trained with backpropagation, yielded the same 
prediction results when the same specific model was trained for the second time. ne 
difference is because ANN trained with backpropagation have different starting random 
weights each time it is trained. In using RBF ANN 
it is important to monitor carefully the 
spread constant since a change 
in it can influence the ANN prediction ability. RBF ANN of 
the, type that neurons are added to the ANN until the sum squared error falls beneath an 
, rror goal 
or maximum number of neurons has been reached, showed better perfor ance Cm 
than the type where there are as many 
RBF neurons as there are input vectors. Hence, the 
,, Umber of neurons 
in RBF ANN is an important factor to be considered and the dynamic 
approach 
for selecting the number of neurons seems better than the rigid one. 
, Ibe concept of combining optimisation method, which was developed before ANN 
rnethodology 
began to spread, with the new modelling technique was employed in Chapter 
6 that optimised ANN trained on part of the tablet data- The ANN was trained only in 
, 
lation to the responses of impact friability and disintegration time. 71be same opfimi fi Ire sa on 
routine could 
have been applied with all responses but only two were chosen for the ease of 
, demonstration and 
explanation. The multiobjective optimisation algorithm of Gembicki 
( 1974) was employed. It was shown that trying to start the optimisation with the data point 
that shows the 
best responses is not a necessary criteria and starting with an arbitrary point 
,. Suited 
in the optimum point with even less time, employing fewer optimisation iterations. Ire 
It was also shown it is worthwhile using optimisation techniques since the optimised 
. Solution 
potentially had much better response values than the point of best responses 
.5e- 
However, only experimental results from a formulation 
, 
jected from experimental results 
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according to the optimised independent parameters could confirm the predicted responses 
()f tWs optimum formulation. As the validation results of the ANN, used in the optimisation 
routine, are better there is more chance the predicted optimised formulation, attained by die 
Optimisation routine, is reliable. 
An expert system, Expha, was created with a wide variety of options for model building 
and optimisation using regression and ANN. The concept of trying various ANN training 
algorithms and various regression models was implemented in Expha. Ibis unique diversity 
in backpropagation learning algorithms of ANN is not presented in any other soft%-arc 
package according to article by Bourquin et al. (1997a), which reviewed current ANN 
_software. 
Other learning algorithms like radial basis function ANN will be incorporated in 
the future, since it was shown they could predict better some of the responses and do this 
faster. 
][n Expha the user steps through the production process of collecting data that is used for 
building up models and optimisation. The system gives the user advice regarding the 
process and selection of 
formulation excipients. Algorithms for process selection were 
irnplemented using pharmaceutical knowledge necessary for its development. The selection 
of exciPients employed 
both an excipients database and implemented rules. There are also 
I rf,. ruIes of thumb and equations 
implemented in Expha. Expha's user inte ace Creates an 
, nvironment 
for creative formulation ideas and pushes the user to be more active in the e 
field of tablet formulation. 
]6ýWha does not suggest a 
formulation like other expert systems, but guides the formulator 
(S or a novice formulator) through the process of tablet formulation development, pod also f 
rno, ving one 
in the direction of trying several formulations, building models with them and 
,, Ptirnisafion. 
Behind Expha is the concept of educating formulators not to be confined to 
database of formulation solutions they 
have in their company. Instead, trying new 
,, X. Cipients, 
new formulation ideas with the old formulations for examples (accessed through 
xample Formulation" in the menu). Hopef the "lE ully, 
this software will educate formulators 
r1ot to give up 
if they fail to solve problems with methods that have been used to solve 
Pre, vious 
formulation problems. This software aims to encourage a creative process of 
, Olving 
tablet formulation problems. 
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To summarise, relevant articles in the field of solid dosage formulation wcre revicwcd. 
New approaches to modelling both ANN and regression were presented. Robust 
C: Ornparison between the methods was conducted using various statistical techniques. 
F, xpha expert system was designed based on a new concept. Its limitations and future will 
be discussed in the subsequent sections. 
yffriculties 
The most difficult problems with the ANN/regression models were how to choose network 
parameters like topology, and how to check the generalisation ability. In relation to the latter 
problem there was also the problem of lack of data resulting in leave-one-out experiments 
jjhat were time-consuming especially for backpropagation. Another problem was to resist 
being biased by previous articles which claim that ANN are better than regression to see 
objectively how regression and ANN stand relative to each other. 
It was difficult to envisage how this expert system would look in the end. It was not 
Clesigned by defining in advance the exact specifications of the product. The creation of 
F, xpha began by gathering many ideas that were thought to be relevant for tablet expert 
System. The next step was deciding how to implement these ideas into the system. Several 
times upon finishing the implementation of an idea a better way was conceived. Ibis meant 
implementing the idea in a completely different way beginning from scratch and trying to fit 
tile new ideas as good as possible to the target user, the pharmaceutical formulator. in 
, Ummary 
developing the flow of the program and the concepts was the most difficult part r 
]FoIr comparison with other expert systems there was attempt to gather information as much 
a, s possible on them. 
The best way of learning about software is trying it and looking at the 
documentation. But since these systems are very expensive it was not possible to finance 
the purchase of one. Even with the possibility to purchase one it is doubtful whether 
rnention is made 
in the program itself or in the documentation how these systems are built 
v; Wch is of major 
interest to any researcher wanting to develop new concepts in formulation 
ci e We , cision making. 
This problem was tackled by resorting to the literature (e. g. Ro & 
Roberts, 1998) which was also lacking a lot of details that were of interest to this research. 
, vertheless, 
the main concepts were included in the literature, which could be used as a -Ne 
source for comparison. 
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]Finally, although the programming for the creation of Expha was done in computcr 
languages that are considered easy ones, it was sometimes a difficult task. One of the main 
problems to resolve as a programmer was how to make the databases communicate %ith 
the optimisation routines. 
Future 
Regression is a reliable methodology, relatively simple to use with a history of many years 
of successful applications in pharmaceutical 
formulations field. Behind this method there is 
a robust statistical base. There 
has however been no significant evolution in this method 
and what was done 30 years ago 
by Schwartz et al., more or less is used by those using this 
; rnethodology today. 
Formulators with an old generation approach might prefer to stick to 
the old regression methodology since it gives more confidence. As opposed to regression, 
ANN is an evolving method with discrepancies yet to be resolved in its use. Various 
approaches have been suggested to reach the 
best ANN topology as well as other important 
ANN parameters. It could be quite difficult to use ANN in a manner that will give it an 
advantage over regression. 
There is a need to invest more time in learning this methodology 
in order to understand it. This is a more complex methodology than regression with much 
rnore possibilities. 
The scientific base of ANN is an extensive resource to research and it 
C , ontinues 
to evolve at magnificent speed in various fields. In the pharmaceutical 
forniulation field, only in the last ten years has usage in ANN begun. Probably studies that 
V, ill be published 
in a few years from now will put in an anachronistic light the recent 
studies in the 
field. There are more and more studies in the field of ANN for 
pharmaceutical 
formulation, so it is quite probable that many formulators that are up to date 
V., ith the literature will choose not 
to ignore this methodology Ile fact that well-kno%%m 
user-friendly statistical software 
like SPSS* has the possibility to add an ANN module 
irriplies a trend in the scientific and commercial world of embracing this methodology. This 
rriethodology 
is incoported into Expha expert system which its future aspects will be 
discussed in the next subsecfions. 
The data in the database of Expha is dependent upon its sources. For the recommended 
CýOrjcentrations of excipients, 
different books present different recommendations. Lieberman 
al. (1989) showed different recommended concentrations (f e or some of the excipicnts) 
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than the ones presented in the book "Handbook of Pharmaceutical Excipicnts" (Wade & 
Weller, 1994). This problem should be tackled in the future in trying to establish more 
rigorously these concentrations, maybe by using other sources including the update of die 
database by current articles. 
-1be algorithm of choosing the process did not take into account the possibility there could 
be several active ingredients. In the select excipients form however (employed in choosing 
the formulation), it is possible to choose several active ingredients. Choosing several active 
ingredients from active ingredients group does this. So, there is no problem saving data on 
formulations with more than one active ingredient. Trying to develop an algorithm for 
several active ingredients could 
be another path. There is a trend however, in the last few 
years to move toward medicaments with only one active 
ingredient. 
The forms that ask for data like those related to process variables, possibly do not take into 
account all parameters. And 
if one wants to do modelling of these parameters one necds to 
put them directly in the Microsoft Excel" sheets 
in the "Data Input" form accessed via the 
Optirnisation menu. This problem could 
be partly tackled in the future by trying to 
characterise better each process with the aim of 
documenting every possible parameter. 
, arding 
drug flow group in the drug properties form there is a need to establish a F , eg 
nurnerical value or range of values 
for flow which is the cut-off between poor flow and 
B ining this 
is necessary for the algorithm that is in use for process selection 
, ood 
flow. Def 
and could be a 
future task. This issue leads to another problem - what should be done in the 
'C 
dru ry ,, Ise where 
several values in the different fields related to g flow have contradicto 
V,,, Ilues. So one field result shows poor 
flow and measuring flow by another method does 
not show poor 
flow. It is possible it will be decided that the decision would be according to 
the worst flow value, or by establishing an index of several 
flow parameters like Caff's 
index. 
]gxpert systems are created 
for usage in numerous fields and examples currently in ordinary 
, Wspapers 
and not just in scientific articles in this field are quite fascinatin . 
be thought 
Ile gI 
t1lat computers might replace 
human experts seemed to be taken om science ic on fr f ti books 
till recently. Obviously, this 
field will continue to develop due also to the fact that the 
technologies that are associated with 
it like ANN are often related to the term artificial 
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intelligence, which continues to evolve rapidly. The general trend in this dircction will 
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10. Appendix A 
TWs appendix gives details regarding the regression equations coefficients for the tablet 
data with their statistics (Table 10.2) along with analysis of variance F-test %vith regard to 
the overall best regression equations 
(Table 10.3). In addition, to give estimate of die 
rnagnitude of differences within the replicates of 
the tablet data (Patel, 1996), standard 
deviations of the replicates are given in Table 10.1. 
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Table 10-1: Standard deviations of the tablet data. 
Lu. Di. Fo. j Weight Thickn. Hard. Tensile Er. Fr Im. Fr Disint. Dissol. 
0.25' 5 6 _ 0.004 0.04 0.28 28.11 0.180 0.070 26.8 1.00 
0.25 2 6 0.004 0.03 0.43 39.88 0.032 0.053 27.3 3.13 
0.25 1 6 0.004 0.04 0.45 41.61 0.046 0.005 19.0 5.72 
0.50 5 6 0.004 0.03 0.28 26.01 0.034 0.160 26.8 1.22 
0.50 2 6 0.003 0.03 0.35 31.85 0.934 0.284 24.1 0.23 
0.50 1 6 0.003 0.04 0.39 36.04 0.035 0.102 17.9 5.24 
1.00 5 6 0.004 0.04 0.19 18.73 0.137 0.089 24.6 3.41 
1.00 2 6 0.004 0.03 0.36 32.69 0.176 0.123 8.7 3.66 
1.00 1 6 0.003 0.04 0.28 26.21 0.046 0.035 18.0 1.55 
0.25 5 12 0.002 0.02 0.36 38.11 0.039 0.028 2.2 3.57 
0.25 2 12 0.002 0.02 0.87 91.03 0.053 0.100 0.5 3.97 
0.25 1 12 0.001 0.03 0.84 86.47 0.053 0.116 1.5 4.13 
0.50 5 12 0.003 0.04 0.43 43.42 0.052 0.249 1.2 4.64 
0.50 2 12 0.002 0.03 0.56 58.00 0.033 0.075 1.9 1.78 
0.50 1 12 0.002 0.03 0.54 55.03 0.207 0.240 0.5 4.04 
1.00 5 12 0.001 0.02 0.33 31.73 0.058 0.057 5.5 1.50 
1.00 2 12 0.002 0.04 0.63 62.08 0.078 0.061 7.9 1223 
1.00 1 12 0.106 0.03 0.75 74.39 0.240 0.220 2.8 0.28 
0.25 5 20 0.003 0.02 1.31 146.15 0.055 0.024 18.8 3.80 
0.25 2 20 0.003 0.04 0.77 80.70 0.023 0.043 8.2 4.22 
o. 25 1 20 0.004 0.03 1.52 161.43 0.037 0.015 8.7 2.81 
0.50 5 20 0.005 0.03 0.93 103.93 0.206 0.146 16.0 2.68 
(). 50 2 20 0.002 0.02 0.68 75.53 0.023 0.041 5.6 2.49 
0.50 1 20 0.002 0.03 0.36 39.54 0.052 0.024 5.5 3.24 





20 0.002 0.03 1.17 122.27 0.046 0.106 4.3 3.51 
1.00 1 20 0.003 0.03 0.79 
1 84.95 0.007 0.017 11.1 0.82 
140te. The first three columns represent the 
independent variables that are lubricant (0/6), 
disintegrant N and compaction force (kN). The compaction force values given here are 
approximate values 
for ease of presentation (the exact compaction force values are 
presented in 
Table 3.1). Columns 4-11 represent the responses that are mean weight (mg), 
thic ty (0, , jaless (mm), 
hardness (kg), tensile strength (W/m2), erosion friabili Vo) impact 
, riability 
(0/o), disintegration time (seconds) and dissolution rate (k, mg/n f -dn) respectively. 
The rnethods of generating the best regression equations were repeated on the raw data 
(unscaled data). The regression coefficients of these regression equations are given in Table 
10.2. The chosen methods for generating the best regression equations are given in Table 
The MIKE for each response was similar to the ones generated when using scaled data. 
an example how to read the 
data in Table 10.2, looking in the third row of thickness 
, esponse, the coefficient value, which 
represents square term of compaction force is 
0.0038. The standarized coefficients are scaleless unlike the coefficients (unstandardizcd). 
, Mey make it more feasible to compare coefficients estimates since the units are the same. 
, calculation of 
the standardized coefficient is done according to the following equation The 





St where aj is the standardized coefficient, a, is the regression coefficicrit (unstandardizcd), 
sx, and sy are the standard deviations of the xj and y values, respectively. 
Table 10.2: The coefficients of the best regression models for the tablet data. Ilic 
abbreviafions "Lu", "Di" and "Fo" stand 
for lubricant, disintegrant and compaction force 
respectively. 
Unstandardized Standardized t Sig. 
Coefficients Coefficients 
MeTn -Welght (mg) 
(constant) 611.2301 127.0333 0.0000 
Di -4.3175 -0.5849 -4.0241 0.0005 
Lu 15.6349 0.3885 2.6733 0.0133 
Thickness (mm) 
(Constant) 6.4217 90.1906 0.0000 
Fo -0.1587 -2.4778 -13.5102 0.0000 
FoFo 0.0038 1.5557 8.4834 0.0000 
Di -0.0370 -0.1743 -6.5580 0.0000 
LU 0.1688 0.1458 5.4846 0.0000 
uý,, Aness (ka) 
ý-constant) -1.9430 -2.1720 0.0410 
Fo 1.2090 2.1470 7.2990 0.0000 
FoFo -0.0161 -0.7580 -2.7000 0.0130 
LuFo -0.9120 -1.5290 -4.3860 0.0000 
LuLuFo 
0.6350 1.2050 3.9560 0.0010 
ile =Strength (kN/m2) s Týen 
1- 
n s (Co 
J 
(constant) -246.0100 -2.5130 0.02E 0 
FO 126.4680 
1.9410 6.9790 0.0000 
FoFo -1.3890 -0.5660 -2.1330 0.0440 
LuFo -98.4460 -1.4270 -4.3300 0.0000 
LuLuFo 




2.8019 21.6104 0.0000 
FO -0.2010 -2.1580 -7.5016 0.0000 
LuLu 
0.5499 0.4241 4.3086 0.0005 
[)iDi 
0.0366 0.7442 4.8039 0.0002 
FoFo 0.0036 
1.0339 3.0973 0.0065 
DiFo -0.0277 -1.4560 -4.0133 0.0009 
E)iDiFo -0.0018 -0.5250 -2.1514 0.0461 
FoFoDi 0.0014 
1.5208 4.4118 0.0004 
LuLuFo -0.0631 -0.7238 -3.1463 0.0059 
FoFoLu 0.0029 
0.6157 2.9754 0.0085 
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Table 10.2 (cont. ): The coefficients of the best regression models for the tablet data. Ilia 
abbreviations "Lu", "Di" and "Fo" stand for lubricant, disintcgrant and compaction force 
respectively. 
Unstandardlized Standardized t Sig, 
Coefficients Coefficients 
Imp; -ct -Friability 
(Constant) 3.3407 14.5096 0.0000 
Lu 1.6736 0.7398 4.9678 0.0001 
Fo -0.2648 -2.1166 -6.6041 0.0000 
DO 0.0260 0.3938 4.1753 0.0006 
FoFo 0.0058 1.2300 3.6959 0.0017 
LuFo -0.2439 -1.8415 -4.0851 0.0007 
DiDiFo -0.0035 -0.7836 -3.5376 0.0024 
FoFoDi 0.0006 0.5275 2.8137 0.0115 
FoFoLu 0.0087 1.3904 3.8530 0.0012 
DisIntegrabon Time (sec) 
(Constant) 84.1923 4.6270 0.0003 
Fo -8.7495 -1.6689 -4.3139 0.0005 
FoFoFo 0.0261 2.9011 8.7638 0.0000 
FoFoDi 0.1324 2.5718 5.1700 0.0001 
Di 101.3963 5.8303 8.5388 0.0000 
DiFo -9.9003 -9.2606 -9.1592 0.0000 
FoFoLu -0.5246 -1.9980 -3.7620 0.0017 
Lu -113.2919 -1.1950 -5.4330 0.0001 
LuFo 17.3993 3.1344 4.7175 0.0002 
DiDiFo 0.7949 4.2168 6.1766 0.0000 
DO -10.0808 -3.6412 -5.6530 0.0000 
[)issojutioýný Rate (k, mg/min) Dls: 'o 
E 
t) t) Constant) 
[ 
( 75.6391 12.1304 0.0000 
Di -28.1757 -1.9849 -5.1773 0.0001 
LuLu 76.1373 1.2782 6.6664 0.0000 
DiFo 3.3462 3.8347 3.6615 0.0017 
LuDiFo 1.1977 1.0191 2.6134 0.0171 
LuLuDl -15.5719 -0.9559 -2.9441 0.0083 
FoFoDi -0.0996 -2.3707 -3.0872 0.0061 







To test the utility of the regression models, analysis of variance F-tcst was conductcd. Ilia 
values of this test are presented with their significance values in Table 10.3. In multiple 
regression when many independent variables are tested for inclusion in the model, it can be 
useful doing this test since it might be that important variables were omitted and non 
significant ones were entered. The chance that this will happen increases as the number of 
statistical tests increase. The null hypothesis of this test is that all the cocflicicnts of die 
regression equation are equal to zero. The test statistic used to test this null hypodiesis is 
based on the multiple coefficient of determination Rý (defined in die Background ch3ptcr) 
which is presented in Table 10.3. As the coefficient of determination becomes large die F. 
test statistic becomes large. The F-test statistic can be calculated from the equation 




(k + 1)] 
Where R2 is the multiple coefficient of determination, n is the number of data points and k is 
the number of parameters in the model not including the constant. 
Table 10.3: Analysis of variance F-test for the best regression equations of the tablet data. 
R F Sig. 
Mean weight 0.493 11.670 0.05-0 
Thickness 0.984 348.940 0.000 
Hardness 0.964 145.980 0.000 
Tensile strength 0.968 163.953 0.000 
F-rosion friability 0.991 197.088 0.000 
Impact friabilitY 0.992 270.027 0.000 
Disintegration time 0.983 92.909 0.000 
Dissolution rate 0.8491 15.2191 0.0001 
263 
11. Appendix B 
This appendix gives details regarding the regression equations coefficients for the capsule 
data with their statistics (Table 11.1) along vAth analysis of variance F-tcst with rcgard to 
the overlI best regression equations (Table 11.2). 
-fbe coding system of 0/1 for dummy variables, described in section 5.2.2, did not generate 
better models than ones generated using arbitrary values for 2 dummy variables. For 
example, the best regression equation, which utilised 0/1 coding system for modelling of 
the qualitative variables and used stepwise regression as a method of variable sclection, 
generated NM of 2.75 for the prediction of Hausner's ratio. 
264 
Table IM: The coefficients of the best regression models for die capsule data. ilia 
independent variables that were used in the regression equations are drug particle size 
(Dp), drug solubility D (Ds), filler type (Ft), disintegrant type (Dt), disintegrant level (DI). 
lubricant level (LI), glidant level (GI), and drug concentration (Dc). 
Unstandardized Standardized t Sig. 
Coefficients Coefficients 
Minimum bulk density (gcm'; ) 
(constant) 0.648791 0.026143 24.816994 0.000000 
DP 0.001406 0.000157 8.950400 0.000000 
IDS 0.000212 0.000088 2.420902 0.023412 
Ft -0.032534 0.002867 -11.349121 0.000000 
Dt 0.000025 0.000006 4.175655 0.000338 
Ll -0.016000 0.010237 -1.562933 0.131160 
GI -0.036000 0.010237 -3.516599 0.001768 
Dc -0.002533 0.000341 -7.423931 0.000000 
Maximum bulk density (gcm-l 
(constant) 0.997981 0.043299 23.048694 0.000000 
Ft -0.042028 0.005660 -7.424836 0.000000 
Dc -0.002733 0.000679 -4.026723 0.000391 
DP 0.001092 0.000310 3.526091 0.001473 
GI -0.070000 0.020364 -3.437446 0.001854 
Hausner's ratio 
(constant) 1.613693 0.039385 40.971888 0.000000 
Dp -0.001973 0.000520 -3.795009 0.000696 
Ft 0.019368 0.009498 2.039187 0.05D637 
Dt -0.000052 0.000020 -2.578232 0.015275 
Carr's compressibility index 
TC-onstant) 34.384646 2.895990 11.873193 0.000000 
Dp -0.096018 0.021834 -4.397533 0.000144 
Ft 0.792106 0.398867 1.985889 0.056916 
Dt -0.002178 0.000849 -2.565153 0.015960 
Dc 0,081133 0.047544 1.7D6476 0.098989 
Disiýntegration time (min) 
(C on st an 
-t) 
F 
1.313391 4.692749 0.279877 0.782310 
Ft -3.814256 0.777733 -4.9D4326 0.000075 
Dt 12.308513 5.174786 2.378555 0.026949 
DI -2.742072 1.154526 -2.375064 0.027149 
Li 2.920000 0.683636 4.271282 0.000340 
DpDp -0.000320 0.000075 -4.293051 0.000322 
FtFt 0.537490 0.120571 4.457876 0.000217 
DtDt -1.596467 0.657499 -2.428090 0.024251 
DCDC 0,000525 0.000156 3.362167 0.002948 
DO 0.001499 0.000686 2.184793 0.040382 
DpDS 0.000651 0.000148 4.391427 0.000255 
UGI 1 -1.280000 0.483403 -2.647893 0.015D47 
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Table 11.2: Analysis of variance F-test for the best regression equations of die capsule 
data. 
R' F Sig. 
Minimum bulk density 0.932 41.110 0.000 
Maximum bulk density 0.781 24.999 0.000 
Hausners ratio 0.490 9.283 0.000 
Carr's compressibility index 0,562 9- 000 0.000 
IDisintegration time 1 0.8271 9.1181 
1 
0.000 
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